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Abstract  
Bacterial microcompartments are isohedral structures composed entirely of protein and contain a 
2-4 nm thick proteinaceous shell. This shell encases enzymes which act in a sequential manner to 
carry out a specific metabolic reaction. There are seven essential shell proteins encoded on the 
propanediol utilization microcompartment (Pdu) operon, Pdu  ?A  ?B  ? ?  ?J  ?K  ?N and  ? U, each 
having a critical role in the formation of the compartment.  Other genes in the Pdu operon interact 
to form enzymes in the metabolic pathway with some having unknown functions such as PduV 
which has been shown to form filament-like structures. These filaments only appear in the presence 
of microcompartments and often co-localise with them and it is thought that PduV plays a role in 
the spatial distribution of microcompartments. This study has explored the interaction between 
PduV and the microcompartment shell. The shell protein involved in this interaction is thought to 
be PduK, and to characterise the mechanism of this interaction PduK truncations were generated 
and novel microcompartments containing these truncations were engineered. The ability of these 
microcompartments to form was examined, as well as the ineraction between PduV and these 
truncated forms of PduK. Filament formation of the small GTPase, PduV, was studied by site 
directed mutagenesis of the GTP binding site, which was then examined by microscopic and 
biochemical approaches. In addition, to further characterise how microcompartments form each 
individual shell protein was tagged with mCherry. Microscopy techniques such as live cell imaging 
and transfer electron microscopy were used in order to determine if these novel compartments 
were able to form correctly, if PduV filament formation was affected in any way and whether this 
subsequently had an effect on the distribution of microcompartments within the bacterial cell. The 
work presented has given insight into the formation of the microcompartment shell, higlighting the 
sensitivity of individual shell proteins to minor modifications such as fluorescent tagging and the 
effect this can have on the formation of the shell. It has also revealed possible previously 
undiscovered regulatory mechanisms of shell proteins on PduV filament formation and length, with 
the modification of shell proteins affecting PduV filaments. Finally, it has given greater evidence to 
previous suggestions that PduV may be a GTPase. 




No part of this thesis has been submitted in support of any other application for a degree or 
qualification of the University of Kent or any other University or institution of learning. 
All work is my own based on research conducted during my PhD. 
 
 
Sarah Packwood 17-3-2017 
 
  
iv | P a g e  
 
Contents 
Abstract ............................................................................................................................................... ii 
Figures ................................................................................................................................................ ix 
Tables ................................................................................................................................................. xi 
Abbreviations .................................................................................................................................... xii 
Chapter 1- Introduction ...................................................................................................................... 1 
1.1. An Introduction to Bacterial Microcompartments .................................................................. 2 
1.1.1. An Overview of Studied Bacterial Microcompartments ................................................... 4 
1.1.2. The Bacterial Microcompartment Shell ............................................................................ 5 
1.1.3. Protein Pores, Molecular Transport and Selective Permeability; Properties of the 
Protein Shell ................................................................................................................................ 6 
1.1.4. A Synthetic Approach to BMCs ......................................................................................... 8 
1.2. Carboxysomes .......................................................................................................................... 9 
1.2.1. The Carboxysome Pathway ............................................................................................. 10 
1.2.2. Alpha and Beta-Carboxysomes ....................................................................................... 12 
1.2.3. Carboxysome Function ................................................................................................... 13 
1.2.4. The Carboxysome Operon .............................................................................................. 15 
1.2.5. The Carboxysome Shell Structure ................................................................................... 16 
1.2.6. The Assembly of Carboxysomes ..................................................................................... 17 
1.3. Ethanolamine Utilisation Microcompartments ..................................................................... 20 
1.3.1. The Eut Pathway ............................................................................................................. 21 
1.3.2. The eut Operon ............................................................................................................... 22 
1.3.3. The Eut Shell .................................................................................................................... 22 
1.3.4.  Eut Metabolosome Function .......................................................................................... 25 
1.4. Propanediol Utilisation Microcompartments ........................................................................ 26 
1.4.1. Ecology of 1,2-PD degradation ........................................................................................ 27 
1.4.2. The pdu Operon .............................................................................................................. 27 
1.4.3. The Pdu Pathway ............................................................................................................ 28 
1.4.4. The Function of Pdu Microcompartments ...................................................................... 31 
1.4.5. Enzymology and Composition of the Pdu BMC .............................................................. 31 
1.4.6. Formation of the Pdu BMC ............................................................................................. 33 
1.4.7. The Pdu Shell ................................................................................................................... 34 
1.4.7.1. PduA ......................................................................................................................... 36 
1.4.7.2. PduB ......................................................................................................................... 38 
1.4.7.3. PduJ .......................................................................................................................... 40 
1.4.7.4. PduK ......................................................................................................................... 40 
1.4.7.5. PduN ......................................................................................................................... 41 
1.4.7.6. PduT ......................................................................................................................... 42 
v | P a g e  
 
1.4.7.7. PduU ......................................................................................................................... 43 
1.4.7.8. PduM ........................................................................................................................ 44 
1.5. Recombinant Pdu studies ...................................................................................................... 45 
1.5.1, Targeting Proteins to the Compartment ......................................................................... 47 
1.5.2. Targeting Pathways to the Pdu BMC .............................................................................. 48 
1.6. The Spatial Organisation of Pdu BMCs .................................................................................. 48 
1.6.1. An introduction to PduV, Structure and Function .......................................................... 49 
1.6.2. PduV interactions ............................................................................................................ 50 
1.6.3. Putative GTPase activity .................................................................................................. 50 
1.7. Aims........................................................................................................................................ 51 
Chapter 2: Materials and Methods ................................................................................................... 52 
2.1. Materials ................................................................................................................................ 53 
2.1.1. Chemicals ........................................................................................................................ 53 
2.1.2. Bacterial Strains .............................................................................................................. 53 
2.1.3. Plasmids .......................................................................................................................... 54 
2.1.4. Primers ............................................................................................................................ 56 
2.1.5. Media and solutions for bacterial work .......................................................................... 58 
2.1.6. Media and solutions for DNA work ................................................................................. 59 
2.1.6.1. Solutions for immobilized metal ion affinity chromatography (IMAC) .................... 59 
2.1.6.2. Solutions for BMC isolation ...................................................................................... 60 
2.1.6.3. Solutions for protein SDS-PAGE ............................................................................... 60 
2.1.6.4. Composition of SDS gels .......................................................................................... 62 
2.1.6.5. Solutions for Western Blot ....................................................................................... 62 
2.2. Microbiological methods ....................................................................................................... 63 
2.2.1. Sterilisation ..................................................................................................................... 63 
2.2.2. Bacterial Growth ............................................................................................................. 63 
2.2.2.1. Plate cultures ........................................................................................................... 63 
2.2.2.2. Liquid Cultures ......................................................................................................... 63 
2.2.3. Preparation of competent cells ...................................................................................... 64 
2.2.4. Transformation of competent cells ................................................................................ 64 
2.2.5. Production of recombinant protein ................................................................................ 64 
2.2.6. Lysis of Bacteria ............................................................................................................... 65 
2.2.6.1. Sonication of cells .................................................................................................... 65 
2.2.6.2. YPER treatment of cells ............................................................................................ 65 
2.2.7. Protein Purification ......................................................................................................... 65 
2.2.7.1. Nickel Column .......................................................................................................... 65 
2.2.7.2. Microcompartment purification using YPer Plus ..................................................... 66 
2.3. Molecular Biological Methods .......................................................................................... 67 
vi | P a g e  
 
2.3.1. PCR reactions .................................................................................................................. 67 
2.3.1.2. Overlap Mutagenesis PCR ........................................................................................ 68 
2.3.2. Electrophoresis of DNA ................................................................................................... 69 
2.3.3. Isolation and purification of a DNA fragment ................................................................. 69 
2.3.4. Isolation of plasmid DNA................................................................................................. 69 
2.3.5. Ligation of DNA ............................................................................................................... 70 
2.3.6. Restriction digest of DNA ................................................................................................ 70 
2.3.7. Cloning into vectors ........................................................................................................ 70 
2.3.7.1. Link and Lock method .............................................................................................. 70 
2.4. Biochemical methods ............................................................................................................. 71 
2.4.1. Bradford assays ............................................................................................................... 71 
2.4.2. GTPase Assay .................................................................................................................. 71 
2.5. Imaging analysis ..................................................................................................................... 71 
2.5.1. Live cell imaging .............................................................................................................. 71 
2.5.1.1 Design of FRET Experiments to Explore the  Interaction Between PduV and PduK . 72 
2.5.2. TEM conventional ........................................................................................................... 73 
2.5.2.1. Preparation of samples ............................................................................................ 73 
2.5.2.2. Sectioning and visualisation of samples .................................................................. 74 
2.5.3. TEM immuno-labelling .................................................................................................... 75 
2.5.4. AFM ................................................................................................................................. 76 
Chapter 3: Exploring possible interactions between the PduK and PduV ........................................ 77 
3.1. Introduction ........................................................................................................................... 78 
3.2. Results .................................................................................................................................... 79 
3.2.1. Cloning of fluorescent tag-fusions .................................................................................. 79 
3.2.1.1. Cloning pduV-cerulean ............................................................................................. 80 
 .................................................................................................................................................. 80 
3.2.1.2. Cloning pduK fusion tags .......................................................................................... 81 
3.2.1.3. Cloning pduK fusions at the end of the Pdu BMC construct .................................... 81 
3.2.1.4. Integration of pduK-ypet with genes for the BMC shell. ......................................... 83 
 ...................................................................................................................................................... 84 
3.2.2. Microscopy analysis to characterise a proposed interaction between PduK and PduV 84 
3.2.2.1. Visualisation of the PduV-Cerulean fusion tag with Pdu BMC shells ....................... 85 
3.2.2.2. The effect of fusing Ypet to PduK on BMC formation and interaction with PduV-
Cerulean by live cell imaging ................................................................................................. 87 
3.2.2.3. Exploring possible interactions between PduK and PduV by live cell imaging ........ 91 
3.2.2.4. The formation of the BMC shell with tagged PduK.................................................. 92 
3.2.3. Analysis of the role of PduK in the BMC shell ........................................................... 94 
vii | P a g e  
 
3.2.3.1. Co-ůŽĐĂůŝƐĂƚŝŽŶďĞƚǁĞĞŶƚŚĞƐŚĞůůĂŶĚWĚƵs ?ĞǆƉůŽƌŝŶŐƚŚĞƌŽůĞŽĨWĚƵ< ?ƐƌŽůĞŝŶ
this interaction ...................................................................................................................... 95 
3.2.3.2. BMC shell formation in BMCs lacking PduK ............................................................. 97 
3.2.5. Recombinant BMCs with PduK C-terminal truncation variants ...................................... 98 
3.2.5.1. Cloning pduK truncations with the genes necessary for shell formation in a 
recombinant system ............................................................................................................. 99 
3.2.5.2. Fluorescence microscopy of BMCs containing truncated variants of PduK co-
expressed with PduV-Cerulean ........................................................................................... 100 
3.2.5.3. Filament length analysis ......................................................................................... 102 
3.2.5.4. TEM analysis to determine if truncated PduK BMC variants form intact 
compartments ..................................................................................................................... 105 
3.3. Discussion ............................................................................................................................. 108 
Chapter 4: Effect of mCherry fusions on BMC formation and the interaction with PduV ............. 110 
4.1. Introduction ......................................................................................................................... 111 
4.2. Results .................................................................................................................................. 114 
4.2.1. Cloning of individual fluorescently tagged shell proteins ............................................. 114 
4.2.1.1. PduA ....................................................................................................................... 115 
4.2.1.2. PduB ....................................................................................................................... 116 
4.2.1.3. PduJ ........................................................................................................................ 116 
4.2.1.4. PduN ....................................................................................................................... 117 
4.2.1.5. PduU ....................................................................................................................... 117 
4.2.2. Optimisation of protein production .............................................................................. 117 
4.2.2.1. Effect of plasmids on protein production .............................................................. 118 
4.2.2.2. Protein expression after induction ........................................................................ 123 
4.2.2.3. Effect of expressing BMCs in strains also containing an empty pLysS plasmid ..... 130 
4.2.2.4. Effect of plasmids on BMC purification ................................................................. 132 
4.2.3. Optimisation of the purification protocol ..................................................................... 137 
4.2.3.1. Effect of growth temperature ................................................................................ 137 
4.2.3.2. Minimisation of protein loss in Pellet 2 ................................................................. 140 
4.2.3.3. Optimisation of BMC visualisation by TEM ............................................................ 140 
4.2.4. The formation of mCherry-Tagged PduB BMCs ............................................................ 144 
4.2.4.1. BMC purification as an indication of correct formation ........................................ 144 
4.2.4.2. Insights into the morphology of tagged-PduB BMCs by TEM and live cell imaging
 ............................................................................................................................................ 146 
4.2.5. Effect of tagging shell proteins with mCherry on BMC shell formation ....................... 149 
4.2.5.1. Live cell imaging of whole cells at time points ....................................................... 149 
4.2.5.2. TEM of whole cells at time points .......................................................................... 153 
4.2.5.2.1. mCherry-tagged PduA ..................................................................................... 153 
4.2.5.2.2. mCherry-tagged PduJ ...................................................................................... 154 
viii | P a g e  
 
4.2.5.2.3. mCherry-tagged PduN .................................................................................... 158 
4.2.5.2.4. mCherry-tagged PduU .................................................................................... 159 
4.2.8. Immuno-gold labelling of thin sections of whole cells and isolated BMCs ................... 159 
4.2.9. Co-expression with PduV-Cerulean .............................................................................. 162 
4.2.9.1. Live cell imaging results of PduV with each tagged shell protein .......................... 162 
4.2.9.2. PduV filament length analysis ................................................................................ 170 
 ........................................................................................................................................................ 172 
 ........................................................................................................................................................ 173 
4.2.10. Analysis of PduV with as, aBj, abjk, abjkn, abjknu, microscopy results ...................... 173 
 ........................................................................................................................................................ 175 
4.3. Summary .............................................................................................................................. 175 
Chapter 5: The Characterisation of PduV ....................................................................................... 179 
5.1. Introduction ......................................................................................................................... 180 
5.2. Results .................................................................................................................................. 182 
5.2.1. Purification of Recombinant PduV ................................................................................ 182 
5.2.1.1. Optimisation of PduV Purification ......................................................................... 183 
5.2.2. Investigating the ability of PduV to Form Filaments in vitro ........................................ 185 
5.2.2.1. Exploring PduV Polymerisation by Sedimentation Assays ..................................... 187 
5.2.2.2. Mutagenesis of Suspected GTPase Residues Within PduV .................................... 188 
5.2.2. Putative GTPase activity analysis of Purified PduV ............ Error! Bookmark not defined. 
5.2.2. Exploring the Presence of PduV Filaments by TEM ...................................................... 195 
5.2.1.1. Thin Section Analysis of Cells Expressing PduV...................................................... 195 
5.2.2.2. Immuno-gold TEM of Cells Expressing PduV ......................................................... 196 
5.3. Summary .............................................................................................................................. 197 
Chapter 6: Summary ....................................................................................................................... 200 












Figure 1.1  ? Simplified model of the BMC structure and pathway.  
Figure 1.2  ? Simplified model of BMC shell assembly. 
Figure 1.3  ? TEM images of carboxysomes from H. neapolitanus. 
Figure 1.4. ŝĂŐƌĂŵƐƐŚŽǁŝŶŐƚŚĞĚŝĨĨĞƌĞŶƚĐŽŵƉŽŶĞŶƚƐŽĨɲĂŶĚɴ- carboxysomes, possible distribution of 
Rubisco within the carboxysomes and their comparative sizes. 
Figure 1.5. Model of the metabolic pathway of the Carboxysome. 
Figure 1.6.  A proposed model for the self-assembly of carboxysomes. 
Figure 1.7. The Eut BMC 
Figure 1.8. The structure of EutM and EutS. 
Figure 1.9. Pdu BMCs 
Figure 1.10. The pathway of 1,2-PD degradation. 
Figure 1.11. The Methyl-Citrate pathway. 
Figure 1.12. The synthesis of empty Pdu BMCs containing the shell proteins PduABJKNUT. 
Figure 1.13. Predicted model for the structure of a PduV monomer. 
Figure 2.1. Diagram summarising the microcompartment purification process. 
Figure 2.2. Schematic to show the process for overlap mutagenesis PCR. 
Figure 2.3. Cerulean and Ypet Spectra Profiles. 
Figure 3.1. Plasmid map of pET3a-pduV-cerulean. 
Figure 3.2. Plasmid maps of engineered constructs containing ypet and pduK. 
Figure 3.3. Plasmid map of pET3a-pduABJNU-ypet-pduK and pET3a-pduABJNU-pduK-ypet. 
Figure 3.4. Plasmid map of pET3a-pduABJ-pduK-ypet-NU. 
Figure 3.5. Comparison PduV-Cerulean co-expressed with BMC shells with and without PduT. 
Figure 3.6. Effect of tagging PduK on BMC formation and PduV function. 
Figure 3.7. Exploring the interaction between PduK and PduV. 
Figure 3.8. Examining the effect of tagging PduK on BMC formation. 
Figure 3.9. Exploring the necessity of PduK in the interaction between PduV and BMCs. 
Figure 3.10. Examining the role of PduK in the formation of BMCs. 
Figure 3.11. Exploring the effect of truncating PduK on the distribution of BMCs and their interaction with 
PduV. 
Figure 3.12. Exploring the effect of truncating PduK on the length of PduV filaments. 
Figure 3.13. Examining the effect of truncating PduK on BMC formation. 
Figure 4.1. The colour of cells expressing constructs from either pET3a or pLysS compared to the observed 
protein profile. 
Figure 4.2. Comparison of cells expressing BMCs with a C-terminal mCherry-tagged PduA cloned with pLysS 
or pET3a. 
x | P a g e  
 
Figure 4.3. SDS PAGE and Western blot analysis of protein expression directly after induction (0 hours), 1 and 
2 hours after induction and also overnight (O/N). 
Figure 4.4. Difference in protein expression between cells containing a pET3a mCherry-tagged BMC construct 
with and without pLysS. 
Figure 4.5. SDS PAGE analysis of tagged-BMC shell purification with and without pLysS. 
Figure 4.6. The purification of PduA-mCherry-BJKNU BMCs after growth at varying temperatures. 
Figure 4.7. Optimisation of TEM visualisation of mCherry-tagged BMCs. 
Figure 4.8. Purification of mCherry-tagged PduB BMCs. 
Figure 4.9.  Analysis of the formation of mCherry-tagged BMCs. 
Figure 4.10. Analysis of the formation of mCherry-tagged BMCs. 
Figure 4.11. TEM analysis of whole cell thin sections and thin sections of pellet 2 from the purification process. 
Figure 4.12. Atomic Force Microscopy images of purified mCherry-tagged BMCs. 
Figure 4.13. TEM thin sections of whole cells prepared for immune-gold labelling using 15 nm gold particles 
conjugated to an anti-Rabbit secondary antibody. 
Figure 4.14. Investigating the effect of each mCherry tagged empty BMC variant on the localisation and 
organisation of PduV within the cell. 
Figure 4.15. The effect of tagging shell proteins of the Pdu MCP on the length of PduV associated filaments 
in the cell. 
Figure 4.16. Investigating which Pdu shell proteins are required for the presence of PduV-associated 
filaments. 
Figure 5.1. Optimising the expression of PduV. 
Figure 5.2. In vitro polymerisation of PduV-GFP. 
Figure 5.3. Exploring the conditions required for PduV to polymerise into filaments in vitro. 
Figure 5.4. Identifying potential residues in PduV involved in GTP hydrolysis. 
Figure 5.5. Effect of mutating residues 8, 13, 14 and 43 on the ability of PduV to form filaments. 
Figure 5.6. Investigating the presence of filamentous structures in cells. 
Figure 5.7. Investigating the presence of PduV-GFP in filamentous structures. 
  




Table 1.1 - dŚĞƉƌŽƚĞŝŶƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚɲĂŶĚɴ-carboxysomes and the role they play in carboxysome 
formation and function. 
Table 2.1. List of bacterial strains used in this study. 
Table 2.2. List of plasmids used in this study. 
Table 2.3. List of primers used in this study. 
Table 2.4. Composition of SDS gels. 
Table 2.5. Composition of typical PCR reactions. 
Table 2.6. Typical PCR conditions. 
Table 2.7. Composition of a typical restriction digest.  
Table 2.8. Excitation and emission filters used to visualise Cerulean, GFP, Ypet and mCherry fusion proteins. 
Table 2.9. The solvent gradient used for the dehydration of samples for electron microscopy.  
Table 2.10. Low viscosity resin constituents used to produce a block of medium hardness  
Table 2.11. The solvent gradient used for the dehydration of samples for immuno-labelled electron 
microscopy.  
Table 3.1. Exploring the effect of truncating PduK on the length of PduV filaments. 
Table 4.1. Engineered constructs that encode BMCs containing a mCherry-tagged shell protein.  






xii | P a g e  
 
Abbreviations 
1,2-PD  1,2-propanediol 
3-HP  3-hydroxypropionic acid 
3-HPA  3-hydroxypropionaldehyde  
3-pga  3-Phosphoglycerate  
ɲ  alpha 
ɴ  beta 
ɶ  gamma 
ȴ  delta, deletion of a gene 
µL  Microlitre 
µM  Micromolar 
BMC  Bacterial microcompartment 
CA  Carbonic anhydrase 
co2   Carbon dioxide  
Da  Dalton 
DDH  diol dehydratase 
DNA  Deoxyribonucleic Acid 
E. coli  Escherichia coli 
Eut  Ethanolamine utilisation 
FLIM  Fluorescence Lifetime Imaging Microscopy 
GDP  Guanosine Diphosphate 
GFP  Green Fluorescent Protein 
GTP  Guanosine Triphosphate 
hco3  Bicarbonate 
IMAC  Immobilised Metal Affinity Chromatography 
kb  Kilobase 
kDa  Kilodalton 
xiii | P a g e  
 
LB  Luria Bertani Broth 
MCP  Microcompartment 
MDa  Megadalton 
mg  Milligrams 
ml  Millilitre 
mM  Millimolar 
nm   nanometer 
nM  Nanomolar 
PCR  Polymerase Chain Reaction 
Pdu  Propanediol utilisation 
PEG-4000 Polyethylene glycol - 4000 
Pi  Inorganic phosphate 
PTAC  Phosphotransacylase 
RuBisCO D-Ribulose 1,5- bisphosphate carboxylase 
RNA  Ribonucleic Acid 
RPM  Revolutions Per Minute 
TRIS  Tris(hydroxymethyl)aminomethane 
YFP  Yellow Fluorescent Protein 
 









Chapter 1- Introduction  
2 | P a g e  
 
1.1. An Introduction to Bacterial Microcompartments 
Organelles are structures that can be used to segregate metabolic processes or compartmentalise 
genetic material.  They are often used to define the difference between eukaryotes and prokaryotes 
as it is commonly thought that prokaryotic cells lack any membrane-bound structures. Although it 
is widely known that the interior of prokaryotic cells are far less organised than that of eukaryotic 
cells, emerging evidence has shown that the interior of prokaryotic cells are more organised than 
initially believed. The recognition of prokaryotic internal cell organisation stems from the discovery 
of cytoplasmic, subcellular inclusions, most of which remain uncharacterised. Some of these 
inclusions act as storage granules for compounds or polymers (Bazylinski & Frankel 2004; 
Steinbuchel et al. 1995) others are more complex and can generally be categorised into two groups. 
The first are the inclusions that are membrane-bound, including compartments such as 
magnetosomes (Murat et al. 2010). However some prokaryotes, specifically bacteria, are able to 
segregate specific processes from the cellular environment by encasing them in a proteinaceous 
shell; these protein bound inclusions constitute the second group that form a diverse family of 
organelles known as bacterial microcompartments, or BMCs. 
 
BMCs are polyhedral inclusions, located within the cell cytoplasm and vary between 100 and 200 
nm in cross section; a simplified model is shown in Figure 1.1 (Kerfeld et al. 2005; Cheng et al. 2008). 
They are composed entirely of protein, with no associated lipids and, based on sequence analysis 
are thought to be present in approximately 20% of all sequenced bacteria (Cheng et al. 2008). They 
are encoded by genes that are clustered into operons that group together genes required to form 
a thin, 3  ? 4 nm protein shell, as well as the enzymes and auxiliary proteins necessary for the 
enclosed pathway (G C Cannon et al. 2001). BMCs primarily function to optimise metabolic 
pathways; the protein shell typically encases enzymes of a single metabolic pathway, which act in 
a sequential manner to carry out a specific metabolic reaction (Huseby & Roth 2013). 
Compartmentalisation of metabolic processes has allowed bacteria to occupy niches that other 
organisms cannot, as BMCs can be the main source of carbon, nitrogen and energy (Bobik 2006).  
3 | P a g e  
 
 
It is thought that BMCs may function in 23 or more different metabolic processes and are used by 
a wide variety of heterotrophic bacteria which express multiple compartments per cell (Bobik 
2006).  BMCs are capable of meeting the functional definition of an organelle, despite not being 
bound by a membrane through the complexity of their metabolic activities. (Shively et al. 1973). 
  
BMCs have several distinctive features; they all contain a thin protein shell, which encapsulates 
functionally related enzymes while allowing the transport of substrates and products across the 
compartment, while the reaction contained within the BMS includes a toxic or volatile 
intermediate, shown in Figure 1.1. Therefore there are a number of advantages for the evolutionary 
emergence of BMCs. With the presence of BMCs, bacteria are able to concentrate and confine 
enzymes together with their substrates to enhance the efficiency of reactions. In addition the 
protein shell not only acts as a barrier to the loss of metabolites, but also acts as a barrier to prevent 
the leakage of any toxic intermediate into the cell cytoplasm, thus preventing DNA damage and cell 













Figure 1.1  ? Simplified model of the BMC structure and pathway. BMCs optimise pathways containing a 
volatile or toxic intermediate. The protein shell functions as a barrier to channel this intermediate to the 
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next reaction step and preventing its release into the cytoplasm where it can cause cellular toxicity or 
volatility. In addition the shell concentrates enzymes, substrates and cofactors together, improving the 
efficiency of reactions. Adapted from (Chowdhury et al. 2014) 
 
1.1.1. An Overview of Studied Bacterial Microcompartments 
To date, only a few BMCs have been characterised. Polyhedral organelles in bacteria were first 
described in 1956 and were isolated and visualised by electron microscopy in 1973 (Niklowitz & 
Drews 1956; Shiveley, Ball & Kline 1973). The inclusions were initially thought to be viruses, but 
after isolation, these structures were named carboxysomes due to the discovery of the carbon 
dioxide fixing enzyme D-ribulose 1,5- bisphosphate carboxylase, commonly known as RuBisCO, 
contained within the compartment lumen (Shiveley, Ball & Kline 1973). Carboxysomes are now 
recognised as the first of three main characterised microcompartments found within bacterial cells, 
followed by the discovery of propanediol utilization (Pdu) and ethanolamine utilisation (Eut) 
microcompartments in 1999 which function to catabolise 1,2 propanediol and degrade 
ethanolamine respectively (T. A. Bobik et al. 1999; Kofoid et al. 1999). Unlike carboxysomes, Pdu 
and Eut BMCs are involved with a specific metabolic activity, so are subdivided into a category of 
compartments known as metabalosomes. These metabolosomes both involve metabolic activities 
that require adenosylcobalamin, or vitamin B12, as a cofactor (Brinsmade et al. 2005; T. A. Bobik et 
al. 1999) and were both identified in heterotrophic bacteria found in the mammalian gut (G C 
Cannon et al. 2001).  
 
There are three main families of BMC that have been characterised to date; these include 
carboxysomes, 1,2-propanediol utilisation (Pdu) and ethanolamine utilisation (Eut) BMCs. These 
three BMCs have three main unifying features. The first is the presence of a compartment shell 
composed exclusively of protein, with no known associated lipids (Fan et al., 2010). This 
proteinaceous shell encases the second unifying feature - enzymes which act in a sequential 
manner to carry out a specific metabolic process; 1,2-propanediol, carbon dioxide or ethanolamine 
are fixed or broken down to generate energy. Lastly these metabolic processes always involve a 
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toxic or volatile intermediate, in the form of an aldehyde or in the case of carboxysomes, an oxygen 
sensitive enzyme (Kerfeld, Heinhorst & Cannon 2010; Yeates et al. 2008) 
There are consequently two suggested primary functions of compartmentalising metabolic 
pathways; (I) to sequester toxic intermediates, preventing the cell from damage and (II) to increase 
the efficiency of metabolic reactions. By the compartmentalisation of pathways, enzymes and 
substrates are concentrated in the same locality, in addition the BMC shell acts as a barrier to 
prevent the loss of metabolites by diffusion (Kerfeld, Heinhorst & Cannon 2010). This phenomenon 
then creates a paradox, how is the compartment shell able to confine intermediates, enzymes and 
substrates, while allowing products and cofactors to pass through? (Cheng et al. 2008). 
 
1.1.2. The Bacterial Microcompartment Shell 
BMCs are organised into a polyhedral structure from the assembly of phylogenetically related shell 
proteins. Open reading frames (ORFs) of bacteria containing BMCs have been found to encode 
proteins that contain BMC domains, associated with the formation of the compartment shell. 
Genomic studies have identified two shell protein families, distinguished by the presence of two 
distinct BMC domains, PFAM 00936 and PFAM 03319 (Kerfeld, Heinhorst & Cannon 2010). These 
BMC domain-containing proteins form the building blocks of the BMC shell. 
 
Typically, the conventional BMC domain consists of 90 amino acids and adopts an alpha/beta fold 
(Kerfeld et al. 2005). Currently there are approximately 1700 proteins that have been identified to 
contain  BMC domains, throughout 10 different bacterial phyla (Yeates, Thompson & Bobik 2011). 
Each shell protein contains one or two copies of these highly conserved BMC domains and each 
domain determines the overall structure of the protein, comprising of either hexamers (upto 2 per 
protein: PFAM 00936) or pentamers (1 per protein: PFAM 03319) (Frank et al. 2013). Structural 
studies have shown that BMC shells usually consist of single layers of protein hexamers; these 
hexamers can also be arranged into pseudo hexameric trimers, and function to form the planar 
facets of the  compartment shell (Kerfeld et al. 2005; Sargent, F. a Davidson, et al. 2013; Yeates, 
Thompson & Bobik 2011). Studies have also suggested that pentameric proteins form the vertices 
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ŽĨƚŚĞƐŚĞůů ?ůŝŶŬŝŶŐƚŚĞŚĞǆĂŵĞƌŝĐĨĂĐĞƚƐƚŽŐĞƚŚĞƌĂŶĚŝƚ ?ƐƚŚŽƵŐŚƚƚŚĂƚƚŚŝƐŐŝǀĞƐƚŚĞDŝƚ ?ƐƵŶŝƋƵĞ
structure, allowing for the curvature and helping it to fold, as shown in Figure 1.2 (Tanaka et al. 
















Figure 1.2  ? Simplified model of BMC shell assembly. Main shell proteins assemble as hexamers which 
further assemble into molecular sheets that form the facets of the BMC shell structure, shown in blue.  
Specialised pentameric proteins, shown in pink, are thought to form the vertices of the BMC and help to 
close the structure. Adapted from (Yeates, Thompson & Bobik 2011) 
 
1.1.3. Protein Pores, Molecular Transport and Selective Permeability; 
Properties of the Protein Shell  
Interestingly, each shell protein hexamer contains a pore through the centre, along the axis of 
symmetry. This pore is thought to facilitate the movement of substrates, products and cofactors 
through the shell, although the mechanism for this is unclear (Kerfeld et al. 2005; Yeates, Thompson 
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& Bobik 2011). Several features of the pores have been identified as potentially important in 
allowing only certain small molecules to be transported; this includes size, electrostatic forces and 
hydrogen bonding (Yeates, Thompson & Bobik 2011). In some cases, these pores are thought to 
have an overall positive charge, allowing opposite charged cofactors to pass, whilst restricting the 
transport of other molecules through the shell (Yeates et al. 2007). In this way the shell can be 
thought of as a semi-permeable barrier.  
 
Similarly, metabolosomes are able to sequester intermediates containing a toxic aldehyde group, 
preventing the cell from damage. To achieve this, the properties of the protein shell would have to 
allow the diffusion of cofactors into the compartment whilst restricting the transport of these toxic 
intermediates into the cellular environment. Therefore the BMC shell would need to be selectively 
permeable. Previous studies have supported this hypothesis; a Salmonella enterica mutant, lacking 
the BMC shell but retaining the Pdu pathway, was found to have an increased build-up of the toxic 
intermediate propionaldehyde. This led to an increased frequency of DNA mutations and the 
inhibition of respiratory processes (Sampson & Bobik 2008). This suggests that the primary function 
of the Pdu BMC is the mitigation of toxicity and consequent DNA damage by propionaldehyde.  
Although the mechanism for selective permeability of the BMC shell remains largely elusive, there 
have been several suggestions to explain how molecules are both sequestered and transported 
across the shell. The first is the association of  lumen enzymes with the shell protein pores which 
could cause molecules that move into the BMC from the cytoplasm to be channelled to active sites, 
ŝŶĂƉƌŽĐĞƐƐƌĞĨĞƌƌĞĚƚŽĂƐ ‘ŵŽůĞĐƵůĂƌƌŽƵƚŝŶŐ ?(Cheng et al. 2008). Another possibility is that these 
substrate-specific pores somehow mediate the transportation of small molecules across the shell 
(Cheng et al. 2008). It has also been shown that one of the Pdu shell proteins, PduB consists of three 
pores within a trimeric structure that function to channel glycerol, and potentially 1,2-propanediol, 
into the metabolosome. In addition to glycerol channelling, glycerol was also found to occupy a 
central binding pocket, with flexible loops above and below it. When glycerol was bound, the loops 
were locked closed. This suggests a role in closing the central pore and providing the possibility of 
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a ligand-gated channel, preventing aldehyde efflux while allowing glycerol, and possibly other 
substrates, to enter the shell (Pang et al. 2012). Similarly the Eut microcompartment shell protein, 
EutL has also been shown to contain a central channel that can adopt an open or closed state 
(Takenoya, Nikolakakis & Sagermann 2010). 
 
The ability to understand the mechanism of transport across the BMC shell is key for the use of 
microcompartments in synthetic biology. To be able to utilise efficiently BMCs as nanobioreactors, 
for large scale production of biofuels, drugs and other products, we need to be able to understand 
how substrates and cofactors enter the compartment and also how intermediates are confined to 
the lumen. Consequently, the study of the BMC shell is key to our understanding of how these 
compartments can be used in synthetic biology.  
 
1.1.4. A Synthetic Approach to BMCs 
The ability to compartmentalise reactions, and possibly whole pathways, is highly desirable, with 
many applications in metabolic engineering, nanotechnology and bioengineering. 
Microcompartments are an ideal method of introducing compartmentalisation into bacterial cells. 
Instead of having to rewrite or revise the genetic code to manipulate the metabolic activities of the 
host organism, the microcompartment is a pre-evolved system which already primarily functions 
as a metabolically active powerhouse of the cell. BMCs represent a comparitively simple solution 
to enhance cellular production of designer chemicals, vitamins, antibiotics, biofuels and non-native 
metabolites (Parsons et al. 2010). To engineer a separate vehicle for the compartmentalisation of 
a complex pathway, many factors need to be considered and the bioreactor must comprise specific 
chemical and physical properties. Firstly, the boundaries of the reactor should allow for selective 
diffusion, to permit substrates and products to pass whilst retaining the catalytic components and 
protecting them against degradation. The exterior of the bioreactor should be able to withstand 
changes to the cellular environment, such as pH and temperature and must be able to be used in a 
living system without stimulating an adverse cellular response. In addition the functional bioreactor 
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size must not exceed the nanometers range to allow the pathway to be subjected to a single 
microenvironment (Monnard 2003). This gives BMCs the leading edge for the potential use as a 
bioreactor; it meets all the specifications required and does not require de novo biochemically 
engineering as it exists in nature, with only minor re-designing needed to tailor the BMC to the 
desired use. It also has the added benefit of potentially allowing any reaction involving a toxic 
intermediate to be produced quickly, efficiently and inexpensively, in living organisms. It could 
therefore be used to improve the yield of chemical reactions and to lower the toxicity to the host 
cell (Bonacci et al. 2012).  
 
Currently it is possible to produce empty, recombinant BMC shells in lab strains of E.coli. This has 
allowed a further understanding of BMCs and how they can potentially be utilised in industry. In 
addition, the recent discovery of a target sequence has allowed the targeting of non-native proteins 
to the BMC (Fan et al., 2010) see section 1.5 Recombinant Pdu Studies. This provides the potential 
to use these organelles to produce non-native metabolites in an environment where substrates, 
enzymes and cofactors are confined. The advantages of BMC use in industry are therefore 
substantial; the targeting of specific proteins to the compartment interior increases local 
concentrations of substrates and enzymes, this confinement has the potential to increase the yield 
of the end product while mitigating any toxic or volatile intermediates. This mitigation would allow 
a pathway, which would otherwise not be viable, to be executed by bacteria.  
 
1.2. Carboxysomes  
Carboxysomes were the first microcompartments to be discovered. They were initially visualised 
by electron microscopy in the cyanobacteria, Phormidium uncinatum in 1956 (Niklowitz & Drews 
1956), and subsequently identified and isolated from the chemoautotroph Halothiobacillus 
neapolitanus as polyhedral bodies in 1973 (Shiveley, Ball & Kline 1973). Initially they were mistaken 
for viruses, but further research by Shiveley et al. indicated a role in carbon fixation via the Calvin 
cycle. It was found that these polyhedral inclusions contained the carbon dioxide-fixing enzyme 
10 | P a g e  
 
RubisCO; they were subsequently named carboxysomes due to their suggested involvement in CO2 
fixation. It has now been shown that carboxysomes do in fact play an integral role in enhancing 
autotrophic CO2 fixation via the Calvin cycle and are widely distributed amongst both 
chemoautotrophs and cyanobacteria (Price et al. 2008).  
 
Even though carboxysomes are fairly sophisticated in that they are large, multi-protein complexes, 
shown in Figure 1.3, they are the simplest of all characterised BMCs. The size of carboxysomes range 
between 80 and 150 nm in cross section and they are bounded by a thin 3-4 nm protein shell. They 
are composed of several thousand polypeptides consisting of 10  ? 15 different types, totalling an 
overall mass of approximately 300 MDa (Yeates et al. 2007; Cheng et al. 2008). 
 
 
Figure 1.3  ? TEM images of carboxysomes from H. neapolitanus A) Negatively stained thin sections of 
cells containing carbozysomes, highlighted by the arrows B) Purified negatively stained intact 
carboxysomes. The interior of the carboxysomes are packed with RuBisCO. Scale bars 100 nm. Adapted 
from (Tsai et al. 2007). 
 
1.2.1. The Carboxysome Pathway 
The carboxysome shell encases two distinct enzymes; carbonic anhydrase (CA) and ribulose bis-
phosphate carboxylase monooxygenase (RuBisCO) (Shively et al. 1973; Fukuzawa et al. 1992). 
Within the confines of the microcompartment lumen, it was hypothesised that CA converts 
bicarbonate (HCO3-) to carbon dioxide (CO2). RuBisCO then converts CO2 and RuBP to two 
molecules of 3-phosphoglycerate (3-PGA) which then leaves the interior of the compartment, 
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through the selectively permeable shell, into the cell cytoplasm. This is the first step of the Calvin-
Benson-Bassham cycle. It was suggested that CA would ensure that cytosolic bicarbonate was 
converted to CO2 at a concentration that would maintain optimum RuBisCO activity (Reinhold, 
Kosloff & Kaplan 1991). It has been shown that partially purified carboxysomes from two 
cyanobacterial strains are associated with CA activity (So et al. 2004). Although it is commonly 
recognised that CA is an essential component of a cellular carbon dioxide concentrating mechanism 
(CCM), the localisation of this enzyme or if many carboxysomes even comprise it was initially 
unclear (So et al. 2004). 
 
Some early conclusions were drawn in 1989 by Price and Badger when the cytosolic levels of CA 
activity were raised, to test if CA needed to be localised within the carboxysome. It was found that 
firstly inorganic carbon must be present as bicarbonate rather than carbon dioxide, for the 
carboxysome to function. In addition, in carboxysome-containing cells, CA is absent from the 
cytosol but located with the carboxysome (Price & Badger 1989). Further research has shown that 
ƚŚĞƌĞ ĂƌĞ ƚŚƌĞĞ ĐůĂƐƐĞƐ ŽĨ  ? ɲ ? ɴ ĂŶĚ ɶ ? ƚŚĞ ĞǆƉĞĐƚĞĚ ĞǀŽůƵƚŝŽŶĂƌǇ ůŝŶĞĂŐĞ ƚŽ ďĞ ĨŽƵnd with 
carboxysomes. CcaA, is a carboxysome-ĂƐƐŽĐŝĂƚĞĚŵĞŵďĞƌŽĨƚŚĞɴĐůĂƐƐ ?ǁŚŝĐŚĂƌĞǁŝĚĞƐƉƌĞĂĚ
among Bacteria, Archaea and Eucarya domains. However, recently, So et al. have shown the 
ĞǆŝƐƚĞŶĐĞŽĨĂŶŽƚŚĞƌůŝŶĞĂŐĞŽĨ ?ɸĐůĂƐƐ ) ?ŝƐŽůĂƚĞĚĨƌŽŵH. neapolitanus. It was demonstrated that 
this new CA, CsoS3, is a catalytically functional component of the carboxysome shell. It is predicted 
that carboxysomes from other species may contain this new lineage, as they contain homologues 
of the carbonic anhydrase CsoS3 (So et al. 2004). This may help to explain why, for so many years, 
the involvement of CA and its localisation in relation to the carboxysome has been so elusive.  
 
The carboxysome is an essential part of the bacterial CCM. It is now recognised that when CO2 
concentrations are low, carboxysomes are formed. The pathway begins with an active transport 
process that concentrates bicarbonate (HCO3-) within the cell cytoplasm. In the cytoplasm, HCO3- 
is maintained at a chemical non-equilibrium against carbon dioxide (CO2) through the absence of 
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CA activity in the cytosol (Price & Badger 1989; Price et al. 2008). Bicarbonate is the preferred form 
of inorganic carbon (Ci) as, compared to uncharged CO2, it is 1000-fold less permeable to lipid 
membranes (Price et al. 2008). This would prevent CO2 leakage out of cells.  Subsequently, a 
carboxysome-associated CA converts the accumulated HCO3- to CO2 and releases it within the 
carboxysomes. The carboxysome shell acts as a diffusion barrier to prevent the loss of CO2. CO2 
then accumulates within the carboxysome lumen, in the location of RuBisCO (Cheng et al. 2008). 
RuBisCO subsequently catalyses the carboxylation of ribulose bisphosphate to form two molecules 
of 3-phosphoglycerate; this is the first step of the Calvin-Benson-Bassham cycle (Price et al. 2008). 
 
1.2.2. Alpha and Beta-Carboxysomes  
Currently two classes of carboxysome, which vary slightly in composition, have been identified. 
dŚĞƐĞŚĂǀĞďĞĞŶ ƚĞƌŵĞĚĂůƉŚĂ  ?ɲ )ĂŶĚďĞƚĂ  ?ɴ )ĐĂƌďŽǆǇƐŽŵĞƐ ? /ƚ ŝƐ ƚŚŽƵŐŚƚ ƚŚĂƚĞĂĐŚŽĨ ƚŚĞƐĞ
ĐůĂƐƐĞƐŚĂǀĞĞǀŽůǀĞĚŝŶƉĂƌĂůůĞůǁŝƚŚĂĚŝĨĨĞƌĞŶƚƉŚǇůŽŐĞŶĞƚŝĐŐƌŽƵƉŽĨZƵŝƐK ?ɲ-carboxysomes 
are associated with 1A RuBisCo and ĂƌĞ ĨŽƵŶĚ ǁŝƚŚŝŶ ĐŚĞŵŽĂƵƚŽƚƌŽƉŚƐ ĂŶĚ ɲ-cyanobacteria, 
ǁŚĞƌĞĂƐɴ-ĐĂƌďŽǆǇƐŽŵĞƐĂƌĞĂƐƐŽĐŝĂƚĞĚǁŝƚŚ ?ZƵŝƐKĂŶĚĂƌĞĐŽŶƚĂŝŶĞĚǁŝƚŚŝŶɴ-cyanobacteria 
(Badger & Price 2003).  
 
It is difficult to distinguish the difference between forms 1A and 1B of RuBisCo. In general form I 
enzymes are considerably diverse and are divided into four clades. Form IA and IB are typically 
known as the green forms as they are found in cyanobacteria and green algae whereas IC and ID 
are associated with red and non-green algae (Badger & Bek 2008). Both IA and IB enzymes are 
composed of a large catalytic subunit and a smaller subunit to form a hexadecameric structure 
consisting of eight copies of each protein; L8S8, or specifically (L2)4(S4)2 with a total Mr of 550,000 
(Tabita 1999). Of forms IA and IB, the enzymes that are associated with carboxysomes are 
ƐƵďŐƌŽƵƉĞĚ ŝŶƚŽ /Đ ĂŶĚ /Đ ? /Đ ZƵŝƐŽ ŝƐ ĂůǁĂǇƐ ĂƐƐŽĐŝĂƚĞĚ ƚŽŐĞƚŚĞƌ ǁŝƚŚ Ă ĐůƵƐƚĞƌ ŽĨ ɲ-
carboxysome genes and are thought to both be inherited by lateral gene transfer events. However 
&Žƌŵ/ŝƐĨĂƌůĞƐƐĚŝǀĞƌƐĞƚŚĂŶ/ĂƐɴ-cyanobacteria are the only bacteria to contain form IB of 
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RuBisCO and the enzyme genes may or may not be associated with the carboxysome gene cluster 
and could be located elsewhere in the genome (Badger & Bek 2008) ?KǀĞƌĂůůɲĂŶĚɴ- carboxysomes 
are thought to have similar architectural and mechanical properties but differ in the associated 








Figure 1.4. ŝĂŐƌĂŵƐƐŚŽǁŝŶŐƚŚĞĚŝĨĨĞƌĞŶƚĐŽŵƉŽŶĞŶƚƐŽĨɲĂŶĚɴ- carboxysomes, possible distribution 
of Rubisco within the carboxysomes and their comparative sizes. Adapted from (Rae et al. 2013) 
 
1.2.3. Carboxysome Function 
It is clear that the primary function of the carboxysome centres on the enzyme RuBisCO as it 
constitutes approximately 60% of the total carboxysome protein content, with the shell accounting 
for 17% (Cannon & Shively 1983). Therefore the key question is what metabolic purpose is there by 
packaging this carbon assimilation enzyme into the BMC? It is thought that the carboxysome either 
acts as a storage vessel to contain excess RuBisCO, or functions to enhance the kinetic ability of the 
enzyme (Gordon C Cannon et al. 2001). Studies have shown that when CO2 is limited, total cellular 
RuBisCO activity levels and the copy number of carboxysomes per cell increase (Beudeker et al. 
1980). This gives some evidence that carboxysomes serve to increase the metabolic activity of the 
cell. They do this through several proposed methods: 
 
(i) RuBisCO is commonly known as an inefficient enzyme, with a 9.6 fold higher specificity for O2 
than CO2 in RuBisCO form I, the type present in all carboxysomes (Tabita 1999). This phenomenon 
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is known as photorespiration; an energetically wasteful process that involves the fixation of O2, 
instead of CO2, to RuBP by RuBisCO. Consequently it is thought that encasing this enzyme in a 
proteinaceous shell would differentially block oxygen from being catalysed to increase the 
efficiency of the enzyme by enhancing the carboxylase activity and excluding the competing 
substrate (Gordon C Cannon et al. 2001).  
 
(ii) Bicarbonate accumulates in the cell cytoplasm, is converted to CO2 and released in the 
carboxysome lumen. Through this method the local concentrations are increased to generate a 
microenvironment of high CO2 levels in the carboxysome (Price et al. 2008). CO2 is prevented from 
diffusion through lipid membranes by releasing it directly into the selectively permeable 
carboxysome shell. By encasing RuBisCO in the same vicinity as CO2, the efficiency of carbon 
fixation by RuBisCO is increased and photorespiration is supressed (Cheng et al. 2008).  
 
(iii) Similarly, the carboxysome shell is capable of differentiating between oxygen and carbon 
dioxide. It does this through charged pores which allow the passage of negatively charged 
molecules such as bicarbonate, a precursor of carbon dioxide, or 3-PGA, the end product of 
catabolism in the carboxysome, to enter the BMC whilst excluding molecules such as oxygen. These 
pores serve two purposes; to allow increased localised concentrations of CO2, increasing the 
efficiency of RuBisCO, but also to prevent the loss of energy during photorespiration by the 
exclusion of O2 (Gordon C Cannon et al. 2001).   
Therefore, it could be considered that the carboxysome acts to improve the efficiency of the carbon 
assimilation enzyme, RuBisCO by providing a carbon dioxide concentrating mechanism (CCM)  
 












Figure 1.5. Model of the metabolic pathway of the Carboxysome: The carboxysome shell confines the 
enzymes required to convert bicarbonate (HCO3-) to CO2. RuBisCO then catalyses the carboxylation of 
ribulose 1,5-bisphosphate (RuBP) . The proposed function is to sequester CO2 and enhance its fixation. 
Adapted from (Yeates, Crowley & Tanaka 2010). 
 
1.2.4. The Carboxysome Operon 
It may appear that different proteins are associated with each form of carboxysome, however many 
protein components are conserved but the gene names can differ.  The exceptions to this are the 
ƐŽ^ ?ĂŶĚƐŽ^ ?ƉƌŽƚĞŝŶƐǁŚŝĐŚĂƌĞĐŚĂƌĂĐƚĞƌŝƐƚŝĐŽĨɲ-carboxysomes whereas CcmM, CcmN and 



















CbbL Form 1A RuBisCO large subunit 
CbbS Form 1A RuBisCO small subunit 
CsoS2A Associated with the shell, encoded by the same gene but different in 
level of glycosylation CsoS2B 
CsoS3 Forms a novel type of CA and is tightly associated with the shell  
CsoS1A 
Closely related in sequence, forms the bulk of the shell. Contains the 












RrcL Form 1B RuBisCO large subunit 
RrbcS Form 1B RuBisCO small subunit 
CcmK BMC-domain proteins with homology to CsoS1, a major shell protein in 
ƚŚĞɲ-carboxysome CcmO 
CcmL 
ZĞůĂƚĞĚŝŶƐĞƋƵĞŶĐĞƚŽ^ĐŽ^ ?ĂŶĚŽĨƚŚĞɲ-carboxysome and may 
also form the shell verticies  
CcmM ZĞƐƚƌŝĐƚĞĚƚŽɴ-carboxysomes. May function as organizing factors or in 
enzyme regulation. CcmM may act as a scaffolding protein to establish 
interactions between the protein shell and encapsulated enzymes 
(Yeates, Thompson & Bobik 2011) 
CcmN 
CcaA (IcfA) Carboxysome-associated carbonic anhydrase 
 
Table 1.1 - dŚĞƉƌŽƚĞŝŶƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚɲĂŶĚɴ-carboxysomes and the role they play in carboxysome 
formation and function. 
 
 
1.2.5. The Carboxysome Shell Structure  
The outer casing, or shell, is the most identifiable feature of the BMC.  It is comprised of small 
proteins of around 100 amino acids and these shell forming proteins contain a BMC domain that 
are thought to form either the facets of the shell, or the pentameric vertices (G. C. Cannon & Shively, 
1983; Kerfeld et al., 2005). Originally mistaken for virions, carboxysomes share many similarities 
with icosahedral viral capsids. They both contain multiple homologues of a small protein, either the 
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ƐŽ^ ? Žƌ Đŵ< ƉƌŽƚĞŝŶƐ ĨŽƌ ɲ ĂŶĚ ɴ-carboxysomes respectively. Many copies of this small but 
distinct protein constitutes the shell of the carboxysome (Yeates et al. 2007). However several other 
ƐŚĞůů ƉƌŽƚĞŝŶƐ ŚĂǀĞ ďĞĞŶ ĨŽƵŶĚ ? ŝŶĐůƵĚŝŶŐ ? ƐŽ ? ŝŶɲ-ĐĂƌďŽǆǇƐŽŵĞƐ ĂŶĚ ĐŵK ĂŶĚ Đŵ> ŝŶ ɴ-
carboxysomes (refs).  To date, six carboxysome shell proteins have been crystallised. These include 
Đŵ< ? ?Đŵ< ?ĂŶĚĐŵ< ?ĨƌŽŵɴ-carboxysomes (Kerfeld et al. 2005; Tanaka et al. 2008; Crowley 
et al. 2008) ĂŶĚƐŽ^/ ?ƐŽ^/ĂŶĚƐŽ^/ĨƌŽŵɲ-carboxysomes (Klein et al. 2009; Tsai et al. 2007). 
These structures have revealed that the protein monomers aggregate into hexameric tiles, giving 
the protein a convex and concave side. It was found that these hexamers formed a two-dimentional 
layer and that CcmK2 hexamers faced the same direction whereas CcmK4 hemamers alternated 
between convex and concave orientations (Kinney, Axen & Kerfeld 2011) ? WƌŽƚĞŝŶƐ ĨƌŽŵ ƚŚĞ ɲ-
carboxysome display the same convex/concave hexamer structure with uniform directionality. In 
addition CsoS4A and CcmL have been found to form pentameric structures (Tanaka et al. 2008). 
They also have concave/convex sidedness but unlike the hexameric proteins, they have a positive 
electrostatic potential. This is thought to be influenced by the presence of an 8-10 amino acid loop 
on the concave face of the pentamer, which is lacking in the hexamers (Kinney, Axen & Kerfeld 
2011).  
 
Structural studies, which have led to schematic modelling of the carboxysome shell, are thought to 
apply to other BMCs too. The shell domains are highly conserved, as well as the presence of 
hexameric and pentameric proteins. The hexamers contain a central pore of 4-7 Å and are thought 
to tile together to form the facets of the shell whereas the pentamers cap the vertices (Cai et al. 
2014).   
 
1.2.6. The Assembly of Carboxysomes 
The individual carboxysome shell proteins have been shown to self-assemble into cyclic disc-shaped 
hexamers (Kerfeld et al. 2005). These hexamers are then able to fold together and form the 
icosahedral structure of the carboxysome shell. This shell assembly must somehow coincide with 
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the assembly of the cargo within. Until recently, the nature of shell protein assembly was largely 
unknown. It was suggested that both the shell proteins and cargo have the ability to self-assemble 
(Orus et al. 1995) but the mechanism for this was undetermined. There is evidence to suggest that 
the carboxysome shell proteins and its cargo are able to assemble together; partially assembled 
carboxysomes have been found to always contain both RuBisCO and shell proteins (Iancu et al. 
2010). The data also suggests that the cargo must be able to self-assemble as RuBisCO is observed 
in the inner layers of the assembling compartment.  
 
Studies carried out on isolated carboxysomes from Synechococcus revealed that there were several 
distinct stages to carboxysome formation visible by EM. These include the initial formation of ring-
shaped structures, followed by electron-translucent inclusions that have the carboxysome shape 
and internal organisation of RuBisCO and lastly carboxysomes with an internal electron-translucent 
area. It was suggested that the electron ? translucent inclusions are grouped molecules of RuBisCO 
and these were present at very early stages of carboxysome biogenesis. It was found that unfixed 
carboxysomes had a tendency to collapse, leaving the RuBisCO to be visualised by EM. This RuBisCo 
ĐŽƵůĚďĞŝĚĞŶƚŝĨŝĞĚďǇŝƚƐ “ĚŽƵŐŚŶƵƚ ?ƐŚĂƉĞ ?ŽŶƐĞƋƵĞŶƚůǇ ?ǁŝƚŚŚŝŐŚZƵŝƐKĐŽŶĐĞŶƚƌĂƚŝŽŶƐ ?ŝƚ
was possible to show that RuBisCO molecules tended to self-assemble, forming structures distinct 
to mature carboxysomes, without the presence of a carboxysome shell (Orus et al. 1995).  
 
To support this, Cameron et al have shown that carboxysome biogenesis begins with the 
aggregation of RuBisCO; this initiation is dependent on CcmM,  a protein thought to act as a scaffold 
between the carboxysome shell and the encapsulated enzymes (Cameron et al. 2013; Long et al. 
2011). During this process, RuBisCO aggregates into a distinct foci, usually localised to a cell pole. 
The resulting nascent carboxysome is therefore comprised of disordered RuBisCO molecules that 
have not yet been enveloped by shell proteins. This gives further evidence that the carboxysome 
cargo self-assembles first, preceding its complete encapsulation by the carboxysome shell.  
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Furthermore it has been shown that partially formed carboxysomes can be visualised. Suggesting 
that RuBisCO is simultaneously aggregated and encapsulated (Cameron et al. 2013). 
 
Overall, through live cell fluorescence microscopy and transmission electron microscopy (TEM), it 
has been shown that carboxysomes do in fact originate as small foci of self-assembling RuBisCO. 
This small aggregate of carboxysome cargo then grows over a timespan of hours, into a larger 
RuBisCO inclusion which is then encased abruptly by the colocalisation of shell proteins to the foci, 
establishing a protected internal environment (Cameron et al., 2013; A. H. Chen, Robinson-Mosher, 
Savage, Silver, & Polka, 2013). 
 
The assembly process of BMCs are important to our understanding of how shell proteins and cargo 
interact to form the structure and package proteins inside. This can then be applied to engineered 
BMCs, allowing the biosynthesis of designer chemicals, drugs, biofuels and other products.  So far 
the assembly of both Pdu and Eut BMCs remain completely unknown, however insights into the 
assembly of carboxysomes can help to advance research into the formation of BMCs as a whole 









Figure  1.6.  A proposed model for the self-assembly of carboxysomes: A) Aggregation of RuBisCO to 
ĨŽƌŵĂ  “ŶƵĐůĞƵƐ ?ŽĐĐƵƌƐ ? )Ɛ ƚŚĞZƵŝƐK  “ŶƵĐůĞƵƐ ? ƌĞĂĐŚĞƐ ŝƚƐ ĨƵůů ƐŝǌĞĐĂƌďŽǇƐŽŵĞƐŚĞůůƉƌŽƚĞŝŶƐ
assemble around the RuBisCO, C) Shell assembly completes and the RuBisCO is sealed off from the 
cytosol, creating an oxidising environment, D) FoƌŵĂƚŝŽŶŽĨĂŶĞǁZƵŝƐĐŽ “ŶƵĐůĞƵƐ ?ƚĂŬĞƐƉůĂĐĞĂĨƚĞƌ
completion of the previous carboxysome assembly. Adapted from (Chen et al. 2013).   
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1.3. Ethanolamine Utilisation Microcompartments 
Ethanolamine is a product of the degradation of the bacterial and mammalian membrane 
component phosphatidylethanolamine and is produced in the gastrointestinal tract of mammals. 
Utilisation of ethanolamine allows a variety of bacteria, including the best-studied case Salmonella, 
as well as Escherichia, Klebsiella, Pseudomonas, Actinobacteria, Clostridium, Mycobacterium and 
Enterococcus, to inhabit diverse environments, such as the mammalian gut. Here the ethanolamine 
is derived from intestinal epitheial and bacterial cells as well as the host diet, as the catabolism of 
this amino alcohol can provide their sole source of carbon and nitrogen (Bradbeer 1965; Tsoy, 
Ravcheev & Mushegian 2009). This catabolic process involves a Cobalamin-dependent pathway and 
the necessary genes involved are clustered in the ethanolamine utilisation (eut) operon, including 
enzymes for ethanolamine degradation and carboxysome shell protein homologs (Chang & Chang 
1975; Stojiljkovic, Bäumler & Heffron 1995).The initial evidence for the existence of Eut BMCs 
stemmed from the discovery of genes encoding shell proteins in Salmonella enterica, this led to the 
finding  of genes for ethanolamine degradation clustered in the same operon (Stojiljkovic, Bäumler 
& Heffron 1995; Kofoid et al. 1999). Subsequent studies have shown that, during growth on 
ethanolamine, S. enterica forms BMCs (Shively et al. 1998).   
 
Both the Eut and Pdu BMCs form less regular structures and do not resemble a regular icosahedron 
as closely as the carboxysome does (Figure 5) (Yeates, Thompson & Bobik 2011). It has been 
suggested that this is due to the differences in the vertex protein properties between the various 
BMCs (Yeates, Thompson & Bobik 2011). Nevertheless, the approximate size of the Eut BMC is 
similar to that of the carboxysome at 100 nm (Held, Quin & Schmidt-Dannert 2013). The Eut BMC 
is also considered to be more complex than that of the carboxysome, housing more enzymes for a 
degradation pathway that involves a volatile intermediate, as shown in Figure 1.7.  
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1.3.1. The Eut Pathway 
Initially the eut pathway begins with the conversion of ethanolamine to ammonia and 
acetaldehyde; the enzyme involved is the Cobalamin-dependent ethanolamine ammonia lyase 
(EutBC) (Bradbeer 1965). Acetaldehyde can then be converted to acetaldehyde, which in turn is 
converted to acetyl-CoA, acetyl-phosphate and lastly to acetate. Acetaldehyde can alternatively be 
converted to ethanol. The conversion to acetate produces one molecule of ATP by substrate-level 
phosphorylation and involves the enzymes; acetaldehyde dehydrogenase (EutE), 
phosphotransacetylase (EutD) and acetate kinase, whose gene is outside of the eut operon. The 
conversion of acetaldehyde to ethanol is catalysed by an alcohol dehydrogenase (EutG) which 
maintains the NADH/NAD+ balance (Kofoid et al. 1999; Roof & Roth 1988).  
 
Figure 1.7. The Eut BMC: A) The irregular icosahedron structure of the Eut BMC is shown to be around 
100 nm in diameter B) The degradation pathway of ethanolamine initiates with the conversion to 
acetaldehyde, a volatile intermediate that is confined in the BMC lumen. The products of this 
internalised pathway are ethanol and the acetate-producing intermediates acetyl-phosphate and acetyl-
CoA. Adapted from (Tanaka, Sawaya & Yeates 2010). 
 
S. enterica uses ethanolamine as a sole carbon and nitrogen source under aerobic conditions. In the 
presence of oxygen, the TCA cycle and glyoxylate shunt metabolise acetyl-CoA (Roof & Roth 1988). 
However under fermentative conditions S. enterica is only able to use ethanolamine as a sole 
nitrogen source but not as a sole carbon and energy source. This is because oxygen is required to 
divert pathway intermediates into biosynthetic reactions (Price-Carter, Tingey, Bobik, & Roth, 
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2001). Despite this, the degradation of ethanolamine provides additional ATP under anaerobic 
conditions when yeast extract is present to provide biosynthetic intermediates. In addition, when 
tetrathionate is accessible as a terminal electron acceptor, ethanolamine also provides a sole 
carbon and energy source during anaerobic respiration (Price-Carter et al., 2001).  
 
1.3.2. The eut Operon  
The Eut metabolosome from S. enterica and E.coli are encoded by an operon consisting of 17 genes. 
This includes 5 structural shell proteins; EutS, EutM, EutN, EutL and EutK, as well as enzymes of the 
ethanolamine degradation pathway mentioned above EutBC, EutE, EutD and EutG (Kofoid et al. 
1999; Tanaka, Sawaya & Yeates 2010; Roof & Roth 1988). The operon also contains the genes eutA 
and eutT which encode the regulatory proteins, ethanolamine ammonia lyase reactivase and a 
corrinoid cobalamin adenosyltransferase that converts cob(I)alamin to Adenosylobalamin (Ado-B12) 
.A positive regulatory protein encoded by eutR is required for transcription induction of the eut 
operon (Roof & Roth 1992). The operon also includes the gene eutH, which encodes a transport 
protein for ethanolamine that is important at a low pH (Penrod, Mace & Roth 2004). It has been 
suggested that eutJ encodes a chaperone protein, but the exact function is unknown (Kofoid et al. 
1999). The functions of EutP and EutQ are also unknown, although EutP has shown to have 
sequence similarity to known GTPases (Kofoid et al. 1999).  
 
1.3.3. The Eut Shell 
There are at least five Eut structural shell proteins; these include EutS, EutM, EutN, EutL and EutK 
(Kofoid et al. 1999). Of these, eutK, eutL, eutM and eutN are essential to the formation of the 
metabalosome. Genetic studies have revealed that mutations in any of these essential genes 
disrupt the growth of S. enterica on ethanolamine; it results in the metabolosome shell being 
malformed, permitting acetaldehyde leakage that ultimately prevents growth due to the loss of 
carbon (Penrod & Roth 2006). 
 
23 | P a g e  
 
EutM is a 96-amino acid hexameric BMC domain shell protein. It forms flat, cyclic hexamers that 
fold into extended sheets. The crystal structure has revealed a central pore occupied by a sulphate 
ion (from the crystallisation buffer), which indicates that the pore may be used for the transport of 
small molecules (Tanaka, Sawaya & Yeates 2010). It is thought that due to its similarity to the major 
structural shell protein PduA; EutM is likely to be the major building block of the Eut metabolosome. 
In contrast, other Eut shell proteins were found to have unusual structural features, suggesting 
specialised functional roles (Tanaka, Sawaya & Yeates 2010). 
 
EutL is the largest Eut BMC domain protein and forms a pseudohexameric trimer and is thought to 
have similarity to PduB. Each monomer is formed from a combination of two tandem, circularly 
permuted BMC domains (Sagermann, Ohtaki & Nikolakakis 2009; Tanaka, Sawaya & Yeates 2010). 
Interestingly, as previously mentioned, EutL  presumably features a gated pore, located at the 
centre of the trimer, for metabolite transport (Tanaka, Sawaya & Yeates 2010). This idea is based 
on crystal structures that reveal both an open and closed pore conformation. These two different 
conformations arise from large movements (15 Å) in the loop residues when the pore is opening or 
closing. The open pore is large enough (between 8 and 11 Å) to transport enzymatic cofactors. It is 
thought that a cofactor binds to the closed pore which subsequently opens and allows the molecule 
to enter the BMC; the pore then closes. In addition to EutM, EutL crystallises in molecular layers, 
suggesting its role as a major structural component of the shell (Sagermann, Ohtaki & Nikolakakis 
2009; Tanaka et al. 2008).  
 
EutS is a 111 amino acid shell protein with an unusual structure. Unlike the typical BMC domain 
ƉƌŽƚĞŝŶƐƚŚĂƚĨŽƌŵĨůĂƚŚĞǆĂŵĞƌƐ ?Ƶƚ^ĐŽŶƐŝƐƚƐŽĨĂ ? ?ȗďĞŶĚ ?dŚŝƐďĞŶĚŝƐƉƌĞƐƵŵĞĚƚŽĂůůŽǁƵƚ^
to form the edges of the shell that help the facets to join together, with a similar role to that of PduJ 
(Tanaka, Sawaya & Yeates 2010). It is thought that a single amino acid (G39), which is conserved 
amongst all EutS proteins, is responsible for the unusually bent structure. The crystal structure of a 
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G39V mutant was found to have a flat hexameric structure, giving evidence that this amino acid is 













Figure 1.8. The structure of EutM and EutS. A) Side by side images of EutM and EutS structure, 
highlighting the 40° bend in the middle of EutS hexamer, in comparison to the flat EutM hexamer. B) A 
proposed model of how EutS (orange) may bring about curvature in a flat shell of hexamers, creating 
the vertices of the Eut BMC shell. Adapted from (Tanaka, Sawaya & Yeates 2010) . 
 
EutK is a unique protein in the Eut BMC system.  Unlike the other shell proteins, which have been 
reported to be either trimeric or hexameric, EutK was found to be monomeric in solution. In 
addition to the conserved BMC domain, it has also been found to include a 60 amino acid C-terminal 
extension, which contains a helix-turn-helix nucleic acid binding motif. Additionally this structure 
has a high positive charge, supporting its function in DNA/RNA binding, although its exact role is 
unknown (Tanaka, Sawaya & Yeates 2010). 
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EutN has a pentameric structure. Although it does not contain a BMC domain, it has sequence 
similarity to CcmL and CsoS4A, which are pentameric proteins in carboxysomes that are predicted 
toform the vertices of the BMC (Forouhar et al. 2007).  
 
1.3.4.  Eut Metabolosome Function 
Eut BMCs are thought to play an essential role in the mitigation of the volatile ethanolamine 
degradation intermediate, acetaldehyde. By the encapsulation of this metabolic pathway, 
acetaldehyde is prevented from leaking into the cytoplasm where it could potentially cause damage 
to cellular components. Genetic tests have shown that polA (DNA repair polymerase) and gsh 
(glutathione biosynthesis) mutants are unable to grow on ethanolamine; it was proposed that this 
was due to the toxic build-up of acetaldehyde (Rondon, Horswill & Escalante-Semerena 1995; 
Rondon, Kazmierczak & Escalante-semerena 1995). In addition, due to the structural and functional 
similarities between the Eut and Pdu BMC systems, the proposed aldehyde toxicity of acetaldehyde 
and a role for the Eut BMC in encapsulating this intermediate has been suggested based on the 
toxicity of propionaldehyde and the Pdu BMCs primary function to mitigate this (Chowdhury et al., 
2014).  
 
Moreover, it has been suggested that the primary function of Eut BMCs is to prevent the loss of 
acetaldehyde as an essential carbon source. The vapour pressure of acetaldehyde is much higher 
than that of propionaldehyde and consequently, carbon loss due to volatility is likely to be more 
significant (Chowdhury et al. 2014).  
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1.4. Propanediol Utilisation Microcompartments 
The research described later in this thesis focuses on the characterisation of Pdu BMCs. For many 
years, carboxysomes were considered to be the only known bacterial organelles. However, in 1994, 
a protein was found that had high sequence similarity to the carboxysome shell protein, CcmK  (P 
Chen, Andersson & Roth 1994; T. A. Bobik et al. 1999). The homologous shell protein was 
subsequently named PduA and was found to be a major component of the Pdu shell. Bobik et al 
found that S. enterica forms BMCs similar in size and shape to carboxysomes when grown in the 
presence of 1,2-propanediol (1,2-PD), however when grown on other carbon sources these 
compartments do not form (T. A. Bobik et al. 1999). This led to the discovery of Pdu 









Figure 1.9. Pdu BMCs: TEM image of a thin section of S. enterica serovar Typhimurium LT2 grown on 
propanediol under aerobic conditions. BMCs can be seen throughout the cytoplasm; they are less regular 
in size and shape than carboxysomes and generally smaller. Scale bar 100 nm. Adapted from (G C Cannon 
et al. 2001) 
 
The Pdu BMCs are polyhedral structures about 80-100 nm in diameter and were found to 
encapsulate enzymes necessary for the catabolism of 1,2-PD. Although they are a similar size and 
shape, Pdu BMCs are more complex than carboxysomes. They are estimated to comprise 18,000 
polypeptides consisting of 18 -20 different types. The overall mass is projected to be twice that of 
carboxysomes at 600 MDa (Cheng et al. 2008). 
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Interestingly some bacterial strains, such as Lactobacillus reuteri, are able to utilise Pdu BMCs for 
the metabolism of glycerol as well as 1,2-PD due to the similarity between these three-carbon 
molecules (Pang et al. 2012). 
 
1.4.1. Ecology of 1,2-PD degradation 
The degradation of common plant cell wall sugars such as rhamnose and fucose, produces 1,2-PD 
under anaerobic conditions. In aquatic sediments and the large intestines of higher animals, the 
breakdown of these sugars leads to the release of 1,2-PD as a major product of the fermentation 
process (Obradors et al. 1988; Toraya, Honda & Fukui 1979).  Enteric bacteria and bacteria in soil 
and aquatic environments are then able to use 1,2-PD as a carbon and energy source. Therefore 
through the production of BMCs, bacteria are able to use 1,2-PD for their metabolism, enabling 
them to occupy niches other bacteria can not, allowing them to live in competition-free 
microenvironments.  
 
Genes associated with the formation of Pdu microcompartments have been found in various 
enteric and soil-inhabiting bacterial genera such as; Salmonella, Citrobacter, Klebsiella, Shigella, 
Yersinia, Listeria, Lactobascillus, Lactococcus, Clostridium and a species of Escherichia coli 
(E24377A) (Jorda et al. 2013; Bobik 2006; Cheng et al. 2008). The pdu gene clusters in these genera 
are highly conserved, suggesting that 1,2-PD degradation is dependent on the BMC (Cheng et al. 
2008). It has been shown that the catabolism of 1,2-propanediol and ethanolamine is closely linked 
to intestinal proliferation and to bacterial virulence (Harvey et al. 2011), whilst more recently, 
studies have shown that 1,2-PD degradation is involved in enteric pathogenesis and is essential to 
ƚŚĞďĂĐƚĞƌŝĂ ?ƐĂďŝůŝƚǇƚŽŐƌŽǁŝŶƚŚĞŝŶƚĞƐƚŝŶe (Staib & Fuchs 2014).  
 
1.4.2. The pdu Operon  
The genetic analysis of the catabolism of 1,2-PD by S. enterica identified a specific gene cluster 
involved in the Pdu pathway (Jeter 1990). This gene cluster, or pdu operon, was found to contain 
28 | P a g e  
 
23 genes; pocR, pduF, pduABCDEGHJKLMNOPQSTUVWX (P Chen, Andersson & Roth 1994; T. A. 
Bobik et al. 1999). These genes encode proteins necessary to form a functional BMC, including (I) 
structural proteins, (II) enzymes and (III) regulatory proteins. This comprises (I) the structural shell 
proteins, PduABJKNUT, (II) 1,2-PD degradative enzymes PduCDELPQW, (III) B12 recycling proteins, 
PduGHOSX as well as other Pdu BMC related proteins, PduM and PduV (P Chen, Andersson & Roth 
1994; T. a Bobik et al. 1999). 
 
Both the pdu and cob (cobalamin, B12, biosynthesis) operons are found on the same regulon. This 
regulon is induced by 1,2-PD and controlled by the expression of two  genes; pocR and pduF, located 
between the two operons (Chen et al. 1995). pocR encodes a positive transcriptional regulatory 
protein which mediates the induction of the regulon by 1,2-PD and pduF, encoding a diffusion 
facilitator which enables the transport of 1,2-PD (T. A. Bobik et al. 1999).  PduF also comprises 
motifs that are associated with lipid membrane-binding  and transmembrane channel proteins 
(Bobik et al. 1997; T. A. Bobik et al. 1999). 
 
Coenzyme B12 is an essential cofactor for the first enzyme in the pathway, the diol dehydratase 
(PduCDE) (Jeter 1990) and therefore, growth on 1,2-PD is dependent on its availability. S. enterica 
is able to synthesise Cobalamin de novo, but only under anaerobic conditions (Jeter, Olivera & Roth 
1984). This however, creates a paradox; S. enterica needs oxygen to catabolise 1,2-PD but cannot 
synthesise Cobalamin under aerobic conditions (Roth, Lawrence & Bobik 1996).  However, it has 
now been established that tetrathionate can be used as an alternative terminal electron acceptor 
for both ethanolamine and 1,2-PD utilisation under anaerobic conditions, supporting the 
endogenous synthesis of Cobalamin (Price-Carter et al. 2001). 
 
1.4.3. The Pdu Pathway  
The catabolism of 1,2-PD involves a complex coenzyme B12-dependent pathway. It ultimately 
provides the cell with energy in the form of ATP and propionyl-CoA, an electron sink.  
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Following the uptake of 1,2-PD by the bacterial cell, 1,2-PD is transported into the BMC through the 
Pdu shell, presumably through a pore in the shell of the BMC.. Within the confines of the BMC, 1,2-
PD is converted to propionaldehyde by the coenzyme Cobalamin-dependent enzyme, diol 
dehydratase (Toraya, Honda & Fukui 1979), formed of three protein subunits; PduC, PduD and PduE 
(Bobik et al. 1997). Propionaldehyde can found in both a reduced or oxidised form. 
Propionaldehyde dehydrogenase, PduP, catalyses an reduction reaction to convert 
propionaldehyde to propionyl-CoA where NAD+ acts as a oxidising agent to accept the free electron, 
converting it to NADH (T. a Bobik et al. 1999). Propionyl-CoA  leaves the BMC and is subsequently 
converted to propionyl-phosphate by a phosphotransacylase, PduL, and then to propionate by a 
reversible propionate kinase, PduW, producing one molecule of ATP (Toraya, Honda & Fukui 1979; 
Obradors et al. 1988; Jeter 1990). Propionyl-CoA can also enter the methyl-citrate pathway to 
release pyruvate as a carbon source and succinate, but only in aerobic conditions (Horswill & 
Escalante-semerena 1997). Alternatively, propionaldehyde can be oxidised by 1-propanol 
dehydrogenase, PduQ, to form 1-propanol; this reaction requires the coenzyme NADH to act as a 
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Figure 1.10. The pathway of 1,2-PD degradation. 1,2-PD enters the Pdu BMC through a selectively 
permeable protein shell and is degraded to propionaldehyde, a toxic intermediate that is sequestered 
in the BMC lumen. It is then catabolised to 1-propanol and propionyl-CoA, which leave the BMC and 
feed into central metabolism pathways in the cytosol.  
 
Overall, the catabolism of 1,2-PD produces one molecule of ATP per propanediol molecule, as well 
as 1-propanol, propionyl-CoA and propionate. These products feed into central metabolism via 
other metabolic pathways. Even though the Pdu pathway can operate under aerobic or anaerobic 
conditions, 1-2-PD cannot produce a source of carbon (such as pyruvate) for biosynthetic reactions 
anaerobically. This is because the Methyl-Citrate pathway (see Figure 1.11 below) involves beta-
oxidases that generate NADH + H+ that require an electron transfer chain (Price-Carter et al. 2001). 












Figure 1.11. The Methyl-Citrate pathway, a key pathway for the metabolism for propionate under 
aerobic conditions. Adapted from (Salomons et al. 2000). 
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1.4.4. The Function of Pdu Microcompartments 
Initially 1,2-PD catabolism may seem uncomplicated, but compartmentalisation of this pathway is 
essential for its viability due to the toxicity of the intermediate propionaldehyde. It has been 
suggested that the Pdu shell acts as a differential diffusion barrier to prevent the leakage of 
propionaldehde into the cell cytoplasm. Due to the high reactivity of this intermediate, 
compartmentalisation prevents damage to other cellular components (T. a Bobik et al. 1999). This 
is supported by the study of mutants unable to form the Pdu shell; it was found that 
propionaldehyde accumulated to toxic levels when grown on 1,2-PD (Sampson & Bobik 2008; 
Havemann, Sampson & Bobik 2002). 
 
Another proposed function of the Pdu BMC is that compartmentalisation increases the local 
concentration of key enzymes, substrates and cofactors involved in the pathway to increase the 
efficiency of metabolic reactions. The Pdu BMC is more complex than that of the carboxysome as it 
contains linked metabolic enzymes and regulatory proteins to recycle the Adenosyl-Cobalamin. 
Therefore the need for concentrating the pathway at a molecular level is even greater.   
 
1.4.5. Enzymology and Composition of the Pdu BMC 
Of the 23 genes associated with the pdu operon, seven are known to encode proteins that are 
associated with the compartment shell; PduABJKNTU. Recently, Sinah et al have shown, through 
the use of PduM deletion mutants in S. enterica that PduM also localises with the BMC shell. Further 
evidence showed that when BMCs were purified and compared to the crude extract, PduM was 
enriched in the purified fraction, indicating that it is a component of the shell, however it is not 
required for the production of empty BMCs (Sinha et al. 2012). There is also evidence to suggest 
that PduV, a currently uncharacterised protein, is associated with the outer surface of the 
compartment shell; this is discussed later in chapter 1.6. 
  
Other proteins encoded by the pdu operon form encapsulated enzymes, or enzyme subunits, which 
contribute to the catabolism of 1,2-PD. PduCDE forms the Cobalamin-dependent diol dehydratase 
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enzyme complex which catalyses the first step in the degradation pathway of 1,2-PD. Three further 
enzymes and enzyme complexes to support the role of PduCDE; diol dehydratase reactivase 
(PduGH), adenosyltransferase (PduO) and cobalamin reductase (PduS). These further enzymes 
function to recycle the Adenosyl-Cobalamin, the metabolically active form of Cobalamin associated 
with BMCs (Roth, Lawrence & Bobik 1996). During this recycling process, the central cobalt ion of 
cobalamin is reduced to Co(I), shown as B12(I) in Figure 1.10, by cobalamin reductase, PduS. The 
Co(I) is  a super-nucleophile that, along with the adenosyltransferase enzyme, PduO, facilitates the 
attachment of the adenosyl group from ATP (Walker, Murphy & Huennekens 1969). This reaction 
is unusual in that it releases triphosphate from the ATP molecule. 
 
PduP, a propionaldehyde dehydrogenase, converts the toxic propionaldehyde to propionyl-CoA in 
the second metabolic stage of the pathway. PduP is a CoA-acylating enzyme and requires NAD+ as 
a cofactor (Leal, Havemann & Bobik 2003).  Interestingly, recent studies on L. reuteri, a bacteria that 
ferments glycerol to 3-hydroxypropionic acid (3-HP) also contains the enzyme PduP. This reaction 
involves the conversion of 3-HP to 3-hydroxypropionaldehyde (3-HPA), which is converted to 3-HP-
CoA by PduP. This starts an enzymatic cascade involving PduL and PduW to produce ATP (Sabet-
Azad et al. 2013), indicating a secondary role for some enzymes encoded by the pdu operon. 
 
All of the metabolic enzymes discussed so far; PduCDE, PduS, PduO, and PduP have been shown to 
be encapsulated in the lumen of the BMC. However, the terminal enzymes of the Pdu pathway, 
PduL and PduW are located outside of the compartment and do not co-purify with it (Havemann & 
Bobik 2003).  
 
Although it had previously been found that a phosphotransacylase (PTAC) was involved in 1,2-PD 
degradation, the enzyme involved had not been identified (Toraya, Honda & Fukui 1979; Obradors 
et al. 1988). However, it has been established that the pduL gene encodes an evolutionarily distinct 
PTAC, which is conserved and functions to convert propionyl-CoA to propionyl phosphate in the 
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Pdu pathway (Liu et al. 2007).  Likewise, PduW is a terminal enzyme associated with the BMC, but 
located outside the confines of the lumen (Havemann & Bobik 2003). Bobik et al found that pduW 
had 87% similarity to the acetate kinase gene ack found in S. enterica, idnetifying PduW as a 
propionate kinase that converts propionyl phosphate to propionate (T. a Bobik et al. 1999).  
 
PduQ was found to be related to alcohol dehydrogenases in 1999 by Bobik et al and has since been 
found to catalyse the conversion of propionaldehyde to 1-propanol (T. a Bobik et al. 1999). More 
recently, studies have shown that PduQ from S.enterica is iron-dependent and is located in the 
BMC, unlike two other terminal enzymes PduL and PduW. Through a series of in vitro and in vivo 
studies, Cheng et al have also identified that the main function of PduQ is to recycle NADH to its 
oxidised form, NAD+ within the confines of the BMC. This allows PduP to be supplied with its 
cofactor, NAD+ internally within the Pdu BMC. However, studies also indicated the regeneration of 
NAD+ can occur via the electron transport chain. This requires the movement of NADH and NAD+ 
across the semi-permeable Pdu shell (Cheng et al. 2012), as shown in Figure 1.10. 
Bioinformatic studies have shown that pduX, the last gene in the pdu operon, encoĚĞƐ ĂŶ ɿ-
Threonine kinase (Rodionov et al. 2003). Fan et al shoǁĞĚ ƚŚĂƚWĚƵyĐŽŶǀĞƌƚƐ ɿ-ƚŚƌĞŽŶŝŶĞ ƚŽ ɿ-
threonine-phosphate in S. enterica, a precursor for the nucleotide loop of Ado-Cobalamin (Fan & 
Bobik 2008). This means it is directly involved in de novo synthesis of Ado-Cobalamin. In addition 
WĚƵyǁĂƐƚŚĞĨŝƌƐƚĞŶǌǇŵĞŝĚĞŶƚŝĨŝĞĚƚŚĂƚƉŚŽƐƉŚŽƌǇůĂƚĞƐĨƌĞĞɿ-threonine (Rodionov et al. 2003).  
 
Overall, the Pdu BMC encases at least 6 enzymes, comprising 9 different proteins; PduCDE, PduGH, 
PduO, PduP, PduQ and PduS. A further three enzymes have been found to associate with the BMC 
but are not located within the lumen, these are PduL, PduW and PduX.  
 
1.4.6. Formation of the Pdu BMC  
The way in which Pdu shell proteins assemble to form the icosahedral structure of the BMC remains 
unresolved. Further study into BMC formation needs to take place to understand fully the potential 
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of BMCs in synthetic biology and biotechnology. However, a recent study into the formation of the 
recombinant carboxysome shell has led to the finding that the internal cargo, RuBisCO, is capable 
of self-assembly; this initiates carboxysome formation and results in the carboxysome shell proteins 
constructing around the cargo  (Cameron, Wilson, Bernstein, & Kerfeld, 2013; A. H. Chen, Robinson-
Mosher, Savage, Silver, & Polka, 2013). However, the Pdu BMC is a more complex system, with 
more proteins involved and a larger number of internalised enzymes, substrates and cofactors. Due 
to the striking similarities between the two BMCs, it is feasible to conceive that Pdu BMC formation 
could use a similar model involving the self-aggregation of internalised components which is 
subsequently enveloped by the Pdu shell proteins. This remains unclear as the Pdu BMC has been 
shown to encapsulate enzymes that contain a specific targeting sequence. This sequence can be 
recombinantly used to target other enzymes and proteins to the BMC (see section 1.5.1). The need 
for a targeting sequence could indicate that the Pdu BMC shell structure may form before some of 
the enzymes are encapsulated, although it could be possible for initiation of compartment 
formation to begin with the self-aggregation and assembly of several specific encapsulated 
proteins.  
 
1.4.7. The Pdu Shell 
BMCs shells are typically composed of 5  ? 10 proteins that contain a specific BMC domain (see 
chapter 1.1.1). Recent crystallography studies have given insights into how Pdu BMC proteins 
assemble to form the organelle shell and also the function of these proteins (Crowley et al. 2008; 
Kerfeld et al. 2005; Tanaka et al. 2008; Havemann, Sampson & Bobik 2002; Pang et al. 2014). Several 
features of the BMC shell make it specialised to its function. At least three properties of shell 
proteins are important for the function of the bacterial organelle; the proteins must interact with 
each other to form a layer which surrounds the BMC, they must form essential interactions with 
internal components of the organelle and also allow the movement of molecules across the shell 
(Crowley et al. 2008).  
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The current model of the Pdu BMC suggests that it is composed of at least seven different proteins; 
PduA, PduB, PduJ, PduK, PduN, PduT and PduU (Cheng et al. 2011). It is also thought that the shell 
could contain another protein, PduM, as it was found that a deletion mutant lacking the pduM gene 
produced BMCs with irregular size and shape, although its exact role is unclear (Sinha et al. 2012). 
In addition, due to two translation start sites, pduB is translated into two separate proteins of varied 
lengths, WĚƵ ? ? ?ŬĂ )ĂŶĚĂƐŚŽƌƚĞƌŝƐŽĨŽƌŵ ?WĚƵ ? ? ? ?ŬĂ )ǁŚŝĐŚĚŝĨĨĞƌƐďǇ ? ?ƌĞƐŝĚƵĞƐ(Havemann 
& Bobik, 2003). These shell proteins were initially identified by their DNA sequence similarity to 
proteins required for carboxysome formation, in particular PduA, PduJ, PduK and PduT proteins 
that have similarity to shell proteins of the carboxysome (T. A. Bobik et al. 1999; Shively et al. 1998). 
 
WĚƵ ?WĚƵ ?WĚƵ ?ĂŶĚWĚƵ:ĂƌĞĐŽŶƐŝĚĞƌĞĚƚŽďĞƚŚĞŵĂũŽƌĐ ŵƉŽŶĞŶƚƐŽĨƚŚĞWĚƵDƐŚĞůů ?
constituting 7.5, 12.8, 12.1 and 11% of purified Pdu organelles from S. enterica, as determined by 
densitometry of 2D electrophoresis (Havemann & Bobik 2003). The minor shell components were 
determined to be PduK, PduN, PduT and PduU, with protein percentages of 1.6, not determined, 
1.6 and 1.5% respectively (Havemann & Bobik, 2003). Parsons et el demonstrated that organelle 
formation was dependent on the concentration of the shell proteins; if these proteins were 
overproduced in an E. coli strain containing the pdu operon, the resulting BMCs were abnormal 
(Parsons et al. 2008).  
 
Studies have also been carried out to determine which of these shell-associated proteins are 
essential to the structure of the BMC. It has been shown that deletion of shell protein genes 
generally have two main phenotypes when grown on 1,2-PD; propionaldehyde toxicity and faster 
growth when cobalamin is limiting (Havemann, Sampson & Bobik 2002; Sampson & Bobik 2008) 
This is characteristic of the non-functional BMCs when pduB and ƉĚƵ ?, pduJ or pduN are deleted, 
indicating that they are essential structural proteins required for complete and intact organelle 
formation. In addition, when the C. freundi pdu operon is expressed in E. coli, a pduA deletion 
mutant is unable to form BMCs in this system, indicating that it could be essential to the formation 
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of the BMC (Parsons et al. 2008). However, later studies using the endogenous S. enterica pdu 
operon suggest then when pduA is deleted, the resulting strains appear to have intermediate 
phenotypes; they form larger organelles and produce an intermediate level of toxicity by 
propionaldehyde (Cheng et al. 2011). When pduK, pduT or pduU were deleted, the BMC structure 
was not impaired and growth on 1,2-PD was not severely influenced (Cheng et al. 2011). Previous 
ǁŽƌŬ ŽŶ ƌĞĐŽŵďŝŶĂŶƚ ?ĞŵƉƚǇ WĚƵ ĐŽŵƉĂƌƚŵĞŶƚ ƐŚĞůůƐ  ?ŝĞ D ?ƐŽŶůǇ ĐŽŶƚĂŝŶŝŶŐ ƐŚĞůů ƉƌŽƚĞŝŶƐ )
showed that not all of these proteins are necessary to form the BMCs in E.coli. The minimum shell 
ĐŽŵƉŽŶĞŶƚƐƌĞƋƵŝƌĞĚƚŽĨŽƌŵƚŚĞĞŵƉƚǇŽƌŐĂŶĞůůĞǁĞƌĞĨŽƵŶĚƚŽďĞWĚƵ ?WĚƵ ?WĚƵ ? ?WĚƵ: ?WĚƵ<
and PduN (Parsons et al. 2010). 
 
X-ray crystal structures of Pdu shell proteins have revealed flat, 6-fold hexamers that package in a 
tile-like formation and form layers, as shown in Figure 1.2 (Crowley et al. 2008; Pang et al. 2014). 
Most of these crystallised hexamers, with the exception of PduU, have distinct openings along the 
central axis. These openings are thought function in molecular transport and act as pores. These 
pores have been found to differ in size and charge, depending on the residues surrounding the 
opening (Kerfeld et al. 2005; Crowley et al. 2010).  
 
As with the Eut BMC it is proposed that the BMC protects the cell from propionaldehyde, the toxic 
intermediate formed from the conversion of 1,2-PD by PduCDE, a diol dehydrase. This is thought to 
be the main function of the Pdu BMC; to mitigate the toxicity by acting as a barrier to prevent 
diffusion and subsequent DNA damage (T. A. Bobik et al. 1999).  
 
1.4.7.1. PduA  
PduA is a 94 amino acid residue shell protein of the Pdu organelle that has been estimated to 
comprise 16% of the total shell (Havemann & Bobik 2003), rendering it a major component. It was 
originally identified due to its similarity to CcmK, a carboxysome shell protein (T. A. Bobik et al. 
1999; P. Chen, Andersson & Roth 1994). PduA was first shown to be part of the Pdu shell in 2002 
by Havemann, Sampson and Bobik (Havemann et al., 2002). They did this through immunogold 
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labelling of S. enterica cells using anti-PduA antibodies and subsequent visualisation by electon 
microscopy. It was found that the majority of gold particles localised to the periphery of the Pdu 
organelles, indicating that PduA is a shell component. They also showed that a pduA deletion 
mutant was unable to form intact BMCs, characterising PduA as an essential protein for the 
formation of compartments (Havemann, Sampson & Bobik 2002). However this strain was actually 
a double deletion mutant lacking both pduA and pduB and further studies showed that a single 
pduA mutant forms enlarged BMCs with similar appearance to that of the wild type (Cheng et al. 
2011). Interestingly it was later found that in recombinant, empty Pdu BMCs expressing the 
minimum number of shell proteins required, when pduA is deleted the resulting BMCs formed are 
elongated and filamentous and no longer resembled intact microcompartments (Parsons et al. 
2010). In addition, when PduA was overexpressed in E.coli, without the other Pdu proteins, the 
structures formed were ordered nanotube-like arrangements in the cell cytoplasm unlike  the 
structure of intact whole BMCs (Parsons et al. 2010; Pang et al. 2014).  
 
PduA has a single BMC domain and the crystal structure reveals that monomers package into a 
symmetrical hexamer on the six-fold axis of symmetry. It is shaped like a hexagonal disc, similar to 
shell protein hexamers from other BMCs (Crowley et al. 2010). The hexamer has an opening in the 
centre of the disc which is a defining feature of BMC shell proteins and is thought to serve as a 
central pore to facilitate the selective movement of molecules across the shell (Crowley et al. 2010; 
Kerfeld et al. 2005). These hexamers have been shown to group tightly into higher order structures, 
namely uniform molecular sheets, with edge-edge interactions between hexameric units (Crowley 
et al. 2010).  
 
Through these findings, it was suggested that PduA potentially functions as a shell protein 
transporter for 1,2-PD (Havemann & Bobik 2003; Havemann, Sampson & Bobik 2002; Crowley et al. 
2010). This proposed function is consistent with the high abundance of PduA, from isolated BMCs, 
compared with the other shell proteins (Havemann & Bobik 2003; Havemann, Sampson & Bobik 
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2002). In addition, the properties of the central PduA pore gives further evidence for its function in 
1,2-PD transport. The exposed atoms forming the pore during crystallography show many hydrogen 
bond donors and acceptors. This could favour the transport of the relatively hydrophilic 1,2-PD over 
propionaldehyde, which presents only one hydrogen bond acceptor and no donors, subsequently 
limiting its loss from the BMC (Crowley et al. 2010). Also, it has been reported that pduA deletion 
mutants are still able to form enlarged functional BMCs, but when cultured on 1,2-PD, there was a 
period of interrupted growth (Havemann, Sampson & Bobik 2002; Cheng et al. 2011), this reinforces 
its role as a 1,2-PD transporter as opposed to a shell support protein. Further evidence stems from 
a crystallisation study that has captured a substrate analog, glycerol (similar to 1,2-PD), bound to 
the central pore of a PduA mutant (Pang et al. 2014). This supports the view that substrates, in 
particular 1,2-PD, can enter the organelle via the central pore of PduA.  
 
Alternatively, PduA interacts with many of the other shell proteins and could therefore potentially 
act as a scaffold for BMC biogenesis. It has been shown to interact with PduB, PduJ,PduK, PduN and 
PduU (Parsons et al. 2010).  
 
1.4.7.2. PduB 
PduB is synthesised in two forms due to the presence of two translation start sites on the 
polysistronic mRNA (Parsons et al. 2008). Essentially, pduB is two overlapping genes expressed in 
ƚŚĞƐĂŵĞƌĞĂĚŝŶŐĨƌĂŵĞ ?dŚŝƐƉƌŽĚƵĐĞƐƚǁŽĚŝĨĨĞƌĞŶƚƉƌŽƚĞŝŶƐ ?WĚƵĂŶĚWĚƵ ?ŽĨ ? ?ĂŶĚ ? ?ŬĂ
respectively (Havemann & Bobik 2003). The significance of the two different forms of PduB have 
not yet been established.  
 
dŽŐĞƚŚĞƌ ?WĚƵĂŶĚWĚƵ ?ŵĂŬĞƵƉŽǀĞƌ ? ?A?ŽĨƚŚĞƚŽƚĂůWĚƵ ƐŚĞůůƉƌŽƚĞŝŶŵĂƐƐ ?Ăƚ ? ?A?ĂŶĚ ? ?A?
respectively (Chowdhury et al. 2014). This indicates that it has an important role in the structure 
and integrity of the compartment shell. Studies have provided evidence for this; ƉĚƵ ? deletion 
mutants produced a strain with no visible BMCs from several hundred examined cells, indicating 
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ƚŚĂƚWĚƵĂŶĚWĚƵ ?ĂƌĞĞƐƐĞŶƚŝĂůĨŽƌƚŚĞĨŽƌŵĂƚŝŽŶŽĨƚŚĞD ?/ŶĂĚĚŝƚŝŽŶ ?ĂƐŝŶŐůĞƉŽůĂƌďŽĚǇ 
was observed in ~20% of cells, consisting of aggregated BMC components (Cheng et al. 2011). 
/ŶƚĞƌĞƐƚŝŶŐůǇ ?ĚĞƐƉŝƚĞƚŚĞŚŝŐŚĂďƵŶĚĂŶĐĞŽĨWĚƵ ?ŝŶƚŚĞWĚƵƐŚĞůů ?ƚŚe only other shell protein it 
was found to interact with, by nickel affinity chromatography pull-down assays, was PduA (Parsons 
et al. 2010). 
 
The crystal structure of PduB from L. reuteri has been solved. Three PduB subunits assemble into a 
trimer with pseudo-hexameric symmetry, as a result of each subunit containing a tandem BMC 
repeat. In total 18 ligands have been found to bind to the trimeric PduB structure; of these 17 were 
glycerol and one was an acetate ion. One of these glycerol ions was found to bind to the central 
pore of the trimeric structure and three glycerol molecules occupy each of the subunit channels 
with the others binding at the chains (Pang et al. 2012).   
 
The PduB trimer subsequently forms higher order structures by packaging into uniform molecular 
sheets, similar to that of PduA and PduT and are thought to form the facets of the BMC. However, 
unlike other Pdu shell protein, PduB contains subunit pores with the ability to bind glycerol. The 
abundance of glycerol bound to sites around the concave face of PduB suggests that it is involved 
in glycerol transport; the crystal structure shows that residues lining the pore have affinity for 
glycerol molecules and could act as a substrate channel. It is thought that due to the structural 
similarity, size and hydrogen bonding potential between glycerol and 1,2-PD, the subunit channels 
are likely to be a transport mechanism for 1,2-PD. It has also been suggested that propionaldehyde 
may not pass through the pores due to the different hydrogen-bonding potential of the aldyhyde 
group compared with that of the hydroxyl group; aldehydes accept two hydrogen bonds in planar 
arrangement whereas alcohols can donate one and accept two hydrogen bonds with tetrahedral 
geometry. There are at least two sites located in the PduB structure which display these 
characteristics, providing evidence that it is able to act as a semi-permeable barrier to prevent the 
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loss of the toxic aldehyde from the BMC but permit the transport of 1,2-PD across the shell (Pang 
et al. 2012).   
 
In addition, the glycerol molecule bound to the central pore contains flexible loops above and below 
it. When glycerol is bound, the loops are locked closed. This suggests that it could be a ligand-gated 
channel that could prevent aldehyde efflux but allow the transport of glycerol and possibly 1,2-PD 
into the BMC (Pang et al. 2012).  
 
1.4.7.3. PduJ 
The crystal structure of PduJ has not yet been solved, however PduJ shares 86% sequence similarity 
to PduA, indicating a similar structure and role in the BMC shell (Crowley et al. 2010). Interestingly, 
PduA and PduJ share 100% similarity over the pore-lining residues, 37-40, suggesting that their 
function in the shell is identical. In contrast to PduA, a pduJ deletion mutant forms elongated 
compartments, suggesting improper closure of the BMC (Cheng et al. 2011; Chowdhury et al. 2014). 
This may infer that PduJ forms the edges that join the BMC facets together for complete closure of 
the organelle. This is supported by the relatively high abundance of PduJ, comprising 11% of the 
total BMC protein. In addition, a pduJ deletion mutant was shown to prevent the formation of BMCs 
in 57% of cells; where no BMC-like structures we seen. In 22% of cells of cells, elongated structures 
were observed, supporting the role of PduJ as an essential structural component of the Pdu shell 
(Cheng et al. 2011).  
 
1.4.7.4. PduK 
Although the structure of PduK has not been solved, it is clear that the sequence contains a 
predicted iron-sulphur (Fe-S) cluster binding motif in the carboxyl terminal domain of the protein, 
namely [CNLCLDPKCPRQKGEPRTLC] (Crowley et al. 2010). This C terminal extension makes PduK 
larger than most of the other shell proteins ?ǁŝƚŚƚŚĞĞǆĐĞƉƚŝŽŶŽĨWĚƵ ? ?Ăƚ ? ? ?ĂŵŝŶŽĂĐŝĚƐŝŶ
length. The function of this Fe-S cluster is unclear; it was proposed that the C terminus could be 
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involved with a specific targeting sequence that enables enzymes to be targeted to the interior of 
the BMC, however, it has since been shown, through the use of PduK C terminal truncations, that 
the N terminus of PduK is involved with targeting peptides to the organelle lumen (Lawrence et al. 
2014).  
 
Interestingly, PduK seems to interact with many proteins in the pdu operon, including PduA, PduT, 
WĚƵD ?WĚƵsĂŶĚWĚƵW ?ĂůƚŚŽƵŐŚŝƚ ?ƐĞǆĂĐƚĨƵŶĐƚŝŽŶŚĂƐŶŽƚǇĞƚďĞĞŶĚĞƚĞƌŵŝŶĞĚ (Parsons et al. 
2010; Lawrence et al. 2014). A recent study has shown that through the use of PduK C-terminal 
truncations, the N-terminus of PduK mediates protein encapsulation into the BMC through an 
interaction with the targeting peptide P18 (see section 1.5.1) (Lawrence et al. 2014). However the 
role of the C-terminal extension is currently unclear, although it is thought to facilitate the binding 
of other Pdu proteins, cofactors or enzymes.  
 
It was found that a pduK deletion resulted in the formation of aggregates of BMCs (Cheng et al. 
2011). These aggregates occurred in ~52% of the cells studied. However they differed from the 
ƉŽůĂƌďŽĚŝĞƐŽďƐĞƌǀĞĚŝŶWĚƵ ?ĚĞůĞƚŝŽŶŵƵƚĂŶƚƐ ?ŝŶWĚƵ<ĚĞůĞƚŝŽŶƐƚƌĂŝŶƐ ?ĂŐŐƌĞŐĂƚĞƐĂƉƉĞĂƌĞĚ
to be composed of BMCs with shell structurĞƐƉƌĞƐĞŶƚ ?WŽůĂƌďŽĚŝĞƐŽďƐĞƌǀĞĚŝŶWĚƵ ?ĚĞůĞƚŝŽŶƐ
seemed to lack any defined structures. Further studies also showed that these PduK deletion 
aggregates were fully functional demonstrating that PduK is not essential to the function of the 
BMC, but does have an effect on its localisation and perhaps its solubility (Cheng et al. 2011). In 
addition the pduK deletion had no effect on propionaldehyde toxicity or growth on 1,2-PD. It has 
been suggested that PduK has a role in the spatial organisation of BMCs in the cell, or a role in BMC 
segregation during cell division (Cheng et al. 2011).  
 
1.4.7.5. PduN 
Currently, it is understood that bacterial organelles are comprised of sheets of hexameric shell 
proteins that are subsequently folded into polyhedral facets, forming the faces of the BMC (Kerfeld 
et al. 2005). These facets are thought to be joined by a pentameric protein present at the vertices 
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of the polyhedral shell (Tanaka et al. 2008).  These pentameric proteins are smaller than the other 
hexamers and belong to family of similar presumed vertex proteins with a distinct sequence and 
structure. However, although crystal structures of hexameric proteins support this model, studies 
of vertex proteins remain inconclusive (Wheatley et al. 2013). 
 
Proteins associated with vertex family include; EutN, PduN, CcmL and CsoS4. Of these proteins, 
CcmL and CsoS4 (carboxysome proteins) have been found to be pentameric, however EutN has 
revealed a hexameric quaternary structure that is almost hexagonal in shape (Tanaka, Sawaya & 
Yeates 2010). However a recent study has found that EutN does have a pentameric assembly 
(Wheatley et al. 2013). 
 
This provides evidence that PduN is very likely to form a pentameric arrangement that helps the 
BMC to close by establishing the vertices of the structure, although it has not yet crystallised. A 
study using a pduN deletion mutant found that in ~90% of cells, BMCs were irregular and had 
abnormal shapes, they were also subject to propionaldehyde toxicity during growth on 1,2-PD, 




PduT accounts for approximately 3% of the total content of the Pdu BMC shell, constituting it as a 
minor component of the shell  (Cheng et al. 2011). It is a unique shell protein in that it contains 
tandem BMC domains with a novel fold variation; it is known to assemble as a pseudohexomeric 
homotrimer (Crowley et al. 2010). The crystal structure reveals that PduT does not form extended 
two-dimensional layers that other shell proteins do. Instead interactions formed between the edges 
of the hexamers bury half the surface area that  PduA does. This may be a control mechanism to 
limit the incorporation of PduT in the shell, allowing it to interact with other Pdu proteins (Crowley 
et al. 2010). 
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The crystal structure of PduT has also revealed a site at the central pore for a [4Fe-4S] cluster to 
bind (Crowley et al. 2010). Interestingly, this cluster is accessible from both sides hinting at a role 
in electron transfer across the BMC shell, or for the regeneration of Fe-S centers in the BMC lumen 
(Crowley et al. 2010; Chowdhury et al. 2014). Each subunit of the trimer provides a cysteine residue 
which are included in the ligands for the metal cluster, however the fourth ligand to the iron 
molecule was not identifiable. Furthermore, two additional cysteine residues (C108 and C136) 
located in close proximity in domain II may form a disulphide bond. It is thought that the formation 
of this disulphide link may alter the conformation of PduT. This could cause a redox-sensitive change 
to the central pore. Considering the putative function of PduT in electron transport; the role of this 
shell protein could be to support PduS, which mediates the reduction of B12 by providing one 
electron to the central cobalt atom (Cheng & Bobik 2010).   
 
1.4.7.7. PduU 
PduU is a minor Pdu shell protein; it is not abundant and is non-essential for the formation and 
function of the Pdu metabolosome (Havemann & Bobik 2003; Cheng et al. 2011). As expected, PduU 
has a hexameric form but unusually, the permuted BMC fold is circular. Instead of forming well-
packaged hexagonal layers, PduU tends to form strips of hexamers. 
 
A unique feature of PduU in comparison to the other shell proteins is the presence of a six-stranded, 
ƉĂƌĂůůĞůɴ-barrel produced by the amino terminus on the other side of the disk forming an extended 
tail (Crowley et al. 2008; Tanaka, Sawaya & Yeates 2010) ?dŚŝƐɴ-barrel allows the central PduU pore 
region to be capped (Crowley et al. 2008) ?dŚĞĂƉƉĞĂƌĂŶĐĞŽĨɴ-barrels in transmembrane proteins 
usually consist of at least 12 strands and function to create pores for molecular transport (Schulz 
2002) ?ŚŽǁĞǀĞƌƚŚĞĐĞŶƚƌĞŽĨƚŚĞWĚƵhɴ-barrel is occluded and therefore unlikely to have a role in 
transport. There is some speculation that this occluded conformation could open under certain 
conditions to allow the transport of small molecules, however due to an unusual deep cavity with 
ƐĞǀĞƌĂůŚǇĚƌŽƉŚŽďŝĐƌĞƐŝĚƵĞƐ ?ŽŶƚŚĞĨĂĐĞŽĨWĚƵhŽƉƉŽƐŝƚĞƚŚĞɴ-barrel, it has been suggested that 
PduU could form several, currently unknown, molecular interactions and/or present a specific 
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enzyme binding site (Crowley et al. 2008; Chowdhury et al. 2014). A recent study has demonstrated, 
through protein-ƉƌŽƚĞŝŶŝŶƚĞƌĂĐƚŝŽŶŵŽĚĞůůŝŶŐ ?ƚŚĂƚƚŚĞWĚƵhɴ-barrel is likely to interact with the 
N-terminus of PduV. Experimental data has confirmed, using a bait and prey method, that PduV 
and PduU do interact (Jorda et al. 2015). This interaction suggests that PduU plays a role in the 
possible spatial organisation of Pdu organelles in the cell.  
 
Studies have been carried out using a recombinant system involving the expression of shell proteins 
alone to form empty Pdu organelle shells. When pduU was deleted from this system, there was no 
effect on the BMC shells (Parsons et al. 2010). Studies using the complete pdu operon also confirm 
that pduU deletion mutants produce BMCs with normal formation and the majority of cells (~90%) 
contained BMCs similar to that of the wild type (Cheng et al. 2011). In addition, when pduU deletion 
mutants were grown on 1,2-PD with limiting B12, the growth rate of cells was similar to that of the 
wild type in limiting B12. This demonstrates that PduU is nonessential for the formation of Pdu 
BMCs and does not affect the mitigation of propionaldehyde toxicity as growth was not impaired 
(Cheng et al. 2011). This suggests a specialised functional role for PduU in the BMC shell, such as 
facilitating molecular transport.  
 
1.4.7.8. PduM 
The role of PduM is completely unknown. There is no distinguishable BMC domain, causing it to be 
overlooked as a shell protein and there are no other identifiable motifs. Sequence analysis shows 
that it is unrelated to proteins of a known function, but a GenBank search reveals that there are 
over 200 PduM homologs among many genera, including those currently known to produce Pdu 
BMCs.  
 
Studies have indicated that PduM could possibly be a structural component. SDS-PAGE and Western 
Blot analysis of BMCs from wild type S. enterica versus a pduM deletion strain shows that PduM 
from the wild type is present in the fraction containing purified BMCs; the band is not present in 
the purified fraction from the deletion strain. In addition overproduction of PduM caused the 
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formation of BMCs to be impaired. EM of the deletion mutant indicated that PduM is required for 
the formation and assembly of Pdu BMCs, however growth rates of the mutant indicated that there 
was no effect on 1,2-PD metabolism. It has therefore been suggested that PduM may be a structural 
component of the Pdu BMC, but has no catalytic function (Sinha et al. 2012). Despite these findings, 
more research needs to be undertaken to determine the exact location and function of PduM in 
the Pdu BMC.  
 
1.5. Recombinant Pdu studies 
The potential uses of BMCs in synthetic biology, metabolic engineering, nanotechnology and 
bioengineering are vast, with many possible applications. (see section 1.1.4).  That being said, the 
capability to engineer recombinant BMCs can not only advance our understanding of these unique 
bacterial organelles, but also help us to realistically apply BMCs to a system that can produce them 
easily, cheaply and quickly, in order for them to be used in an industrial setting.  
 
In order to do this, BMCs have been designed in a recombinant system whereby empty 
compartment shells can be expressed in lab strains of E.coli. These empty shells can then be used 
in various ways to further our knowledge of how the system works and also how BMCs can be 
applied.  
 
Thus far, the Pdu compartmentalisation system is thought to be promising for further use as a 
recombinant vessel for biosynthetic pathways. This is because it contains the most diverse range of 
shell proteins, to allow many different enzymes and metabolites to be encapsulated. In comparison, 
carboxysomes are formed from fewer shell proteins and generally pack the interior with RuBISCo. 
This means the targeting of diverse pathways to the interior of the BMC may prove to be difficult 
due to the limitations of the shell and also the specialised luminal environment. 
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Currently it is possible to express empty Pdu shells in E.coli. This allows further study on the 
formation of the Pdu BMC and shell proteins, but also allows the exploration of protein targeting 
to the BMC.  
 
Parsons et al have shown that empty Pdu BMCs, containing the BMC domain shell proteins 
PduABJKNUT, are capable of forming complete, delimited compartments (Figure 1.12B), although 
PduU and PduT were found to be non-essential to the formation of intact BMCs. Analysis of the 
crude extract of E.coli cells expressing the empty shells revealed protein bands corresponding to 
that of the shell protein sizes by SDS-PAGE. In addition this protein complex could be separated 
from other cytoplasmic protein by ultracentrifugation on a sucrose gradient (Figure 1.12A). 
Furthermore, this study showed that immunogold labelling of these delimiting compartments using 
an anti-PduA primary antibody clearly demonstrates that these structures are that of the Pdu shells, 
see Figure 1.12C (Parsons et al. 2010). 
 
Figure 1.12. The synthesis of empty Pdu BMCs containing the shell proteins PduABJKNUT A) SDS-PAGE 
of the protein extract of cells expressing empty BMCs after sucrose gradient utracentrifugation (lane 2) 
against a protein standard (lane 1) PduN cannot be seen, but is thought to have low expression, 
consistent with its role as a vertex protein. B) TEM thin sections of E.coli cells expressing Pdu Shells, 
individual comparments can be seen C) Immunogold labelling of thin sections of E.coli expressing 
pduABJKNUT, cross-reacted with anti-PduA antibodies and a secondary antobidy conjugated to 15 nm 
gold particles. The particles can be seen to localise at the boundaries of the BMCs, cŽŶƐŝƐƚĞŶƚƚŽWĚƵ ?Ɛ
role as a major structural shell protein. Sourced from (Parsons et al. 2010) with permissions. 
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1.5.1, Targeting Proteins to the Compartment 
Further to the production of empty organelles, Parsons et al have also show that proteins can be 
targeted to the shell, in a step forward to our understanding of how BMCs can be utilised in 
synthetic biology. By the use of PduC, PduD and PduV as delivery vehicles, GFP was localised to the 
empty BMC. Moreover, depending on the targeting protein, GFP could be differentially targeted to 
the outside of the BMC shell, or to the compartment interior; live cell imaging revealed that proteins 
can be directed to the BMC lumen with PduC or PduD, or to the outer surface with PduV. It was 
also shown that the first 42 amino acids of PduV were capable of protein targeting, although the 
exact sequence is still unknown (Parsons et al. 2008).  
 
Moreover, research on the use of luminal enzymes to target proteins to the BMC has identified ~20 
amino acid N-terminal extensions containing specific targeting sequences. The first to be identified 
was that of PduP from S. enterica; it was found that the first 18 amino acids were sufficient for 
encapsulating GFP inside the BMC (Fan et al., 2010). Subsequently, further studies revealed that 
the first 18 amino acids of PduD also acted as a targeting sequence and was able to direct protein 
to the interior of the BMC (Fan & Bobik 2011).  Although interactions that facilitate transport across 
the proteinaceous shell remain largely unknown, specific amino acids have been identified as 
important for shell binding. E7, I10 and L14 of PduP is required for the initial binding to PduA and 
subsequent encapsulation. It has been suggested that E5, L8 and I12 are the analogous targeting 
residues in the N terminus of PduD (Sargent, F. a Davidson, et al. 2013). It has been found that these 
PduP targeting sequence residues, which are locĂƚĞĚ ŽŶ ƚŚĞ ĨĂĐĞ ŽĨ ĂŶ ɲ-helix, bind to the C-
terminal helix of PduA and PduJ (Fan et al. 2012). Recent in vitro studies of Pdu BMCs from 
Citrobacter freundii have found that the PduP targeting sequence mediated encapsulation through 
an interaction with PduK (Lawrence et al. 2014). The variance in identified shell protein for PduP 
interaction could highlight the differences between Citrobacter and Salmonella systems, or could 
indicate that PduP interacts with several shell proteins.  
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However, targeting sequences must only count for one method of directing an enzyme to the BMC 
as other BMC-associated proteins lack extensions that could contain targeting sequences, and no 




1.5.2. Targeting Pathways to the Pdu BMC 
As a relatively new area of research, there is a lot of interest in how targeting peptides can be used 
to direct protein to the BMC. In particular, synthetic 18 amino acid long peptides, from the N 
terminus of PduP or PduD have been have been used to target protein into the lumen of purified, 
empty BMC shells (Lawrence et al. 2014). This gives vast potential for the use of targeting peptides 
and recombinant BMCs for the biosynthesis of entire pathways. Indeed, it has already been shown 
that the use of these targeting sequences to tag both pyruvate decarboxylase and an alcohol 
dehydrogenase in an in vivo empty BMC system, can create an ethanol bioreactor in the interior of 
the Pdu BMC. Moreover, results showed that strains containing these modified BMCs produced 
elevated levels of ethanol compared with strains that did not contain bacterial organelles (Lawrence 
et al. 2014).  
 
1.6. The Spatial Organisation of Pdu BMCs 
Microcompartment dynamics in a growing and dividing cell remains largely elusive. However there 
must be a mechanism to ensure daughter cells obtain BMCs when a cell divides. Live cell imaging 
using time lapse microscopy has demonstrated that fluorescently-labelled Pdu BMCs associate with 
filamentous structures in the cell and, through an unknown mechanism, are able to move across 
these filaments. It has been shown that these filaments are comprised of or at least associated with 
PduV by live cell imaging (Parsons et al. 2010).  
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1.6.1. An introduction to PduV, Structure and Function 
PduV is one of the few Pdu-related proteins whose function is completely unknown. It is a relatively 
small protein, 150 amino acids in length and approximately 16 kDa. The structure is currently 
unknown but is predicted to contain four helices as well as a beta sheet (Figure 1.13). To form 
filaments, it would be necessary for PduV to polymerise, although the orientation and specific 
interactions during protein polymerisation is completely unknown. However it is uncertain if PduV 







Figure 1.13. Predicted model for the structure of a PduV monomer. Based on a target-template 
sequence similarity alignment of 22%, using the Protein Model Portal. 
 
Studies have given insights into the role PduV may have; by the use of live cell imaging, PduV-GFP 
was seen to localise to filaments in the cell cytoplasm, which were often associated with mCherry-
tagged Pdu BMCs (Parsons et al. 2010). This indicates that PduV either forms filamentous 
structures, or localises to pre-existing filaments in the cell. These filaments have been shown to 
associate with BMCs and this interaction is thought to play a crucial role in the dynamics of the 
organelle.    
 
It has also been shown that PduV can direct protein to the BMC; a PduV-GFP fusion was found to 
largely associate with the empty BMC shells by immunogold labelling (Parsons et al. 2010). It was 
subsequently found, through the use of PduV C terminal truncations, that the N terminal region 
was responsible for targeting to the BMC (Parsons et al. 2010). In addition, further experiments 
showed that, while enzymes seemed to localise to the interior of the BMC, PduV was seen to 
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localise to cup-like structures on the outer surface of the shell (Parsons et al. 2010). This indicates 
that PduV is likely to interact on the outer surface of the compartment, as opposed to being 
internalised.  
 
Furthermore, dynamic movement observed during time-lapse microscopy clearly shows interaction 
between Pdu BMC shells and PduV-lined filaments; results indicated that PduV may be involved in 
the regulation of the spatial distribution of BMCs in growing cells (Parsons et al. 2010). 
 
 1.6.2. PduV interactions 
An initial study carried out by Parsons et al identified possible interactions between PduV and other 
proteins, in particular the Pdu shell. It was found, through pull-down assays, that PduV did not 
appear to co-elute with any of the major shell proteins, PduA, PduB, PduJ or PduK (Parsons et al. 
2010). Subsequent data however, revealed that PduV may possibly interact with PduK (unpublished 
data).  
 
A recent study identified, through protein-protein interaction modelling, that PduV is likely to 
interact with the shell component PduU. This was also shown experimentally using target and bait 
fusions (Jorda et al. 2015). It was also predicted that the N-terminal region of PduV binds to the 
WĚƵhɴ-barrel directly, this is consistent with previous data, revealing that the N terminus of PduV 
is responsible for targeting to the BMC (Jorda et al. 2015; Parsons et al. 2010).  
 
1.6.3. Putative GTPase activity 
Interestingly PduV has been found to have some sequence similarity to members of the Ras-like 
GTPase superfamily. Parsons et al have also revealed that preliminary data have shown that purified 
pduV has weak GTPase activity (Parsons et al., 2010). However the exact nucleotide binding site has 
not been identified. This putative GTPase activity gives some similarity to other cytoplasmic, 
filament-forming proteins such as MreB and FtsZ, the bacterial homologs of actin and tubulin which 
are known to require nucleotide binding for their polymerisation.  




In comparison to carboxysomes and other BMCs the Pdu system is a fairly new discovery, and as 
such there are still many key questions that need to be addressed. Through a multi-disciplinary 
approach the work described in this thesis aims to provide further information regarding some off 
these questions. The first question to be investigated was the possible interaction between PduV 
and PduK. The aim of theis work was to use fluorescence microscopy to see if it was possible to 
visualise the interaction between the two, with the potential to quantify this interaction through 
the use of FRET or FLIM FRET. Following this, truncated forms of PduK were to be used to try and 
determine which region of the protein is required for the interaction with PduV. The seoncd, and 
largest portion of the work has focussed on advancing the techniques used to visualise Pdu BMCs 
by fluorescence microscopy, and using this to try and gain further insights into the formation of the 
shell and investigate if any other shell proteins interact with PduV. The first part of this work aimed 
to determine which shell proteins can be tagged with fluorophores whilst still appearing to retain 
functionality. In doing so this work also revealed further information about the role each shell 
protein plays in the formation and stablitiy of the BMC shell, as well as possible regulation of PduV 
filament formation and length. It was hoped that these interractions could be further investigated 
using FRET/FLIM FRET but sadly this was not possible. The third and final question was to further 
understand the function of PduV. This work centred on investigating the conditions in which Pduv 
forms filament like structures and providing further evidence for PduV possessing GTPase activity 
through the use of mutations in the predicted GTP binding region. 
  











Chapter 2: Materials and Methods 
  




Unless otherwise stated, chemicals were purchased from Sigma-Aldrich. Other products were 
purchased from manufacturers as follows; IPTG and ampicillin from Melford Laboratories Ltd, 
chelating sepharose from Amersham Biosciences, QIAprep Spin Miniprep Kit, QIAquick Gel 
Extraction Kit and 50 x TAE buffer from QIAGEN GmbH, T4 DNA ligase and restriction enzymes from 
Promega and New England Biolabs Inc (NEB).  Tryptone, yeast and bacterial agar were purchased 
from Oxoid Ltd, FastStart HF PCR System from Roche Diagnostics GmbH, Yeast Protein Extraction 
Reagent (YPER Plus) from Pierce, 30% acrylamide and bis-acrylamide solution and 5 X sample 
loading buffer and HyperLadder 1 kb from Bioline. 
 
2.1.2. Bacterial Strains 
ĂĐƚĞƌŝĂůƐƚƌĂŝŶƐƵƐĞĚĨŽƌĞŝƚŚĞƌEĐůŽŶŝŶŐƉƵƌƉŽƐĞƐ ?:D ? ? ? ?, ?ɲ )ŽƌƉƌŽƚĞŝŶĞǆƉƌĞƐƐŝŽŶ ?> ? ?
(DE3)/ BL21 (DE3) pLysS) were purchased from Novagen, Invitrogen or Promega. 
 
Strain  Description  Source  
JM109  endA1, recA1, gyrA96, thi, hsdR17 (rk-, mk+), relA1, supE44, 
ȴ ?ůĂĐ-ƉƌŽ ) ? ?&ǲƚƌĂ ? ? ?ƉƌŽ ?ůĂƋ/ƋȴD ? ? ? 
Promega  
BL21 (DE3)  F- ompT gal dcm lon hsdSB(rB- mB- )ʄ ? ? ?ůĂĐ/ůĂĐhs ?-T7 
gene 1 ind1 sam7 nin5])  
Novagen  
Bl21 (DE3) pLysS  F- ompT gal dcm lon hsdSB(rB- mB- )ʄ ? ? )Ɖ>ǇƐ^ ?ĐŵZ ) Novagen  
, ?ɲ F- -argF)U169 recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 thi- ?ŐǇƌ ? ?ƌĞů ?ʄ-  
Invitrogen 
Table 2.1. List of bacterial strains used in this study. 
 




Plasmid Description Source 
pET14b Over-expression N-terminal His-tag 
fusion protein vector with T7 promoter, 
AmpR 
Novagen 
pET23b Over-expression C-terminal His-tag 
fusion protein vector with T7 promoter, 
AmpR 
Novagen 
pET3a Over-expression vector with T7 
promoter, AmpR 
Novagen 
pLysS contains T7 lysozyme gene, CmR. used in 
lDE3 lysogenic hosts to suppress basal 
expression from the T7 
promoter 
Novagen 
pET14b-pduV pduV is an NdeI/SpeI fragment Warren Lab 
pET23b-pduV-gfp pduV is an XbaI/SacI fragment, GFP is a 
SacI/EcoRI fragment 
Warren Lab 
pET3a-pduV-cerulean pduV is an NdeI/SpeI fragment, cerulean 
is a SacI/SpeI fragment 
This Study 
pET3A-pduV(G8A)-cerulean pduV(G8A) is an NdeI/SpeI fragment, 
Cerulean is a SacI/SpeI fragment 
This Study 
pET3A-pduV(G13A)-cerulean pduV (G13A) is an NdeI/SpeI fragment, 
cerulean is a SacI/SpeI fragment 
This Study 
pET3A-pduV(K14A)-cerulean pduV(K14A) is an NdeI/SpeI fragment, 
cerulean is a SacI/SpeI fragment 
This Study 
pET3A-pduV(T43A)-cerulean pduV(T43A) is an NdeI/SpeI fragment, 
cerulean is a SacI/SpeI fragment 
This Study 
pLysS-mCherry-pduA-BJKNU mcherry is an XbaI/NdeI fragment, 
subsequent pdu genes cloned as 
XbaIII/HindIII fragments using link and 
lock 
Warren Lab 
pLysS-mCherry-pduA-BJKNUT mcherry is an XbaI/NdeI fragment, 
subsequent pdu genes cloned as 
XbaIII/HindIII fragments using link and 
lock 
Warren Lab 
pLysS-pduV-cerulean pduV-cerulean is a HindIII/XbaI fragment. This Study 
pET3a-pduK-Ypet pduK is an NdeI/SpeI fragment. ypet is an 
SpeI/BamHI fragment. 
This Study 
pET3a-Ypet-pduK ypet is an AseI/SpeI fragment. pduK is an 
NdeI/SpeI fragment. 
This Study 
pET3A-pduABJNU pdu genes cloned as XbaIII/HindIII 
fragments using link and lock   
Warren Lab 
pET3A-pduABJNU-pduK-Ypet pduK-ypet is an XbaI/HindIII fragment. This Study 
pET3a-pduABJNU-Ypet-pduK ypet-pduK is an XbaI/HindIII fragment This Study 
pET3a-pduA pduA is an XbaIII/HindIII fragment   Warren Lab 
pET3a-pduAB pdu genes closed as XbaIII/HindIII 
fragment 
Warren Lab 
pET3a-pduABJ pdu genes closed as XbaIII/HindIII 
fragments using link and lock   
Warren Lab 
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pET3a-pduABJK pdu genes closed as XbaIII/HindIII 
fragments using link and lock   
Warren Lab 
pET3a-pduABJKN pdu genes closed as XbaIII/HindIII 
fragments using link and lock   
Warren Lab 
pET3a-pduABJKNU pdu genes closed as XbaIII/HindIII 
fragments using link and lock   
Warren Lab 
pET3a-pduABJ-pduK-Ypet pduK-ypet is an XbaI/HindIII fragment This Study 
pET3a-pduABJ-Ypet-pduK ypet-pduK is an XbaI/HindIII fragment This Study 
pET3a- pduABJ-pduK-Ypet-pduN pduN is an XbaI/HindIII fragment This Study 
pET3a- pduABJ-pduK-YpetN-pduU pduU is an XbaI/HindIII fragment This Study 
pET3a-pduABJ-Ypet-pduK-pduN pduN is an XbaI/HindIII fragment This Study 
pET3a-pduABJ-Ypet-pduKN-pduU pduU is an XbaI/HindIII fragment This Study 
pET3a-pduN pduN is an NdeI/SpeI fragment Warren Lab 
pET3a-pduK96 pduK96 is an XbaI/HindIII fragment This Study 
pET3a-pduK119 pduK119 is an XbaI/HindIII fragment This Study 
pET3a-pduK133 pduK133 is an XbaI/HindIII fragment This Study 
pET3a-pduK96-pduN pduK96 is an XbaI/HindIII fragment This Study 
pET3a-pduK119-pduN pduK119 is an XbaI/HindIII fragment This Study 
pET3a-pduK133-pduN pduK133 is an XbaI/HindIII fragment This Study 
pET3a-pduK96N-pduU pduU is an XbaI/HindIII fragment This Study 
pET3a-pduK119N-pduU pduU is an XbaI/HindIII fragment This Study 
pET3a-pduK133N-pduU pduU is an XbaI/HindIII fragment This Study 
pLysS-mCherry-PduABJK mcherry is an XbaI/NdeI fragment, 
subsequent pdu genes cloned as 
XbaIII/HindIII fragments using link and 
lock 
Warren Lab 
pLysS-mCherry-PduABJ-pduK96NU pduK96NU is an AatII/HindIII fragment This study 
pLysS-mCherry-PduABJ-pduK119NU pduK119NU is an AatII/HindIII fragment This study 
pLysS-mCherry-PduABJ-pduK133NU pduK133NU is an AatII/HindIII fragment This study 
pET3a-mCherry (N-terminal) mcherry is an AseI/SpeI fragment  This Study 
pET3a-mCherry (C-terminal) mcherry is an NdeI/SpeI fragment  This Study 
pET3a-mCherry-pduA pduA is an NdeI/SpeI fragment This Study 
pET3a-mCherry-pduA-pduB pduB is an XbaI/HindIII fragment This Study 
Pet3A-mCherry-pduAB-pduJKNU pduJKNU is an AscI/HindIII fragment This Study 
pLysS-pduA-pduB-mCherry pduB-mcherry is an NdeI/SacI fragment This Study 
pLysS-pduAB-mCherry-pduJ pduJ is an XbaI/HindIII fragment This Study 
pLysS-pduAB-mCherryJ-pduKNU pduKNU is an StuI/HindIII fragment This Study 
pLysS-pduA-mCherry-PduB mcherry-pduB is an NdeI/SpeI fragment This Study 
pLysS-pduA-mCherry-PduB-PduJKNU pduJKNU is an AscI/HindIII fragment This Study 
pET3a-pduJ-mCherry pduJ-mcherry is an NdeI/SacI fragment This Study 
pET3a-pduAB-pduJ-mCherry pduJ is an XbaI/HindIII fragment This Study 
pET3a-pduAB-pduJ-mCherry-pduKNU pduKNU is an StuI/HindIII fragment This Study 
pET3a-mCherry-pduJ mcherry-pduJ is an NdeI/SpeI fragment  This Study 
pET3a-PduAB-mCherryPduJ mcherry-pduJ is an XbaI/HindIII fragment This Study 
pET3a-PduAB-mCherryPduJ-pduN pduN is an XbaI/HindIII fragment This Study 
pET3a-PduAB-mCherryPduJN-pduU pduU is an XbaI/HindIII fragment This Study 
pET3a- pduN-mCherry pduN-mcherry is an NdeI/SacII fragment This Study 
pET3a-PduABJK-PduN-mCherry pduN-mcherry is an NdeI/SacI fragment This Study 
pET3a-PduABJK-PduN-mCherry-PduU pduU is an XbaI/HindIII fragment This Study 
pET3a-mCherry-pduN mcherry-pduN is an NdeI/SpeI fragment This Study 
pET3a-PduABJK-mCherryPduN mcherry-pduN is an XbaII/HindIII 
fragment 
This Study 
pET3a-PduABJK-mCherryPduN-PduU pduu is an XbaII/HindIII fragment This Study 
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Table 2.2. List of plasmids used in this study. 
 
2.1.4. Primers 
All primers were supplied from Invitrogen Life Technologies. 
pET3a- pduU-mCherry pduU-mcherry is an NdeI/SacII fragment This Study 
pET3a-PduABKJN-PduU-mCherry pduU-mcherry is an XbaI/HindIII 
fragment 
This Study 
pET3a-mCherry-PduU mcherry-pduU is an NdeI/SpeI fragment This Study 
pET3a-PduABJKN-mCherry-PduU mcherry-pduU is an XbaI/HindIII 
fragment 
This Study 
Primer Name Sequence Restriction 
Enzyme Site 
PduA Forward GGC CAT ATG CAA CAA GAA GCG TTA GG NdeI 
PduV G8V 
Forward 
ATA ATG CTA ATT GTC CCC AGC CAG TGC N/A 
PduV G8V 
Reverse 
GCA CTG GCT GGG GAC AAT TAG CAT TAT N/A 
PduV Forward GGC ATT AAT AAA CGC ATA ATG CTA ATT GGC CCC  AseI 
PduV Stop 
Reverse 
GCC ACT AGT TCA CAT ATG TTT TGT GAG ACA    SpeI/NdeI 
PduB Reverse GGC ACT AGT TCA GAT GTA GGA CGG AC SpeI 
Ypet Forward CG ATT AAT ATG GTG AGC AAA GGC GAA GAG CTG AseI 































PduJ Reverse GCGAGCTCTGCGGATTTAGGTAAAATGGCTTCAACGTC 
 
SacI 
PduU Reverse TAGAGCTCTGTCCGGGTGATGGGACAGGCGGTAAAA 
 
SacI 
PduA Forward GGCCATATGCAACAAGAAGCGTTAGGA NdeI 
PduA Reverse GGCGAGCTCGCTAATTCCCTTCGGTAAGA  
 
SacI 
PduB Forward GGCCATATGAGCAGCAATGAGCTG    
 
NdeI 
PduB Reverse GGCGAGCTCGATGTAGGACGGACGATCGTTT  
 
SacI 
PduJ Forward GGCCATATGAATAACGCACTGGGACTG 
 
NdeI 
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Table 2.3. List of primers used in this study. 
 
PduJ Reverse GCGGAGCTCTGCGGATTTAGGTAAAATGGCTTCAACGTC 
 
SacI 
PduN Forward GGCCATATGCATCTGGCACGGGTT 
 
NdeI 
PduV N Reverse GGCGAGCTCACGAGAAAGCGTGTCGACAAT 
 
SacI 
PduU Forward GGCCATATGGAAAGACAACCCACC 
 
NdeI 
PduU Reverse TTTGAGCTCTGTCCGGGTGATGGG 
 
SacI 




















C AGC CAG TGC GCT AAA ACG TCA C N/A 
PduV G13A 
Reverse 
G TGA CGT TTT AGC GCA CTG GCT G N/A 
PduV K14A 
Forward 
C CAG TGC GGT GCA ACG TCA CTC A N/A 
PduV K14A 
Reverse 
T GAG TGA CGT TGC ACC GCA CTG G N/A 
PduV T43A 
Forward 
ACA ACG ATA GAC GCA CCG GGT GAA TAT N/A 
PduV T43A 
Reverse 
ATA TTC ACC CGG TGC GTC TAT CGT TGT N/A 
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2.1.5. Media and solutions for bacterial work 
Luria-Bertani (LB) broth: 
Tryptone 10 g 
Yeast extract 5 g 
NaCl  5 g 
The broth was made up to 1 L with dH2O and autoclaved  
 
Luria-Bertani (LB) agar: 
15g of Bacterial agar were added to 1 L of LB broth and then autoclaved  
 
Super optimal broth (SOB) Medium: 
Tryptone 2 g 
Yeast extract 0.5 g  
NaCl   0.05 g 
Made up to 90 ml with dH2O 
 
1 ml of 250 mM KCl solution was then added to SOB medium and adjusted to pH 7.0. This was 
consequently made up to 100 ml with dH2O and then autoclaved. 0.5 ml of 2 M MgCl2 solution 
was added after cooling. 
 
Antibiotics 
Ampicillin: 50 mg/ml stocks were made by dissolving ampicillin in dH20, and was used at a working 
concentration of 50 µg/ml. 
Chloramphenicol: 34 mg/ml stocks were made by dissolving chloramphenicol in ethanol, and was 
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2.1.6. Media and solutions for DNA work 
TAE Buffer 
Tris   40 mM 
Acetic Acid  20 mM 
EDTA   1 mM  
 
2.1.6.1. Solutions for immobilized metal ion affinity chromatography (IMAC)  
Charge Buffer 
NiSO4   0.1% 
 
Binding Buffer 
Tris-HCl, pH 8.0   20 mM 
NaCl    100 mM 
Imidazole   5 mM 
 
Wash Buffer 1 
Tris-HCl, pH 8.0  20 mM 
NaCl    100 mM 
Imidazole   50 mM 
 
Wash Buffer 2 
Tris-HCl, pH 8.0  20 mM 
NaCl    100 mM 
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Elution Buffer 
Tris-HCl, pH 8.0  20 mM 
NaCl     100 mM 
Imidazole   400 mM 
 
Strip Buffer  
EDTA    100 mM 
NaCl    100 mM 
Tris-HCl, pH 8.0  20 mM 
 
2.1.6.2. Solutions for BMC isolation 
No Salt Solution 
20 mM Tris-HCL pH 8.0 
 
Normal Salt Solution 
20 mM Tris-HCL pH 8.0 
20mM NaCl 
 
High Salt Solution 
20 mM Tris-HCL pH 80.0 
80 mM NaCl 
 
2.1.6.3. Solutions for protein SDS-PAGE 
1x Running Buffer:  
 
Tris-HCl  25 mM 
Glycine   250 mM 
SDS  0.1% 






Coomassie Blue (500ml) 
Glacial acetic acid  250 ml 
Coomassie blue  0.6 g 
SDS   0.1 g 
Tris-HCl   0.25 g 
Glycine   0.15 g 
Made up to 500 ml with dH2O. 
 
SDS-Loading Buffer (5x) 
Tris-HCl pH 6.8   50 mM 
SDS    2% 
Glycerol,   10% 
ɴ-Mercaptoethanol  1% 
EDTA    12.5 mM 
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2.1.6.4. Composition of SDS gels  
Protein samples were analysed by gel electrophoresis, using 15% SDS-PAGE acrylamide gels, as 




Table 2.4. Composition of SDS gels. 
Protein samples were mixed with 5x protein loading buffer and boiled at 95 ࣙC for 5 minutes. 
Samples were then run at 200 Volts for 1 hour in SDS running buffer alongside Kaleidoscope 
Prestained Standards (Bio Rad) or SeeBlue Pre-stained Protein Standard (Invitrogen). Protein bands 
were visualised by Coomassie Blue staining. 
 
2.1.6.5. Solutions for Western Blot 
PBST Buffer 
NaCl   137 mM 
KCl   2.7 mM 
Na2HPO4  100 mM  
KH2PO4   2 mM 
Tween   0.25% 
Alkaline Phosphatase Pre-Incubation Buffer 
NaCl   100 mM 
Tris pH 9.6  100 mM 
MgCl2   5 mM 
 15% Resolving Gel  5% Stacking Gel 
Water 1.75 ml Water 7 ml 
1.5 M Tris pH 8.7 3.75 ml 1 M Tris pH 6.8 1.25 ml 
10% SDS 0.1 ml 10% SDS  ? ?ʅů 
30% Acrylamide 4 ml 30% Acrylamide 1.7 ml 
APS 0.1 ml APS  ? ?ʅů 
TEMED  ? ?ʅů TEMED  ? ?ʅů 




SDS-PAGE gels were run as described above and a protein transfer was then undertaken onto to 
Immun-Blot PVDF membrane (Bio Rad) using a Trans-Blot SD Semi-Dry Transfer Cell (Bio Rad) 
ĨŽůůŽǁŝŶŐƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽůƐĂƚ ? ?sŽůƚƐ for 30 minutes. The membrane was then blocked 
by PBST + 3% milk at room temperature for 1 hour. The membrane was then incubated in PBST + 
3% milk including the primary antibody (anti-mCherry -Roche) at a 1 in 1000 dilution for 1 hour. The 
membrane was then washed 4 times in PBST at room temperature with 10 minutes for each wash 
step. The membrane was then incubated in PBST + 3% milk including the secondary antibody (Anti-
mouse alkaline phosphatase -Sigma) at a 1 in 5000 dilution for 1 hour. The membrane was again 
washed 4 times in PBST. The membrane was then washed in the alkaline phosphatase pre-
incubation buffer and subsequently developed using 2 ml of BCIP/NBT substrate until bands were 
visible. The reaction was then stopped by washing with water to prevent over-development. 
 
2.2. Microbiological methods 
2.2.1. Sterilisation 
All media and buffers were sterilized for 15 minutes at 121° C /1 bar pressure in an autoclave, 
unless they contained temperature sensitive components. In this case buffers were filter sterilised 
using a  ? ? ?ʅŵƉŽƌĞƐŝǌĞDŝŶŝƐĂƌƚƐǇƌŝŶŐĞĨŝůƚĞƌ ?^ĂƌƚŽƌŝƵƐ ) ? 
 
2.2.2. Bacterial Growth 
2.2.2.1. Plate cultures 
Baceterial cells were either spread or streaked onto agar plates supplemented with appropriate 
antibiotics which were incubated at 37 °C overnight. 
2.2.2.2. Liquid Cultures 
Liquid cultures were either inoculated with a single colony from an agar plate or inoculated with a 
sample from an overnight starter culture (at 1:100 dilution factor). These cultures were then 
incubated at a temperature of 25 °C, 30 °C or 37 °C, shaking at 180 rpm.   
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2.2.3. Preparation of competent cells 
, ?ɲ ?:D ? ? ? ?, ? ?ɴŽƌů ? ?-DE3 E. coli, were streaked out onto LB agar plates and incubated at 
37 ࣙC overnight. 5 ml of LB medium was then inoculated with a single colony and grown shaking at 
37 ࣙC at 220 rpm  overnight.  50 ml of  fresh  LB medium was then inoculated with 0.5 ml of the 
starter culture and grown at 37 ࣙC shaking at 180 rpm until the culture had an optical density of 
0.6-0.8 at 600 nm. The cells were then cooled on ice for 10 minutes, before being centrifuged at 
2700 rpm at 4 ࣙC for  10  minutes.  The  pelleted  cells  were  then  resuspended  in  10  ml  of ice 
cold  0.1  M CaCl2/10% glycerol solution and incubated on ice for 15 minutes. Cells were again 
centrifuged at 2700  rpm  at  4  ࣙC  for  10  minutes and the pelleted  cells  were  resuspended  in  1  
ml  of  0.1 M CaCl2 ? ? ?A?ŐůǇĐĞƌŽůƐŽůƵƚŝŽŶ ?ĞůůƐǁĞƌĞƚŚĞŶĚŝƐƉĞŶƐĞĚŝŶƚŽ ? ?ʅůĂůŝƋƵŽƚƐĂŶĚƐƚŽƌĞĚ
at -80 ࣙC. 
 
2.2.4. Transformation of competent cells 
 ? ?ʅůŽĨĐŽŵƉĞƚĞŶƚďĂĐƚĞƌŝĂůĐĞůůƐǁĞƌĞĚĞĨƌŽƐted on ice and inoculated with  ?ʅůŽĨNA . The cells 
were then incubated on ice for 20 minutes before being heat shocked at 42 ࣙC for 60 seconds. Cells 
were then incubated on ice for 2 minuƚĞƐǁŝƚŚ ? ? ?ʅůŽĨ^KŵĞĚŝĂ subsequently added to the cells, 
followed by incubation at 37 ࣙC shaking at 220 rpm for 30 minutes. The cells were then spread LB 
agar plates supplemented with appropriate antibiotics. 
 
2.2.5. Production of recombinant protein 
BL21-DE3 competent cells were transformed with the plasmid containing the gene(s) for the 
protein to be purified. 3-4 colonies were then inoculated into 5 ml of LB media with the appropriate 
antibiotic and grown shaking at 37 °C at 220 rpm overnight. This 5 ml starter culture was then 
diluted down into 500 ml of fresh LB. The cells were grown shaking at at the required temperature 
at 220 rpm until the optical density at 600 nm was between 0.4-0.5. IPTG was then added (100 
mg/litre) in order to activate transcription from the T7 promoter located on the plasmid. Cells were 
grown for between overnight after induction at 18 °C and then harvested by centrifugation at 4000 
rpm at 4 ࣙC for 30 minutes. 
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2.2.6. Lysis of Bacteria 
2.2.6.1. Sonication of cells 
Harvested cells were lysed by sonication using a Sonics Vibracell Ultrasonic processor, with 6x 30 
sec bursts at 50% power with 30 second breaks between each burst. The sonicated cells were then 
centrifuged at 17,500 rpm for 15 min at 4 °C and the supernatant was retained.  
 
2.2.6.2. YPER treatment of cells 
1 g of cell pellet was re-suspended in 10 ml YPER Plus supplemented with 1 tablet of Complete 
WƌŽƚĞĂƐĞ/ŶŚŝďŝƚŽƌŽĐŬƚĂŝůĂŶĚĞŶǌŽŶĂƐĞ ?EƵĐůĞĂƐĞ ? ?ʅůƉĞƌ ? ?ŵůzWZ ) ?dŚĞůǇƐĂƚĞǁĂƐĂŐŝƚĂƚĞĚ
on a mechanical rocker at room temperature for 3 hours. 
 
2.2.7. Protein Purification 
2.2.7.1. Nickel Column 
Proteins tagged with 6-Histidine residues were purified by immobilized metal ion chromatography 
using Chelating Sephraose Fast Flow resin loaded with Nickel. All protein purifications were carried 
out at room temparture, however all protein samples were kept on ice and all buffers (as described 
in Section 2.1.6.1) had been stored at 4 °C and subsequently kept on ice.  A column was prepared 
by adding 5 ml of Chelating Sephraose Fast Flow (GE Life Sciences) to a syringe with a valve 
attached. The column was then prepared allowing 30 ml water to flow through the column and 
then charged with 30 ml of Charge buffer containing 0.1% NiSO4. The column was then equilibrated 
with with 50 ml of Binding buffer. The protein extract after sonication was passed through the 
column and the flow through collected. Any unbound proteins were washed off of the column by 
passing through 50 ml of Binding buffer followed by 25 ml of Wash buffer I and then followed by 
25 ml of Wash buffer II. The flowthrough was collected for each of these washes. The protein was 
then extracted from the column with 30ml of Elution Buffer, with this elution collected in 1 ml 
fractions and stored at 4 °C. The column was then cleaned for subsequent purfications by washing 
with 50 ml of Strip Buffer. 
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2.2.7.2. Microcompartment purification using YPer Plus  
BL21(DE3) strains containing plasmid DNA for Pdu microcopmartment shell expression were 
cultured in 200 ml LB (at 37 °C, shaking at 160 rpm) to an OD600 of 0.8 and protein production was 
induced with 400 µM IPTG at 18 ºC overnight (shaking at 160 rpm). The cells were harvested by 
centrifugation for 10 minutes at 4 °C at 2683 x g. 1 g wet cell pellet was re-suspended in 10 ml YPER 
Plus (Pierce) supplemented with 1 tablet of Complete Protease Inhibitor Cocktail (Roche) and 1250 
units Benzonase® Nuclease (5 µl per 10 ml YPer). The lysate was incubated for 3 hours at room 
temperature and gently agitated using a shaking platform.  
The lysate was pelleted for 5 min at 11,300 x g, 4°C. Supernatant 1 and pellet 1 were collected. 
Pellet 1 contained the microcompartments and was re-suspended in 2 ml 20 mM Tris-HCl, pH 8.0, 
20 mM NaCl. The suspension was centrifuged at 4 °C for 5 min at 11,000 x g and supernatant 2 and 
pellet 2 were collected. Supernatant 2 contained the microcompartments. The NaCl concentration 
of supernatant 2 was raised to 80 mM by addition of 5 M NaCl (24 µl of 5M NaCl in 2 ml supernatant 
2). Supernatant 2 was then centrifuged at 4 °C for 5 min at 11,000 x g and supernatant 3 and pellet 
3 were collected. Pellet 3 (containing the microcompartments) was re-suspended in 1 ml of 20 mM 
Tris-HCl, pH 8.0 and clarified by centrifugation (4 °C for 5 min at 11,000 x g). The final supernatant  
should contain the purest microcompartments. 10 µl of total lysate, S1, P1, S2, P2, S3 and 5µl of P3, 
final supernatant and final pellet were loaded onto 15 % SDS gels. This method has been published 











Figure 2.1. Diagram summarising the microcompartment purification process. 
 
2.3. Molecular Biological Methods 
2.3.1. PCR reactions 
All PCR reactions were performed in an Eppendorf AG 22331 PCR machine. The basic PCR reaction 
and the cycles used are outlined as follows: 
 
 With DMSO Without DMSO 
ddH2O  ? ? ? ?ʅů  ? ? ? ?ʅů 
10 x PCR Buffer (Roche with 18 
mM MgCl2 
 ?ʅů  ?ʅů 
DMSO  ?ʅů - 
5 mM dNTPs  ?ʅů  ?ʅů 
 ? ?ʅD ? ?WƌŝŵĞƌ  ?ʅů  ?ʅů 
 ? ?ʅD ? ?WƌŝŵĞƌ  ?ʅů  ?ʅů 
DNA Template  ?ʅů  ?ʅů 
Taq polymerase  ?ʅů  ?ʅů 
Table 2.5. Composition of typical PCR reactions  
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Step Temperature Time Cycles Process 
1 95 °C 2 mins 1 Initial denaturation 
of template DNA 





3 50-60 °C 30 secs Annealing of 
primers 
4 72 °C 1 min per 1000 bp Elongation 
5 72 °C 5 mins 1 Final Elongation 
Table 2.6. Typical PCR conditions 
Once the PCR reaction was completed the product was subjected to agarose gel electrophoresis. 
 
2.3.1.2. Overlap Mutagenesis PCR 
In order to generate PduV mutations described in section 6.2.2.2, overlap mutagenesis PCR was 
used, as described by (Hoa et al. 1989). This method uses 2 sets of primers and 2 rounds of PCR 
reactions to generate the target gene with the desired mutation. In the first round of PCR reactions 
the gene is amplified from the template DNA using two flanking primers master primers (1 and 2) 
that amplify ĨƌŽŵƚŚĞ ?഻ĞŶĚŽĨďŽƚŚƐƚƌĂŶĚƐ ?and two internal primers (1M and 2M) that introduce 
the desired mutation. The two flanking primers are also used to introduce restriction sites to allow 
the insertion of the mutated gene into an expression vector. During the second PCR when the 
ƐƚƌĂŶĚƐŽĨƉƌŽĚƵĐƚƐ  ?ĂŶĚ  ?ĂŶĚ  ?DĂŶĚ  ?DĂƌĞĚĞŶĂƚƵƌĞĚƚŚĞƐƚƌĂŶĚƐǁŝƚŚ  ?഻ ĐŽŵƉůĞŵĞŶƚĂƌǇ
generated using primers 1M and 2M will anneal. Primers 1 and 2 will then amplify this to generate 
the full length target gene containing the desired mutation. This is shown in Figure 2.2 below. 












Figure 2.2. Schematic to show the process for overlap mutagenesis PCR. Figure adapted from 
(Mccullum et al. 2010). 
2.3.2. Electrophoresis of DNA 
DNA was visualised for cloning purposes by running agarose gels. 1% agarose gels were made using 
1x TAE and 1 µl of ethidium bromide (10 µg/ml) was added per 1 ml of gel. The DNA sample was 
then run alongside 5 µl of Bioline Hyperladder at 70 volts for 1 hour and DNA bands were visualised 
by exposure to ultraviolet light on a transilluminator. 
 
2.3.3. Isolation and purification of a DNA fragment 
The DNA band of interest was excised from an agarose gel using a scalpel blade. Purification was 
carried out using Qiagen QIAquick® gel extraction kit following ƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽůǁŝƚŚ
their reagents. 
 
2.3.4. Isolation of plasmid DNA 
5  ml  of  LB  media  with  appropriate  antibiotics  was  inoculated  with  a  single  colony  from  a 
transformation plate and grown shaking at 37 ࣙC at 220 rpm overnight. Plasmid DNA isolation was 
then carried out using a Qiagen Qiaprep Spin Miniprep KiƚĨŽůůŽǁŝŶŐƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐƉƌŽƚŽĐŽů
with their reagents. 




2.3.5. Ligation of DNA 
Vector and insert DNA were digested with the relevant restriction enzymes as described 
in Section 2.3.6. The ligation of DNA fragments into the vector was carried out at 4 °C. 
 
Typical ligation reaction: 
Insert 5 µl 
Vector 3 µl 
10x Rapid Ligation buffer (Promega) 1 µl 
T4 DNA Ligase (Promega) 1 µl (= 1 U/10 µl) 
 
2.3.6. Restriction digest of DNA 
Plasmid DNA was digested using the relevant enzymes. The optimal buffer was chosen according 
to either the Promega or New England Biolabs information provided. The reactions were incubated 
for 2 hours at the temperature required by the restriction enzyme before being subjected to 
electrophoresis. 
 
 Single Digest Double Digest 
ddH2O 6 µl 5 µl 
10 x Buffer 1 µl 1 µl 
Restriction Enzyme 1 1 µl 1 µl 
Restriction Enzyme 2  1 µl 
Plasmid DNA 2 µl 2 µl 
 Table 2.7. Composition of a typical restriction digest.  
 
2.3.7. Cloning into vectors 
2.3.7.1. Link and Lock method 
Many of the constructs ŐĞŶĞƌĂƚĞĚ ŝŶƚŚŝƐƐƚƵĚǇǁĞƌĞƉƌŽĚƵĐĞĚƵƐŝŶŐƚŚĞ  ‘ůŝŶŬĂŶĚůŽĐŬ ?ŵƵůƚŝƉůĞ
cloning method (Mcgoldrick et al. 2005). This method of cloning allows multiple genes to be cloned 
consecutively into the same construct through the use of the same restriction sites. This was 
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achieved using using SpeI/XbaI, which have compatible cohesive ends, and HindIII. In this process 
the SpeI/XbaI sites are destroyed leaving only one XbaI and SpeI site in the newly formed constructs 
to allow insertion of the next gene. 
 
2.4. Biochemical methods 
2.4.1. Bradford assays 
The Bradford assay is dependant on coomassie blue G250 binding to proteins, especially  to arginyl 
and lysyl residues. In the presence of protein,  the absorbance the dye moves fro the red cationic 
form (470 to 550 nm) to the blue anionic form (590 to 620 nm). As a result the quantity of the 
protein can be estimated by measuring the amount of coomassie in the blue form at 595 nm 
(Bradford, 1976). The coomassie blue dye from BioRad was added to diluted protein solution. The 
reaction was left at room temperature and the OD595 was measured. A standard curve was 
generated with bovine serum albumin (5, 10, 15, 20 and 25 mg) amd this was used to determine 
the protein conetration of the purified sample. 
 
2.4.2. GTPase Assay 
Two different assays were used to try and measure the GTPase activity of PduV. The first was a a 
photometric ATP/NADH coupled assay, as described in (Hess & Wurster 1970). Later, a more 
recently described assay using Anitmony was used, as described in (Bartolommei, Moncelli & 
Tadini-Buoninsegni 2013).     
 
2.5. Imaging analysis 
2.5.1. Live cell imaging 
Samples were visualised using an Olympus IX81 microscope with PlanApo 150x OTIRFM-SP 1.49  NA  
lens  mounted  on  a  PIFOC z-axis  focus  drive  (PhysikInstrumente,  Karlsruhe, Germany), and 
illuminated using  LED light sources (Cairn Research Ltd, Faversham, UK) with appropriate filters 
(Chroma, Bellows Falls, VT). An Optisplit device (Cairn Research Ltd) was used to allow simultaneous 
acquisition of multiple wavelengths.  Samples were visualised using a ProEM CCD (Princeton 
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Intruments) camera, and the system was controlled with Metamorph software (Molecular Devices). 
Each 3D-maximum projection of volume data was calculated from 21 z-ƉůĂŶĞŝŵĂŐĞƐ ?ĞĂĐŚ ? ? ?ʅŵ
apart, using Metamorph software.  During live-cell imaging,  cells  were  mounted  onto agar pads 
on glass slides and fitted onto an ASI motorised stage (ASI, Eugene, OR) on the above system.  All 
live-cell imaging was undertaken using LB media supplemented with appropriate antibiotics at 
room temperature. Once acquired, deconvolution of images was carried out using Autoquant 
software and figures prepared using Microsoft Powerpoint, where adjustments to contrast or 
brightness were applied uniformly to the entire image. All filters used were supplied by Chroma, 
Vermont,USA and detail of excitation and emission filters are in Table 2.8 below. 
Fluorophore Excitation Filter Emission filter 
Cerulean ET436/20x ET480/40m 
GFP ET480/20x ET510/20m 
Ypet ET500/20x ET535/30m 
mCherry ET580/25x ET625/30m 
Table 2.8. Excitation and emission filters used to visualise Cerulean, GFP, Ypet and mCherry fusion 
proteins. 
 
2.5.1.1 Design of FRET Experiments to Explore the Interaction Between PduV and PduK 
Initially, to determine if there is an interaction between PduV and PduK, the common FRET pairs 
Ypet (a derivative of YFP) and Cerulean (a derivative of CFP) were chosen as fluorescent tags. 
Cerulean has an excitation peak at 433 nm and emits light at 475 nm while Ypet has excitation and 
emission peaks at 517and 530 respectively, shown in Figure 3.1. This makes the use of these 
proteins highly advantageous in fluorescent live cell imaging. If the localisation of Cerulean and Ypet 
are within a distance of 10 nm, the excitation of Cerulean will cause an emission of Ypet signal. This 
is due to the overlap of the two spectra. Cerulean acts as a donor fluorophore, when excited to a 
higher energy state, instead of returning to the ground state by energy emission, energy is 
transferred to Ypet, the acceptor molecule and consequently Ypet signal is emitted as it returns to 
the ground state. In theory the best FRET pairs are the ones that have higher spectral overlap. 
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However, this causes problems with background fluorescence and spectral bleed-though (SBT), 
where even if FRET is not occurring, the donor signal may still be seen on excitation of the acceptor.  
For this reason Cerulean and Ypet make good FRET pairs with a Förster distance overlap of 4.9 nm  
as opposed to GFP and Ypet, for example, which have a larger overlap of 5.6 nm as shown in Figure 
2.3 (Kaminski, Rees & Schierle 2014).   
 
Figure 2.3. Cerulean and Ypet Spectra Profiles. The excitation and emission profiles of Cerulean and Ypet 
are shown, with peaks for absorbance and emission at 517 and 530 for Cerulean and 433 and 475 for 
Ypet respectively. The area of overlap between Cerulean emission and Ypet excitation is shown in grey 
and is known as the spectral overlap, or Förster distance (Ro). The Forster distance is used to determine 
the FRET efficiency, i.e. the fraction of energy that is transferred to the acceptor, for each donor 
excitation event. It is therefore used to decide on the best fluorophore pairs to use for FRET. An overlap 
between the two spectra is necessary to ensure that energy can transfer between two fluorophores if 
within a distance of 10 nm from each other, however if the overlap is too small the FRET efficiency would 
be too low. If the overlap is too high, background fluorescence or spectral bleed-though (SBT) can occur. 
 
2.5.2. TEM conventional 
2.5.2.1. Preparation of samples 
 A 5 ml culture of E. coli (JM109 or BL21(DE3)pLysS) producing proteins of interest was grown 
overnight at 37 ºC. The cells were harvested by centrifugation at 4,000 x g at 4 °C for 10 minutes, 
re-suspended in 2 ml of 2 % paraformaldehyde, 0.5 % glutaraldehyde in PBS and fixed for 1 hour at 
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room temperature. Traces of the fixing solution were then removed by twice washing the cells with 
1 ml of PBS. The samples were then resuspended in the primary stain, 1 % osmium tetroxide, and 
incubated at room temperature for 1 hour. The samples were twice washed with PBS prior to 








Table 2.9. The solvent gradient used for the dehydration of samples for electron microscopy.  
The embedding medium used was Agar Low Viscosity Resin and the constituents for a block of 
medium hardness is shown in Table 2.10. The samples were placed in 0.5 ml embedding tubes and 
centrifuged for 10 minutes at 4000 x g to concentrate the cells to the tip and incubated at 60 ºC 
overnight to polymerise. 
Component Mass 
LV Resin 48 g 
VH1 Hardener 16 g 
VH2 Hardener 36 g 
LV Accelerator 2.5 g 
Table 2.10. Low viscosity resin constituents used to produce a block of medium hardness  
 
2.5.2.2. Sectioning and visualisation of samples 
Specimens were thin sectioned at a thickenss of ~80nm with a glass knife on an RMC MT-6000-XL 
ultramicrotome. Sections were collected on copper grids and post-stained with 5 % uranyl acetate 
for 30 minutes at 60 ºC and 0.1 % lead citrate for 10 minutes at room temperature. Sections were 
then observed and photographed with a JEOL-1230 transmission electron microscope. 
Composition Solvent Time (minutes) 
70% Ethanol 20 
100% Ethanol 20 
100% Ethanol 30 
100% Propylene Oxide 30 
100% Propylene Oxide 30 
50:50 Propylene Oxide:Embedding medium 60 
100% Embedding medium 180 
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2.5.3. TEM immuno-labelling  
For immunogold labelling of PduV-GFP, BL21(DE3) cells expressing PduV-GFP and the associated 
BMC shell were embedded in Agar Low Viscocity Resin. A 5 ml culture of E. coli (JM109 or 
BL21(DE3)pLysS) producing proteins of interest was grown overnight at 37ºC. The cells were 
harvested by centrifugation at 4,000 x g at 4 °C for 10 minutes, re-suspended in 2 ml of 2 % 
paraformaldehyde, 0.5 % glutaraldehyde in PBS and fixed for 15 minutes at room temperature. 
Fixed cells were then washed three times in 1 ml of PBS. Dehydration of the cells was again 
accomplished by subjecting the cells to a solvent gradient, (Table 2.11). 
Table 2.11. The solvent gradient used for the dehydration of samples for immuno-labelled electron 
microscopy.  
The samples were then placed in embedding tubes and centrifuged for 10 minutes at 4000 x g to 
concentrate the cells to the tip and incubated at 60 ºC overnight to polymerise. Sections were then 
cut as described in section 2.5.2.2 and, placed on copper grids. Immunolabelling was achieved by 
the following method; The grids were washed in TBST (20 mM Tris, 500 mM NaCl, 0.05% Tween-
20, 0.1 % BSA, pH 7.4), blocked in 2 % fish gelatine in TBST for 30 minutes and incubated for 1 hour 
with the primary antibody (1:100 anti-GFP rabbit IgG) (Gullick Lab, University of Kent). The grids 
were washed in TBST and incubated with goat anti-rabbit IgG immunogold conjugate, 15 nm gold 
particles (British Biocell) 1:50 for 30 minutes. Finally the samples were washed in TBST, then 
millipore water and were then dried. Samples were then stained and visualised as described in 
Section 2.5.2.2. 
 
Composition Solvent Time (minutes) 
30% IMS 120 
60% IMS 120 
90% IMS Overnight 
100% Dried Ethanol 60 
100% Dried Ethanol 60 
100% Dried Ethanol 60 
1:1 Ethanol:Resin 60 
1:2 Ethanol Resin 60 
100% Resin 60 
100% Resin Overnight 
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2.5.4. AFM 
Samples were visualised using a Bruker Multimode 8 scanning probe microscope. Purified BMCs 
were mounted on hydrophobic MICA by incubating 20 µl of purified BMCs on the surface for 5 
minutes. 2.5 % (v/v) glutaraldehyde in PBS buffer was then used to fix the sample, and this was 
then dried using nitrogen gas. Images were collected in air using the peakforce tapping mode with 
peak-asyst air cantilever probe (Bruker) with a nominal spring constant of 0.4 N/m. Images were 
then processed using the supplied Nanoscope software. 
 
2.5.5. Experiment Design 
When microscopy analysis was used for investigative purposes at least 3 slides were examined in 
all experiements to ensure any findings were both accurate and repeatable, and not simply as a 
result of biological variation. In addition to this, when drawing conclusions from microscopy 
analysis it was ensured that at least 50 cells were imaged.   






Chapter 3: Exploring possible interactions 
between the PduK and PduV 
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3.1. Introduction 
The potential ability to utilise recombinant shells to produce designer chemicals, drugs and biofuels 
relies on our understanding of the structure of the shell, as well as the properties of the shell 
proteins that form it. The Pdu shell is the second best-studied of all known BMCs, after the 
carboxysome. However, very little is known about the assembly of proteins to form the Pdu BMC 
structure or how small molecules are transported across the shell. Currently it is known that the 
essential proteins involved in recombinant Pdu shell formation are PduA, PduB (expressed as two 
ŝƐŽŵĞƌƐ ? WĚƵ ĂŶĚ WĚƵ ? ) ? WĚƵ: ? WĚƵ< ĂŶĚ WĚƵE ? dŚĞ ĂĚĚŝƚŝŽŶ ŽĨ WĚƵh ƚŽ ƚŚĞ ĐŽŵƉůĞŵĞŶƚ ŽĨ
PduABJKN resulted in the formation of slightly larger BMCs. However the functional role of these 
shell proteins within the BMC still remains largely unknown, see section 1.4.7.   
 
Previous studies have given insights into the phylogenetic relationship between shell proteins and 
identified which other shell proteins interact with other shell proteins. Interestingly PduA appears 
to interact with all of the essential shell proteins. The other proteins were shown to interact only 
with PduA, with the exception of PduK which co-purified with PduT by IMAC (Parsons et al. 2008). 
Further studies carried out by Dr S. Frank revealed that PduK also co-purified with PduV, a protein 
thought to be involved in the spatial organisation of the Pdu BMC (unpublished data). Furthermore, 
overexpression of PduK in E. coli, cells housing PduA-X, displayed a single large aggregate complex 
that still contained the delimiting structure of the BMC; this indicates that overexpression 
prevented the spatial separation of the organelles, but did not affect the BMC structure (Parsons 
et al. 2008).  This leads to the question: what is the role of PduK in the BMC shell? 
 
One potential role for PduK is for the protein to help facilitate the transport of molecules into the 
BMC through an interaction with the P18 targeting sequence (Lawrence et al. 2014). The C-terminus 
of PduK is unique to shell proteins in that it contains an extension that harbours an amino-acid 
sequence containing 3 cysteine residues, reminiscent of a motif associated with the presence of an 
iron-sulphur centre. However no evidence has been shown that this region of the protein does 
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indeed house such a redox centre. A recent study found that a BMC shell that lacks PduK has a 
similar phenotype to that of PduK overexpression described above  ? protein aggregates can be 
seen, but these contained defined shell structures. It was also found that a pduK deletion had no 
effect on propionaldehyde toxicity or growth on 1,2-PD (Cheng et al. 2011). Although PduK is 
considered to be an essential shell protein, its exact function is currently unknown. It is likely that 
PduK is involved in several processes, such as mediating the internalisation of molecules and 
facilitating the distribution of BMCs throughout the cell cytoplasm, through an interaction with 
PduV.  
 
This investigation aims to characterise further the role of PduK in the recombinant Pdu shell. To do 
this, fluorescence live cell imaging was used to identify possible interactions between PduK and 
PduV and to determine if PduK is involved in the distribution of BMCs in the cell, as previous studies 
have suggested. In addition, through the use of C-terminal PduK truncations, the role of the C-
terminal extension in the spatial organisation of BMCs was investigated. In order to identify protein-
protein interactions by live cell imaging it was necessary to engineer protein fusions whereby PduK 
and PduV were tagged with fluorophores to allow visualisation by microscopy. However in so doing, 
it was also necessary to determine if the resulting protein fusions were functional, i.e. if 
compartments containing tagged PduK could still form, and if tagged PduV still associated with 
filaments. Any loss of function due to fluorescent tags could generate artefactual results that may 
be difficult to interpret.  
 
3.2. Results 
3.2.1. Cloning of fluorescent tag-fusions 
Initially, to determine if there is an interaction between PduV and PduK, the common FRET pairs 
Ypet (a derivative of YFP) and Cerulean (a derivative of CFP) were chosen as fluorescent tags. Genes 
for expression of these flurophores where cloned into expression plasmids with either pduV or pduK 
as described below. 
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3.2.1.1. Cloning pduV-cerulean 
pduV was originally sourced from the pdu operon of Citrobacter freundii by Dr J Parsons (Parsons 
et al. 2008). For this study, pduV was sub-cloned into pET3a ƵƐŝŶŐƚŚĞƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞƐ ? ?EĚĞ/ĂŶĚ
 ? ?^ĂĐ/ ?dŚĞĐerulean ŐĞŶĞǁĂƐƐƵďƐĞƋƵĞŶƚůǇĨƵƐĞĚŽŶƚŽƚŚĞ ? ?ĞŶĚĐŽƌƌĞƐƉŽŶĚŝŶŐƚŽƚŚĞ-terminus 
of PduV , as it has previously been shown that tagging PduV on the N terminus inhibits function 
(Parsons et al. 2010). The cerulean was sourced from (Rizzo et al. 2004) and primers were designed 
ĐŽŶƚĂŝŶŝŶŐƚŚĞƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞƐ ? ?^ĂĐ/ĂŶĚ ? ?^ƉĞ/ ?ĨƚĞƌWZĂŶĚƐubsequent digest to remove extra 
bases, cerulean was ligated with pduV, as outlined in Section 2.3.5. The resulting plasmid is shown 
in Figure 3.1. PduV-Cerulean was also later sub-cloned into the chloramphenicol resistant plasmid 
pLysS, in order to co-express with ampicillin-resistant plasmids containing other pdu genes. This 
was sub-cloned by restriction digests of pLysS-(pduN) and pET3a-pduV-cerulean with XbaI and 
HindII. The pduV-cerulean fragment was then ligated with plysS and transformed into JM109 
competent cells as outlined in Section 2.2.4. JM109 cells were then cultured from the 
transformation plate and grown overnight at 37 °C, as described in Section 2.2.2.1. To harvest the 
plasmid, Qiagen Minipreps were carried out and the DNA was test digested to ensure the genes 
had been inserted correctly into the plasmid, as outlined in Section 2.3.6. This cloning method was 







Figure 3.1. Plasmid map of pET3a-pduV-cerulean. Length is 5786 bp and plasmid contains an ampicillin 
resistance gene.  
pET3a 
81 | P a g e  
 
 
3.2.1.2. Cloning pduK fusion tags  
It was not known if tagging PduK on the N- or C- termini had any effect on the formation of Pdu 
BMCs. Consequently, two separate constructs were engineered in order to tag PduK separately on 
both the N and C terminus with Ypet. For the N-terminal tag, ypet was amplified by PCR using 
ƉƌŝŵĞƌƐĐŽŶƚĂŝŶŝŶŐĂ ? ?ƐĞ/ĂŶĚ ? ?^ƉĞ/ĂŶĚEĚĞ/ ?^ĞĞdĂďůĞ ? ? ? ) ? The digested ypet PCR product 
ǁĂƐĐůŽŶĞĚŝŶƚŽƚŚĞ ? ?EĚĞ/ ? ? ?^ƉĞ/ŽĨpET3a, locking the gene in the plasmid with the compatible 
sites AseI and NdeI, which are subsequently destroyed when ligated together. pduK was then sub-
cloned after ypet ƵƐŝŶŐƚŚĞ ? ?EĚĞ/ĂŶĚ ? ?^ƉĞ/ƐŝƚĞƐ ?-terminal tagged PduK was engineered by the 
PCR of ypet with the reƐƚƌŝĐƚŝŽŶƐŝƚĞƐ ? ?^ ƉĞ/ ? ? ?Ăŵ,/ ?ypet was then ligated behind pduK in a pET3a 
plasmid. pduK was re-cloned by PCR in order to remove the stop codon and ligated with the pET3a 
plasmid using the NdeI and SpeI sites, (Figure 3.2). 
 
 
Figure 3.2. Plasmid maps of engineered constructs containing ypet and pduK. A) pET3a-ypet-pduK. Total 
plasmid length is 5807 bp B) pET3a-pduK-ypet. Total plasmid length: 5798 
 
3.2.1.3. Cloning pduK fusions at the end of the Pdu BMC construct 
It was necessary to engineer a construct containing a fluorophore-tagged PduK as well as genes 
required for recombinant Pdu shell formation. This is because initial results revealed that when 
pET3 pET3
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PduK-Ypet and Ypet-PduK were co-produced with PduV-Cerulean, the function of PduV was 
impaired as filaments were no longer visible. In addition tagged-PduK alone appeared to aggregate 
at the cell poles, (data not shown). Therefore the expression of BMCs are necessary to determine 
possible interactions between PduV and PduK.   
 
Previously it has been shown that changing the order of the shell protein genes, by inverting the 
minimal shell protein assembly to give pduN-K-J-B-A resulted in the appearance of aberrant 
structures. However due to ease of cloning, pduK fusion genes were added to the end of the BMC 
construct pET3a-pduABJNU, outlined in Table 2.2. To do this, pduK-ypet and ypet-pduK were 
restricted with XbaI and HindIII, to cut the fragment from the plasmid. These fragments were ligated 
with pET3a-pduABJNU restricted with SpeI and HindIII as shown in Figure 3.3. The compatible 
cohesive ends of SpeI and XbaI allows the fusion gene to be inserted into the construct after the 










Figure 3.3. Plasmid map of pET3a-pduABJNU-ypet-pduK and pET3a-pduABJNU-pduK-ypet. This construct 
contains the pduK fusion tags, pduK-ypet and ypet-pduK integrated after the other genes required to 
form the BMC shell. Total plasmid length: 8091 
 
pET3a pET3a 
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3.2.1.4. Integration of pduK-ypet with genes for the BMC shell.   
Live cell imaging revealed that BMCs do not form correctly when expressed from a construct that 
has a pduK fusion cloned after the genes encoding the other shell proteins, however images 
revealed that PduABJNU-K-Ypet contained BMCs that were more similar to the control than 
PduABJNU-Ypet-K (Figure 3.6.). To investigate further the effect of gene order on the formation of 
BMCs and the effect this has on PduV, pduK-ypet was integrated in the normal gene order; PduABJ-
K-Ypet-EhďǇƚŚĞ ‘>ŝŶŬĂŶĚ>ŽĐŬ ?ƉƌŽĐĞƐƐ ? 
 
Initially pET3a-pduABJ (See Table 2.2) was restriction digested with SpeI and HindIII. pET3a-pduK-
ypet was also digested, with the restriction enzymes XbaI and HindIII. The fragment ends were 
joined by ligation, with XbaI and SpeI forming a new site as they have compatible cohesive ends. As 
a result, the previous XbaI/SpeI site is destroyed, locking the genes with the plasmid and allowing 
further genes to be sub-cloned into the plasmid using the same restriction sites. The pET3a-PduABJ-
K-Ypet plasmid was restricted with SpeI and HindIII, and pduN was cut from pET3a with the 
restriction enzymes XbaI and HindIII. Once again the fragments were ligated, resulting in the 
formation of a new restriction site and the destruction of XbaI/SpeI. Finally pET3a-PduU was 
restricted with XbaI and HindIII and ligated into pET3a-PduABJ-K-Ypet-N that had been digested 
with SpeI and HindIII. This process resulted in the construct shown in Figure 3.4.  
 








Figure 3.4. Plasmid map of pET3a-pduABJ-pduK-ypet-NU. This construct contains the pduK fusion tag, 
pduK-ypet integrated in the correct order of genes required to form the BMC shell. Total plasmid length: 
8091 
 
3.2.2. Microscopy analysis to characterise a proposed interaction between 
PduK and PduV 
The recombinant shell protein constructs, expressed in E. coli and used in this study consists of 
genes that encode the proteins necessary to form the BMC shell. These genes were derived from 
the pdu operon of Citrobacter freundii and include; ƉĚƵ ?ƉĚƵ ? ?ƉĚƵ: ?ƉĚƵ< ?ƉĚƵE ?and pduU. 
Expression of these genes produced empty BMCs that were similar in size and shape to the wild 
type compartments produced in S. enterica (Parsons et al. 2008). In addition, studies have also been 
carried out using empty, recombinant Pdu BMC shells containing mCherry-labelled PduA. These 
mCherry-PduABJKNU compartment shells were also very similar to the wild-type Pdu shells and 
formed intact structures of approximately 100 nm in diameter (Parsons et al. 2010).  
 
As well as the shell proteins required to form an empty BMC, PduT is associated with the BMC but 
its role within the BMC is not known. It is considered to be a non-essential component of the shell 
as described in Section 1.4.7.6. Therefore, an investigation was initiated to determine whether or 
pET3a 
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not the addition of PduT had any effect on the localisation or formation of filaments. In addition, 
the effect of tagging PduV with a fluorophore was investigated. Previously, studies had been carried 
out to give insights into the function of PduV. From this it was known that PduV can be tagged on 
the C-terminus with GFP however, no other PduV fusion tags have been explored (Parsons et al. 
2010).  
 
In order to examine the functionality of PduV-Cerulean, the presence of filaments and the 
distribution of mCherry-tagged empty microcompartment shells were examined by fluorescence 
microscopy. It is necessary to express PduV-Cerulean in conjunction with BMC shells for filamentous 
structures to be observed. In the absence of Pdu BMC shells, PduV-Cerulean can be seen to localise 
only at the cell poles in inclusion-like foci (Parsons et al. 2010).  
 
3.2.2.1. Visualisation of the PduV-Cerulean fusion tag with Pdu BMC shells 
PduV-Cerulean was expressed with empty Pdu shells in order to investigate the effect of a C-
terminal Cerulean tag. Two separate E. coli BL21 (DE3) strains were engineered. The first contained 
the plasmids pLysS-mCherry-PduABJKNUT and pET3a-pduV-cerulean and the second contained the 
plasmids pLysS-mCherry-PduABJKNU, and pET3a-pduV-cerulean. For the purpose of live cell 
imaging, cultures (25 mL) were inoculated from a starter culture containing one colony from a 
double transformation. The cultures were then grown at 37°C to mid-log (OD600 of between 0.4 and 
0.6), see Section 2.2.2.2, and mounted on an agarose pad and were then visualised by microscopy, 























Figure 3.5. Comparison when PduV-Cerulean is co-expressed with BMC shells that either contain or lack 
PduT. Live cell images acquired show the Phase, mCherry, Cerulean and Composite signals. The E.coli 
strains visualised include A-D  ? mCherry-PduABJKNUT, PduV-Cerulean and E-H  ? mCherry-PduABJKNU, 
PduV-Cerulean. Colocalisation between empty BMC shells and PduV can be seen in both samples (white 
arrows), however the level of colcalisation appeared reduced when PduT was present in the empty BMC 
shell (Top Image). ^ĐĂůĞĂƌ P ?ʅŵ 
 
Elongated cells have previously been visualised when recombinant Pdu BMCs are expressed in E. 
coli (Parsons et al. 2010; Sargent, F. A. Davidson, et al. 2013) presumably as they exert a stress 
response. Figure 3.6 is consistent with this observation and shows that the cells were elongated in 
strains co-producing PduV-Cerulean in conjunction with either mCherry-PduABJKNU or mCherry-
PduABJKNUT. PduV-Cerulean was observed in filamentous structures in both of these strains and 
was also seen in discrete foci throughout the cytoplasm, often co-localised with the empty BMC 
shells (as shown by arrows). The distribution of the microcompartments also appeared unaffected 
when PduV was labelled with Cerulean. mCherry-tagged Pdu BMCs were distributed throughout 
A B C D 
E F G H 
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the cytoplasm of the cell in discrete foci, corresponding to previous results observed by Parsons et 
al (Parsons et al. 2010).  
 
Interestingly, the level of co-localisation appeared visibly reduced in the presence of PduT at the 
end of the empty microcompartment construct. This is shown by the white foci in the composite 
image of Figure 3.6, which represents co-localisation between the Cerulean and mCherry signal. As 
a result of the reduction in co-localisation, all future experiments were carried out with empty 
microcompartments lacking PduT.  
 
3.2.2.2. The effect of fusing Ypet to PduK on BMC formation and interaction with PduV-
Cerulean by live cell imaging 
In order to examine the possible interaction between PduK and PduV, fluorescence microscopy was 
initially carried out with BL21 (DE3) strains containing pLysS-PduV-Cerulean and either pET3a-pduK-
ypet or pET3a-ypet-pduK (images not shown). Microscopy images showed that both PduV-Cerulean 
and the Ypet-labelled PduK localised to the cell poles. The Cerulean and Ypet signal seemed to co-
localise but this may be a result of insoluble-protein aggregation and the formation of packed 
inclusions. To explore the possible interaction between PduK and PduV, it was therefore necessary 
to include genes for Pdu shell protein expression to prevent protein aggregation and visualise 
individual foci. As a result, due to ease of cloning, pduK-ypet and ypet-pduK were sub-cloned at the 
end of the shell construct, see Section 3.2.1.3. 
 
BL21 (DE3) strains co-producing PduV-Cerulean and either PduABJNU-K-Ypet or PduABJNU-Ypet-K 
were grown at 37°C by inoculation of a culture (25 mL) from an overnight starter culture containing 
cells from one colony of a double transformation agar plate. The cells were grown to mid-log (OD600 
0.4-0.6) and visualised by microscopy as outlined in Section 2.5.1. 
 
Results, from the images in Figure 3.7, showed that when PduV-Cerulean was co-expressed with 
empty BMC shells containing a PduK-Ypet or Ypet-PduK fusion, there were no obvious elongated 
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filamentous structures. Short linear structures were observed in some of the cells (as indicated by 
the white arrow heads), although these shorter filaments were not as prevalent as filaments seen 
in the mCherry-PduABJKNU control. To quantify this, strains were imaged by microscopy and the 
number of filaments in 200 cells from each strain were counted in MetaMorph (Section 2.5.1).  A 
moderate number of filaments, at 53 per 200 cells were observed in images of the strain expressing 
PduABJNU-K-Ypet and PduV-Cerulean, whereas only 24 filaments were seen when PduABJNU-Ypet-
PduK and PduV-Cerulean were co-expressed. However both of these were markedly reduced when 
compared to the control where 241 filaments were counted in 200 cells; with many cells containing 
multiple filaments.   
 
Interestingly, the fluorescent foci of BMCs containing PduK fusions were much larger compared to 
that of mCherry-PduABJKNU shells. Compartments of PduABJNU-Ypet-PduK were not distributed 
as evenly throughout the cytoplasm as the control and individual compartments, represented by 
discrete foci of Ypet fluorescence signal, were not observed (Figure 3.6). In comparison, PduABJNU-
K-Ypet BMCs appeared to be more evenly distributed compared with the N-terminal PduK tag and 
discrete foci were visible, as indicated by the circled cell in Figure 3.6.  
 
Overall, as seen in Figure 3.7, PduV and PduK appeared to co-localise, as suggested by the green 
tint in the composite images. However it is difficult to assess whether the BMCs had formed 
correctly, incorrect folding could lead to the exposure of residues that would not normally be 
revealed and may cause interactions that would not normally occur. The higher number of 
filaments observed with PduABJNU-K-Ypet and visualisation of discrete foci suggests that shell 
protein may be folded correctly to form intact compartment structures when the C terminus of 
PduK is tagged as opposed to the N terminus.  
 
The method of Pdu BMC shell protein assembly is currently unknown and the effect of reordering 
the genes encoding shell proteins was largely also unknown. The result of cloning pduK at the end 
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of the shell construct may have inhibited possible assembly processes. For this reason, PduK-Ypet 
was incorporated in the recombinant Pdu shell construct in the same gene order as the pdu operon 
from C. freundii.  
  



























Figure 3.6. Effect of tagging PduK on BMC formation and PduV function. Live cell images acquired show 
the Phase, Ypet or mCherry, Cerulean and Composite signals. The E. coli strains visualised include PduV-
cerulean co-expressed with 1) mCherry-PduABJKNU 2) PduABJNU-Ypet-PduK 3) PduABJNU-K-Ypet. Two 
corresponding images are shown for strains 2 and 3, with the bottom images zoomed in to visualise 
structures more clearly. The expression of BMC shells containing PduK with Ypet fused to either the N 
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or C terminus appeared to greatly reduce the presence of filamentous PduV-Cerulean filaments. 
Occassionally short filamentous structures were observed (white arrows). BMC shells containing Ypet-
PduK were not distributed as evenly throughout the cytoplasm as the control and discrete foci of Ypet 
fluorescence signal, were not observed. However BMC shells containing PduK-Ypet appeared to be more 
evenly distributed discrete foci were visible, as indicated by the circled cell. In both cases PduK and PduV 
did appear to colacalise ^ĐĂůĞĂƌ P ?ʅŵ 
3.2.2.3. Exploring possible interactions between PduK and PduV by live cell imaging 
To explore the possible interaction between PduV and PduK, pduK-ypet was cloned in the functional 
BMC shell gene order. A BL21 (DE3) E.coli strain was engineered to contain the plasmids pET3a-
PduABJ-K-Ypet-NU and pLysS-pduV-cerulean. Cells were then grown for microscopy at 37°C in 25 
ml cultures by inoculation from an overnight starter culture as described in Section 2.2.2.2 and 
visualised by live cell imaging at an OD600 of between 0.4 and 0.6 (mid-log).  
 
Fluorescent images in Figure 3.8 showed that the incorporation of pduK-Ypet with the rest of the 
shell genes resulted in the appearance of elongated filaments containing PduV-Cerulean. These 
filaments were not visible when strains expressing tagged pduK, reordered to the end of the shell 
construct, were studied (see Section 3.2.2.2). This suggests the need for shell proteins to be 
expressed in a particular order for PduV to function.  Despite the presence of elongated filaments, 
similar to that observed with the mCherry-PduABJKNU BMC control, the BMCs present in the 
PduABJ-K-Ypet-NU strain in some cases appeared to aggregate and amassed in large, bright foci 




























Figure 3.7. Exploring the interaction between PduK and PduV. Live cell images acquired show the Phase, 
Ypet or mCherry, Cerulean and Composite signals. The E. coli strains visualised include PduV-cerulean 
co-expressed with 1) mCherry-PduABJNU 2) PduABJK-Ypet-NU 3) PduABJNU-PduK-Ypet. The cloning of 
PduK-Ypet into the correct positon in the Pdu operon resulted in the formation of PduV-Cerulean 
filament similar ot that in the control sample, however the BMC shells accumulated into large foci, 
suggesting they shells were not forming correctly (White Arrows). ^ĐĂůĞĂƌ P ?ʅŵ 
 
3.2.2.4. The formation of the BMC shell with tagged PduK 
To investigate the structure of BMCs formed when PduK is labelled with Ypet, cells were thin 
sectioned and visualised by TEM. BL21 (DE3) cells were transformed with the engineered BMC 
constructs. Starter cultures were then grown overnight at 37°C by inoculation using several colonies 
from the transformation plate. Larger 100 ml cultures were then grown by inoculation from the 
starter culture (1:100), at 37°C until an OD600 of 0.8 was reached. The cultures were subsequently 
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induced, as outlined in Section 2.2.5, and grown overnight at 19°C. Cells were spun down and 



















Figure 3.8. Examining the effect of tagging PduK on BMC formation. TEM analysis of whole cell thin 
sections of cells expressing mCherry-PduABJKNU (A & B), a negative control of BL21 (DE3) pLysS cells (C) 
and cells expressing PduABJ-K-Ypet-NU (D). BMC shells were observed in control cells as expected (white 
squares in panes A and B) and were not observed in then negative control. However when PduK-Ypet 
was incorporated into the Pdu operon BMC shells were not observed (Pane D). However elongated tube 
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Results showed that compartments from the control strain expressing mCherry-PduABJKNU BMCs, 
Figure 3.8 (A & B), are able to form intact structures that vary in size between 70  ? 100 nm, 
measured using ImageJ software. These compartments appear less regular than wild-type S. 
enterica Pdu BMCs, however, this may be a result of the angle of sectioning. Cells were densely 
packed with BMCs and as a result were enlarged in both width and length. The shells of the BMC 
can be seen as electron dense strands that close to form the intact, empty, compartment. Cellular 
components such as ribosomes and DNA can be seen around the edges of the cell, or packed in 
discrete areas, separate from that of the densely packaged BMCs. A negative control strain, Bl21 
(DE3) pLysS was grown at the same time and subjected to the same growth and TEM sectioning 
conditions. No compartment-like structures were observed in this control, as shown in Figure 3.8 
(C).  
 
Interestingly, TEM of thin sections of cells containing PduABJ-K-Ypet-NU showed very similar results 
to that of the negative control, BL21 (DE3) pLysS, shown in Figure 3.8 (D)  BMC-like compartments 
were not present in any of the cells visualised (n=200), although some cells (~10%) contained 
unusual patterned structures. These structures were highly uniform, consisting of elongated, 
narrow tube-like arrangements that comprised outer, delimitated walls with a segmented interior. 
In addition many cells contained inclusion bodies. These structures were not present in the negative 
control and are likely to be due to the expression of PduABJ-K-Ypet-NU. This experiment was carried 
out twice and the same result was observed on both occasions. 
 
3.2.3. Analysis of the role of PduK in the BMC shell 
It was found that PduK-fusions prevented the formation of the BMC shell.  The role that PduK has 
on a recombinant Pdu system was then explored. Two E.coli strains were created that harboured 
the genes necessary for shell formation but lacked pduK; (1) pET3a-mCherry-pduABJNU with pLysS-
pduV-cerulean and (2) pET3a-mCherry-pduABJNU alone. These strains were visualised by live cell 
imaging and TEM to determine: the localisation of PduV in relation to the BMC, the presence of 
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PduV-Cerulean associated filaments and also the effect on BMC formation in the absence of PduK 
in a recombinant system.   
 
3.2.3.1. Co-locaůŝƐĂƚŝŽŶďĞƚǁĞĞŶƚŚĞƐŚĞůůĂŶĚWĚƵs ?ĞǆƉůŽƌŝŶŐƚŚĞƌŽůĞŽĨWĚƵ< ?ƐƌŽůĞŝŶ
this interaction 
Strains were grown for fluorescent live cell imaging including; mCherry-PduABJKNU PduV-Cerulean 
as a positive control for BMC formation and PduV function as well as mCherry-ABJNU and PduV-
Cerulean. These were grown in the same conditions as previous cultures, at 37°C in a 180 rpm 
shaking incubator until a cell density of OD600 0.4-0.6 was reached. Cells were then mounted and 














































Figure 3.9. Exploring the necessity of PduK in the interaction between PduV and BMCs. Live cell images 
acquired show the Phase, mCherry, Cerulean and Composite signals. The E.coli strains visualised include 
Top Row mCherry-PduABJKNU and PduV-Cerulean and Bottom Row  ? mCherry-PduABJNU, PduV-
Cerulean. The absence of PduK resulted in the BMC shells accumulating into large foci (white arrows), 
however there was co-localisation between PduV-Cerulean and these BMC shells. It is unclear if this was 
due to the two interacting or was a result of protein aggregation. ^ĐĂůĞĂƌ P ?ʅŵ ? 
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Compared to the control strain, images showed that cells co-expressing mCherry-ABJNU and PduV-
Cerulean produced large BMCs, as indicated by the bright mCherry foci. Each cell appears to have 
only a few spots of compartment localisation, and the signal intensity indicates that the BMCs may 
be clumped together. This suggests that the BMC shells did not form correctly and are likely to be 
aggregated.  
 
Cerulean signal shows that PduV accumulated into large foci compared with the control (Figure 
3.9). These foci had a high signal intensity and PduV-Cerulean filaments were barely visible. 
However, the filaments that are observed are similar to those in the control and indicate that PduV 
is still able to either polymerise to form filaments, or attach to pre-existing filaments in the cell. The 
Cerulean signal appeared to be more cytoplasmic than the control. The results also revealed that 
recombinant BMCs lacking PduK were still able to co-localise with PduV. This can be seen in Figure 
3.9, where mCherry signal and Cerulean signal overlap in the composite image. This indicates that 
either PduK is not essential for the interaction between the Pdu shell and PduV or that the proteins 
have aggregated together.  
 
3.2.3.2. BMC shell formation in BMCs lacking PduK 
Live cell imaging results suggests that PduV is able to associate with Pdu BMC shells that lack 
PduK. However it was unclear if the resulting compartments were able to form correctly. To 
investigate this further, mCherry-PduABJNU BMCs were expressed in BL21 (DE3) cells. Cultures 
were grown at 37 °C to an OD600 of 0.8, induced and grown overnight at 19°C. Cell were then 
harvested and prepared for thin sectioning as outlined in Section 2.5.2.  
 
A control strain, mCherryPduABJKNU, grown on the same day and in the same conditions revealed 
intact compartments from TEM imaging. The BMC shells were ~100 nm in diameter and identical 
to previous TEM images of this strain, Figure 3.10. Interestingly, cells expressing PduABJNU formed 
a variety of structures. Larger compartments can been seen, demonstrated by the white square in 
image B, ranging in diameter from 80-150 nm. Some of these structures did not appear intact as 
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the shell border was not entirely delimited, with gaps visible. In addition to these large malformed 
BMCs, strands of protein filaments could be seen wrapped around the periphery of the cell, on the 
cytosolic side of the cell membrane, as shown by the white arrow. This suggests that the larger 
mCherry foci seen in this strain by fluorescence microscopy could either be large disconnected 









Figure 3.10. Examining the role of PduK in the formation of BMCs. TEM analysis of whole cell thin 
sections of cells expressing mCherry-PduABJKNU (A) or PduABJNU (B). The absnce of PduK resulted in 
the formation of larger, incomplete BMC shells (white square). In addition bundles of protein filaments 
were observed around the cytosolic side of the cell membrane.  
 
3.2.5. Recombinant BMCs with PduK C-terminal truncation variants  
PduK is known to contain a C-terminal extension of approximately 70 amino acids. The role of this 
extension is unknown, although it has been proposed to house an iron-sulphur centre. Like all 
characterised shell-proteins, PduK contains a BMC domain, located in the N-terminus of the 
protein. The BMC domain identifies the protein as a shell component and mediates the interaction 
with other shell constituents to form the structure of the compartment.  
 
By the use of C-terminal PduK truncations, the role of this extended region can be characterised. 
Little is currently known about the C-terminal extension of PduK however previous studies using 
PduK truncations have demonstrated that the P18 targeting peptide directs protein to the BMC 
through an interaction with the N terminus of PduK (Lawrence et al. 2014). Although this does not 
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provide any clues about the function of the extended region, it does show how the use of such 
truncations can provide insights into the role that PduK may have in the BMC shell.  
 
To identify any possible interaction between PduK and PduV, BMC shells containing PduK C-
terminal truncations were engineered; this involved integrating the PduK truncated variants into 
the shell construct. Three novel constructs were generating by integrating a stop codon after amino 
acid residues 133,119 and 96 giving rise to the variants PduK*133, PduK*119 and PduK*96. Full 
length PduK is 160 amino acids in length, with the C-terminal extension spanning from 90-160 
amino acids (Crowley et al. 2010). 
 
In this study, BMCs were engineered to contain an mCherry tag, allowing compartment visualisation 
by fluorescent microscopy. Strains containing the BMC variants were co-produced with PduV-
Cerulean to determine if the C-terminal extension of PduK has any effect on the localisation or 
function of PduV.   
 
3.2.5.1. Cloning pduK truncations with the genes necessary for shell formation in a 
recombinant system 
Three PduK truncations of total amino acid lengths of 133,119 and 96 were provided by Dr Andrew 
Lawrence.  To further characterise the co-localisation between PduV and PduK, it was necessary for 
the pduK truncations to be integrated in the correct order with the other structural shell genes.  
In order to do this, the following restriction digests were set up: pET3a-PduK* with SpeI, HindIII and 
pET3a-pduN with XbaI and HindIII. Due to the compatible nature of XbaI and SpeI, when ligated 
together, pduK and pduN fragment ends were joined in a manner that could not be further 
ƌĞƐƚƌŝĐƚĞĚĂƚƚŚĞƐŝƚĞŽĨũŽŝŶŝŶŐ ?ŝƚŝƐƚŚĞƌĞĨŽƌĞƐĂŝĚƚŽďĞ ‘ůŽĐŬĞĚ ? ?dŚŝƐŶĞǁƉd ?Ă-pduK*N plasmid 
was further digested with restriction enzymes SpeI, HindIII; pET3a-pduU was also restricted with 
XbaI and HindII. pduU was then ligated with pET3a-pduK*N to link and lock the genes together.  
Subsequently, pET3a-pduK*NU was restricted with AatII, which cuts in pduK, and HindIII. The 
pduK*NU fragment was ligated with pLysS-mCherry-pduABJK that had been digested with the same 
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restriction enzymes. Consequently pduK was partially replaced with the appropriate truncated form 
of the gene.  
 
3.2.5.2. Fluorescence microscopy of BMCs containing truncated variants of PduK co-
expressed with PduV-Cerulean 
BL21 (DE3) strains co-producing PduV-Cerulean with either BMCs with full length PduK (control 
strain) or with BMCs containing the truncated PduK variants were grown in 25 ml cultures from 
inoculation by an overnight starter culture. Initially cells were grown at 37°C to an OD600 of 0.6-0.8 
and visualised by microscopy. This experiment was repeated twice. In addition, cells were also 
grown at 28 °C to assess if results were due to the rate of cell growth, although for stains containing 
BMC shells with C-terminal truncations, growth temperature did not affect the outcome and the 
results were found to be identical.  
 
Compared with a strain expressing BMCs with full length PduK, mCherry-PduABJK*NU BMC shells 
appeared aggregated, as demonstrated by the larger, brighter mCherry foci, Figure 3.11. They were 
not distributed throughout the cell as evenly as the control strain. Visually, mCherry-
PduABJK*96NU BMCs appeared to more similar to the control compartments than either mcherry-
PduABJK*119NU or mCherry-PduABJK*133NU. The distribution of the shells were more spread out 
and the foci of mCherry signal did not appear as enlarged. In strains expressing mcherry-
PduABJK*119NU and mCherry-PduABJK*133NU BMC shells, the mCherry foci were large, with 
fewer per cell than the other strains. In addition the foci can be seen to at the poles of the cell, 
indicating that the shell proteins are likely forming inclusion bodies; this suggests that the BMCs 
may not be folding correctly, Figure 3.11.  
 
The presence of PduV differed in strains containing the various BMC PduK truncation variants. PduV 
filaments and foci were present in the control strain, Figure 3.11. PduV foci in the control strain 
were distributed throughout the cell, with a similar size to the BMC foci and appeared largely 
associated with the mCherry signal of the BMCs. PduV foci in the PduK*96 truncation variant strain 
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were similar to that of the control. In comparison, PduV foci in the PduK*119 and 133 BMC variants 
were much larger, a similar size and shape to the enlarged BMCs and often localised to the poles of 
the cell. Despite the enlarged BMCs and PduV-cerulean foci in some strains, PduV-Cerulean foci still 























Figure 3.11. Exploring the effect of truncating PduK on the distribution of BMCs and their interaction 
with PduV. Live cell images acquired show the Phase, mCherry, Cerulean and Composite signals. The 
E.coli strains visualised include Top Row mCherry-PduABJKNU, Second Row mCherry-PduABJK*96NU, 
Third row mCherry-PduABJK*119NU and Bottom Row  ? mCherry-PduABJK*133NU, all with PduV-
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Cerulean. The truncation of PduK resulted in the BMC shells aggregating into larger, brighter foci, which 
were not distrubted throughout the cell as evenly as in the control (white arrows), however this effect 
appeared more severe in cells expressing PduK*119 or PduK*133. In addition, a similar effect was 
ovserved with PduV, with the expression of PduK*119 or PduK133 resulting in large accumulations of 
PduV (white arrows). Pdu V filaments also appeared longer in these two strains. Scale Bar P ?ʅŵ 
 
Unexpectedly, PduV-associated filaments appeared to vary in length. The control and also mCherry-
PduABJK*96NU strains contained both shorter filaments and longer ones. However, strains with 
the PduK truncated variants, mCherryPduABJK*119NU and mCherryPduABJK*133NU, contained 
filaments that seemed considerably longer (Figure 3.11). To evaluate this difference, images were 
analysed in MetaMorph in order to measure accurately and compare the filament length for each 
strain.  
 
3.2.5.3. Filament length analysis 
BL21 (DE3) strains co-expressing PduV-Cerulean with A) mCherry-PduABJKNU (full length PduK as a 
control sample), B) mCherry-PduABJK*96NU, C) mCherry-PduABJK*119NU and D) mCherry-
PduABJK*133NU were grown for microscopy. Starter cultures were set up from one colony of a 
double transformation plate and grown as outlined in Section 2.2.2.2. Subsequent cultures (25 mL) 
were set up and grown at both 37°C and 28 °C to an OD600 of between 0.4 and 0.6. Results shown 
are of the analysis of images from E.coli growth at 37°C from >200 cells.  
 
Cells were mounted on an agarose pad, and visualised by live cell imaging outlined in Section 2.5.1. 
Images were then processed in MetaMorph software to calibrate distance per pixel and allow the 
accurate measurement of filament length. Data for filament length was collected in Microsoft Excel 
and grouped to be able to plot a histogram. OriginLab was subsequently used to plot the data to a 
LogNormal fit.  
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Results show that when fitted to a LogNormal distribution, the peak PduV-Cerulean-associated 
filament length with BMCs containing full-length PduK is 2.365 µm. The histogram demonstrates 
that filament length ranges from approximately 0.5 µm to 14 µm. The shape of the histogram for 
PduV-Cerulean-associated filaments with a PduK*96 BMC variant is very similar to the control, as is 
the range of filament length. The peak length for PduK*96 is also very similar to full length PduK, at 
2.429 µm, a difference that does not appear to be significant, (Figure 3.12). 
 
Peak filament lengths with BMCs containing PduK*119 and 133 variants were higher than both the 
control and PduK*96 BMC strains, at 3.519 and 4.341 µm respectively. This amounts to filament 
length increases from the control sample of 48.8 and 83.6% for PduK*119 and 133 strains 
respectively. This shows that filament length is nearly 1.5 x and 2 x longer in these strains compared 
to the control. The shape of the LogNormal distribution also differs with these samples compared 
to PduK*96 and the control. The fit had a shoulder on the right of the distribution curve, indicating 
that a higher number of filaments were longer in length. This is also shown by the range of filament 
length which is as high as 22 µm for PduK*133 BMCs. T-Testing was also carried out which showed 
that the difference in filament length between cells expressing PduK*96 and the control cells was 
not statistically significant, whilst the difference in filament length between cells expressing 
PduK*119 or PduK*133 and the control cells was statistically significant, (Table 3.1). Raw data can 
be found in Appendix 1. 







Figure 3.12. Exploring the effect of truncating PduK on the length of PduV filaments. Graphs showing 
the distribution of PduV filaments lengths in cells expressing (A) mCherry-PduABJKNU, (B) mCherry-
PduABJK*96NU, (C) mCherry-PduABJK*119NU  and (D) mCherry-PduABJK*133NU. PduV-Cerulean 
filaments were on average longer when shells containing PduK*119 or PduK*133 were expressed. There 
was also a much larger range of filament lengths in cells expressing PduK*133. 
 
Table 3.1. Exploring the effect of truncating PduK on the length of PduV filaments. Table showing the 
peak length of PduV filaments lengths in cells expressing (A) mCherry-PduABJKNU, (B) mCherry-
PduABJK*96NU, (C) mCherry-PduABJK*119NU  and (D) mCherry-PduABJK*133NU and T-Test results to 
analyse the significance of the difference from the control sample. PduV-Cerulean filaments were on 
BMC Variant 
Length of PduK (amino acids)  
Peak Filament Length 
(µm)  
T-Test 
A)            Full length PduK (160) 2.365 ± 0.05   
B)                   PduK*96 (96) 2.429 ± 0.06 0.137976361 
C)                 PduK*119 (119) 3.519 ± 0.10 9.92263 *10-13 
D)                 PduK*133 (133) 4.341 ± 0.12 3.08972 *10-21 
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average longer when shells containing PduK*119 or PduK*133 were expressed and T-Testing showed 
the difference to from the control strain to be statistically significant. 
 
Overall the variability of PduV-associated filament length suggests that the C-terminus of PduK may 
interact with PduV. BMCs with PduK C-terminal truncations appear to be related to the increase of 
PduV-Cerulean-associated filament length. The length of filaments are similar with full-length PduK 
BMCs and a PduK truncated variant of 96 amino acids (total length). This is surprising as longer 
length PduK truncated variants, PduK*119 and PduK*133 are associated with longer filaments, 
even though a higher proportion of the protein remains.  
 
3.2.5.4. TEM analysis to determine if truncated PduK BMC variants form intact 
compartments 
Fluorescence live cell microscopy images revealed that BMCs containing PduK truncations did not 
appear to form correctly. Compared to the control strain, which contained BMC shells with full-
length PduK, the truncated variants appeared aggregated, with larger mCherry foci that localised 
to the cell poles rather than distributed throughout the cell (Figure 3.11). To explore the formation 
of Pdu compartment shells containing truncated PduK, BL21 (DE3) strains were grown and prepared 
for TEM thin sectioning as outlined in Section 2.5.2. These strains expressed only the BMCs 
containing either full length PduK, mCherry-PduABJKNU (control strain) or truncated PduK variants; 
mCherry-PduABJK*96NU, mCherry-PduABJK*119NU or mCherry-PduABJK*133NU. None of the 
strains co-expressed PduV-Cerulean. Cell sections were then stained and visualised by electron 
microscopy, as described in Section 2.5.2.2. 
 
TEM images revealed that the control strain, expressing Pdu BMC shells with full length PduK 
formed complete, intact structures ranging from ~80-100 nm in diameter. These compartments 
were identical to the Pdu BMCs visualised previously in Section 3.2.4. In comparison, BMCs 
containing truncated PduK varied in size and shape and tended to form shells that were not 
completely intact. mCherry-PduABJK*96NU BMCs were much larger than that of the control (Figure 
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3.13), ranging from ~100-200 nm in diameter. The majority of these shells appeared to be broken, 
containing an opening where the two ends of the shell failed to meet, this is shown by the white 
arrows in Figure 3.13 (B). mCherry-PduABJK*119NU shells appeared malformed, with several layers 
of shell protein wrapped around, in a spiral-like structure, where the BMC was unable to close. The 
size of the shells varied from ~80-150 nm with the vast majority of the shells remaining fractured. 
Similarly, mCherry-PduABJK*133NU BMCs appear completely malformed. Shell protein strands can 
be seen to form spiral structures that fail to close to form completed compartments. These 
structures are ~80-200 nm in diameter and do not have a consistent or defined shape. 
  
Overall TEM results show that BMCs containing truncated PduK variants form broken, malformed 
structures that tend to be larger than control Pdu shells. Interestingly, despite the increase in size, 
compartments formed with the PduK*96 truncation are most similar to the control in shape and 
structure. In comparison the other BMC variants form incomplete, spiralled structures that mostly 
fail to close.  
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Figure 3.13. Examining the effect of truncating PduK on BMC formation. TEM analysis of whole cell thin 
sections of cells expressing (A) mCherry-PduABJKNU, (B) mCherry-PduABJK*96NU, (C) mCherry-
PduABJK*119NU and (D) mCherry-PduABJK*133NU. BMCs containing truncated PduK varied in size and 
shape and tended to form shells that were not completely intact. The expression of truncated PduK variants 
resulted in much larger BMC shells being formed. In the case of PduK*96 the majority of the shells appeared 
to be broken, containing an opening where the two ends of the shell failed to meet, as seen in cells highlighted 
by white squares. The sells varied in size from 100-200 nm. PduK*119 shells appeared malformed, with 
several layers of shell protein wrapped around, in a spiral-like structure, where the BMC was unable to close 
(white square). The size of the shells varied from ~80-150 nm with the vast majority of the shells remaining 
fractured. Similarly, mCherry-PduK*133 shells appear completely malformed. Shell protein strands can be 
seen to form spiral structures that fail to close to form completed compartments (white square). These 
structures are ~80-200 nm in diameter and do not have a consistent or defined shape. 
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3.3. Discussion  
The aim of the research described in this chapter was to develop the tools and reagents that were 
required to be able to monitor physiological in vivo interactions between PduK and PduV. Does 
PduV specifically interact with one region of PduK to allow the region-specific localisation of BMCs 
within the bacterial cell? In aiming to address this key fundamental question a large array of 
plasmids has to be constructed to reflect the various permutations and combinations of shell 
proteins to allow this interaction to be probed fully. In so doing a number of further essential 
discoveries were made about the requirements for BMC function.  
 
Key to the success of being able to draw meaningful conclusions form this research is the ability to 
detect BMCs by either live cell imaging or by TEM of sectioned cells. There is a clear requirement 
for PduK within the normal formation of BMCs. The absence of this protein gives rise to aberrant 
structures that are not fully formed. More surprising is the observation that PduK has to be present 
in the natural order of shell-encoding proteins for the BMC to take shape correctly. Previous work 
has shown that the reversal of the full set of genes for empty shell synthesis resulted in the 
formation of aberrant structures similar to those observed in the absence of PduA (Parsons et al. 
2010). However it was thought this affect was mainly due to the importance of PduA in shell 
formation, making contacts with the other shell proteins. However the finding that the 
translocation of just one shell protein gene to the end of the operon suggests that the protein, as 
it is being made has to interact under the appropriate conditions with the correct shell proteins to 
allow completion of the structure. More recently it has been shown that the position of PduJ within 
the operon directly affects its function (Chowdhury et al. 2016). ^ƵĐŚĂŶ “ŽƌĚĞƌĞĚ ?ƐǇŶƚŚĞƐŝƐŵĂǇ
underline some of the higher order quaternary structure organisation of this remarkable 
macromolecular complex.  
 
From bio-informatics we know that PduK represents a BMC-shell protein domain of about 110 
ĂŵŝŶŽĂĐŝĚƐƚŚĂƚŝƐƚĞƚŚĞƌĞĚƚŽĂŶ “ƵŶŬŶŽǁŶ ?-terminal extension. The natural thought would be 
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that the C-terminal region would be associated with biding either internalized protein cargo, 
binding external facing proteins (such as PduV) or the uptake/control of external substrates. The N-
terminal region would therefore be involved in forming the structural hexameric tile that forms a 
key component of the facet of the overall structure. It was surprising therefore to discover that 
none of the C-terminal truncations of PduK were able to replace PduK within the minimal shell-
gene repertoire for empty BMC formation (pduABJKN).  Moreover the truncated variants revealed 
structures, upon thin sectioning, suggesting that the BMC was unable to close properly. The 
ƉƌĞƐĞŶĐĞŽĨƚŚĞƐĞ “ŽƉĞŶ ?DƐƐƵŐŐĞƐƚƐƚŚĂƚWĚƵ<ĂĐƚƵĂůůǇŚĂƐĂŶŝŵƉŽƌƚĂŶƚƌŽůĞƚŽƉůĂǇŝŶĐůŽƐŝŶŐ 
the structure, perhaps by generating a bend or fold along one of the edges of the BMS, in a similar 
way to the envisaged role for PduU. This finding has the potential to signiciantly change the way in 
which the structure of Pdu proteins is interpreted as it had previopusly been thought that it was 
the BMC-shell protein domain that was key for the structural role of Pdu proteins. Now we can see 
that other regions within the protein can also bekey to them carrying out their structural roles. 
 
Although the research was successful in generating the required variety of tools and reagents for 
this study, the research was ultimately unsuccessful in attaining its original goal of detecting specific 
PduV-PduK interactions. This was caused by the fact that addition of either N- or C- extensions to 
PduK resulted in forms of PduK that could not replace wild type PduK. Any tagged form of PduK was 
found to prevent proper formation of BMCs and thus would not reflect the normal situation. Such 
an effect could not have been predicted from the outset of this research, especially given the 
observation that wild type BMCs are easily observed with a tagged version of the more abundant 
PduA. However as will be seen in subsequent chapters, many shell proteins are sensitive to 
modification. 
  










Chapter 4: Effect of mCherry fusions on 
BMC formation and the interaction with 
PduV  
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4.1. Introduction 
The function of the bacterial microcompartment is completely dependent on its outer shell. 
Salmonella enterica expressing mutant Pdu shell proteins which prevent proper formation of the 
Pdu compartment shell, were found to accumulate propionaldehyde to levels that induced 20-30 
hours of growth arrest and resulted in DNA damage (Cheng et al. 2011). This highlights the 
importance of the shell to the role of the BMC in sequestering toxic intermediates. Although it is 
evident that BMC shell mutants, lacking any one of the essential genes, pduA,B,J,K or N were unable 
to form intact, delineated compartments, the exact roles of these shell proteins are largely 
unknown (Cheng et al. 2011). Studies have provided insights into roles that these proteins may have 
in the formation of the organelle, or specific roles in protein localisation, see section 1.4.7 
(Lawrence et al. 2014; Wheatley et al. 2013; Havemann, Sampson & Bobik 2002; Sargent, F. A. 
Davidson, et al. 2013).  
 
The formation of the Pdu shell remains largely elusive, although it is beleived that the shell 
undergoes a self-assembly process. Recombinant empty BMCs, consisting of PduABJKNU(T) 
expressed in E.coli are able to form in the absence of any other Pdu proteins (Parsons et al. 2008). 
This differs from the carboxysome assembly process which involves the simultaneous aggregation 
of cargo (RuBisCo) which is subsequently encapsulated by the shell proteins. Therefore despite 
structural and functional similarities it appears the process of shell formation differs greatly 
ďĞƚǁĞĞŶ ƚŚĞ ƚǁŽ ? ǁŝƚŚ ƚŚĞ ĐĂƌďŽǆǇƐŽŵĞƐ ĚĞƉĞŶĚĞŶĐĞ ŽĨ ƚŚĞ ƉƌĞƐĞŶĐĞ ŽĨ ŝƚ ?Ɛ ĐĂƌŐŽ ŶŽƚ ďĞŝŶŐ
replicated in the case of the Pdu Microcopmartment. Although little is understood about this 
formation process of the Pdu shell, the proteins that form it have been investigated.  
 
ƐƉƌĞǀŝŽƵƐůǇĚĞƐĐƌŝďĞĚ ?ŝŶƐĞĐƚŝŽŶ ? ? ? ? ? ?WĚƵ ?WĚƵ ?ĂŶĚWĚƵ:ĂƌĞƚŚĞŵŽƐƚĂďƵŶĚĂŶƚƉƌŽƚĞŝŶƐ
found within fully formed BMCs, with PduK, PduN, PduT and PduU constituting a smaller proportion 
of the shell  (Havemann & Bobik 2003).  Altering the expression levels of any of the shell proteins, 
including those that are major and even minor components of the compartment, can cause the 
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BMC to misfold, forming unusual, broken structures (Parsons et al. 2008). This is integral to the 
function of the BMC, as the shell not only allows substrates, cofactors, coenzymes and products to 
enter or exit the organelle, it also acts to confine intermediates within the lumen to increase the 
efficiency of reactions and prevent toxicity to the cell. Therefore, understanding the role of each of 
these proteins, how they interact with other components to assemble the compartment structure 
and how they are distributed in the cell, especially during cell division, is important for their use as 
metabolosomes for specific pathways.  
 
Previous research have investigated the effect of tagging various shell proteins with fluorophores. 
An N-terminal PduA fusion expressed with the other genes necessary for recombinant empty BMC 
shell formation, mCherry-PduA-BJKNU, results in the formation of intact shell structures and BMC 
formation with this modified version of PduA was not impaired (Parsons et al. 2010). In addition a 
C-terminal GFP fusion with PduN was able to rescue the formation of intact BMCs when co-
expressed with PduABJKU, suggesting that PduN-GFP does not hinder the integration of PduN in 
the shell. Conversely, an N-terminal GFP fusion did not rescue the formation of BMCs suggesting 
that PduN function was impaired (Parsons et al. 2010).  Similarly, results shown in chapter 3 of this 
thesis have shown that when PduK was tagged on either the N or C terminus, compartments were 
no longer able to form, as described in section 3.2.2.2. Aside from PduA, PduN, and now PduK, no 
other Pdu shell proteins have been tagged with fluorophores or analysed by fluorescence 
microscopy.  
 
In order to provide insights into each of the shell components, proteins were tagged on the N- and 
C- termini with mCherry, creating two separate constructs in each case, with the exception of PduK 
which does not form intact BMC shells when tagged. These tags were integrated into the gene order 
from the C. freundii operon and expressed in E. coli. The expression and formation of compartments 
in each case aimed to give structural information on how the shell component is integrated into the 
compartment  ? if tagging either end of the protein disrupts the formation of the shell clues could 
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be provided into the importance of the terminus in the interaction with other components to 
assemble the compartment structure. Limited experiments were carried out with PduABJK-
mCherry-N-U as studies had shown that this fusion tag is non-functional. 
 
This study also aims to investigate the interaction between shell proteins and PduV-Cerulean 
through live-cell imaging. By tagging each shell protein with mCherry, the localisation between red 
and blue signal can be visualised and consequently, interactions between each shell component 
and PduV can be investigated.  
  




4.2.1. Cloning of individual fluorescently tagged shell proteins 
Genes encoding shell proteins were tagged with mCherry. This involved production of nine novel 
constructs (numbers 2-10), listed in Table 4.1 below.   
Construct ID Shell protein tag Completed construct 
1 mCherry-PduA   pLysS-mCherry-PduA-BJKNU  * 
2 PduA-mCherry pET3a-Pdu-A-mCherry-BJKNU 
3 mCherry-PduB pLysS-PduA-mCherry-B-JKNU 
4 PduB-mCherry pLysS-PduA-B-mCherry-JKNU 
5 mCherry-PduJ pET3a-PduAB-mCherry-J-KNU 
6 PduJ-mCherry pET3a-PduAB-J-mCherry-KNU 
7 mCherry-PduN pET3a-PduABJK-mCherry-N-U 
8 PduN mCherry pET3a-PduABJK-N-mCherry-U 
9 mCherry-PduU pET3a-PduABJKN-mCherry-U 
10 PduU-mCherry pET3a-PduABJKN-U-mCherry 
 
Table 4.1. Engineered constructs that encode BMCs containing a mCherry-tagged shell protein.  
* This construct has been shown to form intact BMCs when expressed and has therefore been used as a 
control in this study. 
 
Initially mCherry was amplified by PCR from pLysS-mCherry-PduABJKNU with the addition of the 
following restriction sites: N-terminal -  ? ?ƐĞ/ ? ? ?EĚĞ/ ?^ƉĞ/ĂŶĚ-terminal  ?  ? ?EĚĞ/ ?^ĂĐ/ ? ?^ƉĞ/ ?
The presence of the extra restriction sites is to allow gene insertion between NdeI and SpeI for the 
N-terminal mCherry tag and between NdeI and SacI for the C-terminal mCherry tag. After restriction 
digestion (AseI, SpeI for N-terminal mCherry and NdeI, SpeI for C-terminal mCherry) to remove extra 
ďĂƐĞƐĂŶĚĐƌĞĂƚĞƚŚĞ ? ?ĂŶĚ ? ?ŽǀĞƌŚĂŶŐƐ ?ƚŚĞmCherry N and C terminal PCR fragments were ligated 
into pET3a, which had been restricted with NdeI and SpeI. Ligation of the N-terminal mCherry 
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ĨƌĂŐŵĞŶƚǁŝƚŚƉd ?ĂƵůƚŝŵĂƚĞůǇĚĞƐƚƌŽǇƐƚŚĞ ? ?ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞďǇƚŚĞũŽŝŶŝŶŐŽĨƚŚĞĐŽŚĞƐŝǀĞĞŶĚƐ
of AseI and NdeI. This allows the insertion of genes that encode shell proteins between the NdeI 
and SpeI sites behind mCherry. Once ligated with pET3a, both N- and C- terminal tags were 
sequenced to ensure that no mutations had been introduced.  
 
ĂĐŚŽĨ ƚŚĞŐĞŶĞƐĞŶĐŽĚŝŶŐƚŚĞƐŚĞůůƉƌŽƚĞŝŶƐ ?WĚƵ ?WĚƵ ? ?WĚƵ: ?WĚƵ< ?WĚƵEĂŶĚWĚƵhǁĞƌĞ
subcloned from pET3a. The genes had been originally cloned after PCR from C. freundii by Dr Josh 
WĂƌƐŽŶƐǁŝƚŚƚŚĞƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞƐ ? ?EĚĞ/ĂŶĚ ? ?^ƉĞ/ ?dŚĞƐĞpET3a-pdu constructs were restricted 
with NdeI and SpeI, to cut out the pdu gene which was subsequently ligated with the compatible 
NdeI and SpeI ends of the pET3a-mCherry fragment. This created pET3a-mCherry-pdu* constructs 
where the asterisk represents the gene for the shell constituent.  
 
Genes encoding Pdu shell proteins to be ligated at the C-terminus of mCherry were amplified by 
PCR from the corresponding pET3a-ƉĚƵ ?ĐŽŶƐƚƌƵĐƚĂƐĂ ƚĞŵƉůĂƚĞ ?ǁŝƚŚƚŚĞĂĚĚŝƚŝŽŶŽĨĂ  ? ?^ĂĐ/
ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞ ŝŶƐƚĞĂĚŽĨ^ƉĞ/Ăƚ ƚŚĞĞŶĚŽĨ ƚŚĞŐĞŶĞ ?dŚĞ  ? ?EĚĞ/ƐŝƚĞ ƌĞŵĂŝŶĞĚƚŚĞƐĂŵĞ ?dŚĞ
primers used are listed in Table 2.3. PCR fragments, restricted with NdeI and SacI were ligated into 
the C-terminal mCherry construct; pET3a-mCherry, which had also been restriction digested with 
the same enzymes, to create the plasmid, pET3a-pdu*-mCherry. The mCherry and Pdu fusions tags 
were then cloned with the other genes necessary for recombinant shell formation. The Link and 
Lock method of cloning was used to subclone genes into the same plasmid, see Section 2.3.7.1.  
 
4.2.1.1. PduA 
An N-terminal PduA mCherry tag, pLysS-PduAmCherry-BJKNU, engineered by Dr Josh Parsons, was 
used in this study, see Table 2.2.  
 
The C-terminal PduA tag was engineered as above, to create a pET3a-pduA mCherry construct. 
Subsequently, pduB was subcloned from pET3a by restriction with XbaI and HindIII. pET3a-mCherry-
pduA was also restriction digested with SpeI and XbaI and the fragments were ligated. Due to the 
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compatible cohesive ends of XbaI and SpeI, these sites can join to create the construct pET3a-pduA-
mCherry-PduB by the Link and Lock method.  
 
pduB contains the restriction site AscI, which is only present in that gene once and is not present in 
pET3a. By the restriction digest of AscI and HindIII sites of both pET3a-pduA-mCherry-PduB and 
pET3a-mCherry-pduABJKNU, the plasmids can be cut in the middle of pduB allowing the rest of the 




A C-terminal PduB-mCherry tag was constructed as described in Section 4.2.1. pduB-mCherry was 
subcloned with plysS-pduA by the Link and Lock method to produce the construct; pLysS-pduAB-
mCherry. To subclone the shell constituents pduJKNU at the end of the construct, firstly, pduJ had 
to be added to the plasmid. To do this, pduJ was cloned at the end of the construct by Link and Lock 
using XbaI and SpeI as well as HindII. A restriction site StuI, unique to pduJ in both constructs; pLysS-
mCherry-PduABJKNU and pLysS-pduAB-mCherry-pduJ was used, along with HindIII, to cut in the 
middle of pduJ and introduce the remaining shell genes to engineer the construct: pLysS pduAB-
mCherry-JKNU. 
 
 The N-terminal PduB tag was created as described in Section 4.2.1 mCherry-pduB was subcloned 
with pLysS-pduA by the Link and Lock method. Subsequently pLysS-pduA-mCherry-pduB was 
restriction digested with AscI, which cuts the plasmid once within PduB as well as HindIII. pLysS-
mCherry-PduABJKNU was restricted with the same enzymes and the fragments were ligated to form 
the completed construct: pLysS-pduA-mCherry-pduB-JKNU. 
 
4.2.1.3. PduJ 
pET3a-mCherry-pduJ was engineered as described in Section 4.2.1 mCherry-pduJ was subcloned by 
the Link and Lock method, with pET3a-pduAB (Table 2.2). pET3a-pduAB-mCherry-pduJ and pLysS-
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mCherry-PduABJKNU were then restricted with StuI and HindIII and ligated to construct the 
plasmid: pET3a-pduAB-mCherry-J-KNU.  
To engineer pET3a-pduAB-J-mCherry-KNU, pduJ-mCherry was subcloned with pET3a-PduAB by the 
Link and Lock method. Each consecutive gene was then cloned after the last by Link and Lock from 
pET3a plasmids containing each gene, as described in Table 2.2. The Link and Lock method is 
described in Section 2.3.7.1. 
 
4.2.1.4. PduN 
pET3a-mCherry-pduN and pET3a-pduN-mCherry were cloned as described in Section 4.2.1. The 
pduN tags were restricted using XbaI and HindIII and subsequently ligated with pET3a-pduABJK 
which had been restriction digested with SpeI and HindIII (Link and Lock method, Section 2.3.7.1). 
For both engineered constructs, pduU was subcloned by the Link and Lock method resulting in: 
pET3a-pduABJK-mCherry-N-U and pET3a-pdu-ABJK-N-mCherry-U.  
 
4.2.1.5. PduU 
As with all shell protein fusions, pET3a-mCherry-pduU and pET3a-pduU-mCherry were cloned as 
described in Section 4.2.1. The fusion tags were subcloned by a restriction digest with XbaI and 
HindIII and then ligation with pET3a-pduABJKN, which had been restricted with SpeI and HindIII 
(Link and Lock method). This resulted in the following constructs: pET3a-PduABJKN-mCherry-U and 
pET3a-PduABJKN-U-mCherry.  
 
4.2.2. Optimisation of protein production  
This investigation aimed to analyse the protein content of strains expressing the genes for the BMC 
tagged-shell protein variants by SDS PAGE and Western Blot analysis. However, growth of each 
strain under identical growth conditions revealed that protein production may differ depending on 
the plasmid used to engineer the BMC constructs. The colour of the cells within the various cultures 
appeared to vary depending on the plasmid used; pLysS or pET3a.  
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4.2.2.1. Effect of plasmids on protein production 
When strains containing each construct were grown for expression studies, the colour of cells were 
observed. The production of fluorescent proteins is known to cause the colour of cells to change, 
depending on the properties of the fluorophore. For example, when cells expressing Ypet-tagged 
PduK were grown for live cell imaging, Section 3.2.2.2, the cell pellet had a dark yellow appearance. 
In this case, cells expressing mCherry were expected to have a magenta colouration, however only 
certain strains seemed to generate the expected appearance. 
 
Cultures of BL21(DE3) cells (200 mL)  containing each of the tagged-BMCs listed in Figure 4.1 (C) 
were grown at 37°C. This experiment was initially carried out to investigate the protein content of 
purified BMCs containing tagged-shell proteins. The cultures were inoculated from an overnight 
starter culture to an OD600 of 0.05. The starter cultures were in turn inoculated with ~4 colonies 
from a fresh transformation plate. The 200 mL cultures were induced with IPTG when an OD600 of 
0.8 was reached and the cultures were transferred to a shaking platform at 19°C overnight.  
The following day, the colour of the cultures were observed; 2 mLs of culture were transferred to a 



































Figure 4.1. The colour of cells expressing constructs from either pET3a or pLysS compared to the 
observed protein profile. Cell samples were taken from a culture grown at 19 °C overnight after induction 
for the imaging of cell colouration. Cells from the cultures were then pelleted, resuspended in Ypet 
solution and incubated for 3 hours. Samples of the cell lysate were then taken for SDS PAGE analysis A) 
The difference in the colour of cells expressing each construct was imaged. Cells expressing mCherry-
tagged BMC variants from a pLysS plasmid (constructs 1,3 and 4) appear magenta compared to cells 
expressing tagged-BMCs from pET3A. B) 15% SDS PAGE of cell lysates after exposure to Yper detergent 
C) Table displaying each of the corresponding construct ID numbers from A and B, note Construct 8 is 
Pdu A, Pdu J & 
PduN (9 kDa) 
Pdu U (13 kDa) 
Pdu K (16 kDa) 
* runs at 
higher MW 
Pdu B (24 kDa) 




(51 kDa)  ? ?
(55kDa) 
38 
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not present in either A or B as it was cloned at the end of the study for a complete data set. Previous 
studies had already identified that tagging PduN on the C terminus was unsuccessful, see Section 4.1.   
 
Interestingly only three of the nine samples were magenta and these three strains contained a 
pLysS construct with the others involving shell genes cloned with pET3a. Even though the 
colouration of cells differed when mCherry-tagged shell proteins were expressed from the two 
varying plasmids, earlier studies in Section 4.2.2.2 showed that all of the mCherry-tagged proteins 
were still produced from both plasmids. However the effect of the two different plasmids on the 
amount of protein expressed, causing a change in cell colour, was unclear. 
 
The cells were pelleted and exposed to a protein extraction reagent solution for 3 hours as 
described in the BMC purification method, outlined in Section 2.2.7.2 Samples were then taken for 
SDS PAGE analysis after treatment with YPer; 1 mL of cells were spun down and resuspended in 50 
ʅ>ŽĨ ?yW^ďƵĨĨĞƌĂŶĚƚŚĞŶƉƌĞƉĂƌĞĚĨŽƌ^^ĂĐĐŽƌĚŝŶŐƚŽ^ĞĐƚŝŽŶ ? ? ? ? ? ? ? ? 
 
Figure 4.1 (B) shows that shell proteins were a lot more visible in lanes 1, and 4 and slightly clearer 
in lane 3 compared to the other lanes which appeared to contain many more proteins. These lanes 
contained cell lysates of proteins expressed from pLysS constructs. The band pattern for constructs: 
2, 5, 6, 7, 9 and 10, all cloned into pET3a, appeared identical. Although all lanes contained samples 
of a crude cell lysate, the band pattern of pET3a constructs were very different to that observed in 
Figure 4.3. This could be due to several factors such as protein extraction treatment or growth 
conditions due to a larger culture.  Nevertheless, the results demonstrate that the production of 
shell proteins was higher, with less background protein production by pLysS constructs compared 
with pET3a.   
 
To ensure that the results are comparable, it was necessary to maintain consistency between 
constructs and minimise differences in expression patterns because of the plasmid used. 
Differences in expression due to the design of the constructs were not anticipated due to the same 
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promotor, T7, being present in both plasmids. To explore the difference in cell colouration, pET3a-
pdu-A-mCherry-BJKNU was re-cloned into a pLysS vector. This involved restriction of sequenced 
pET3a-pduA-mCherry construct with XbaI and HindIII and the subsequent ligation with pLysS-pduU 
which had been restricted with the same enzymes, removing the gene already cloned in the 
plasmid. The succeeding gene encoding PduB was then cloned after the fusion by Link and Lock, 
see Section 2.3.7.1. pLysS-pdu-A-mCherry-B and pET3a-pdu-A-mCherry-BJKNU were restriction 
digested with AscI and HindIII to cut in the middle of pduB and replace the fragment with the rest 
of the shell genes, forming pLysS-pdu-A-mCherry-BJKNU. 
 
Three BL21(DE3) strains containing the constructs: pLysS-mCherry-PduA-BJKNU, pLysS-pdu-A-
mCherry-BJKNU and pET3a-pdu-A-mCherry-BJKNU were grown in 25 mL cultures at 37°C to an OD600 
of ~0.6. Cells were then induced with IPTG and  grown at 19 °C for 2 hours as described in Section 
2.2.5. A 1 mL cell culture sample was taken for each strain, cells were centrifuged at 4000 rpm for 
 ?ŵŝŶĂŶĚƌĞƐƵƐƉĞŶĚĞĚŝŶ ? ?ʅ>ŽĨ ?yW^ďƵĨĨĞƌ ?dŚĞƐĂŵƉůĞƐǁĞƌĞƚŚĞŶĚĞŶĂƚƵƌĞĚĂƐŽƵƚůŝŶĞĚŝŶ
Section 2.1.7.4 and run on a 15% SDS gel, as shown in Figure 4.2.  
 
Figure 4.2. Comparison of cells expressing BMCs with a C-terminal mCherry-tagged PduA cloned with 
pLysS or pET3a. Expected molecular weights of the Pdu proteins expressed had previously been 
identified (Parsons et al. 2010).  A) Cell pellets from a 25 mL cell culture demonstrate the colour of cells 
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expressing an mCherry-tag. Interestingly cells expressing mCherry-PduA-BJKNU and PduA-mCherry-
BJKNU cloned with pLysS were magenta compared to cells expressing PduA-mCherry-BJKNU from a 
pET3a plasmid. B) 15% SDS PAGE gel of cell samples taken from the corresponding cell pellets in image 
A.  
 
Figure 4.2 (A) shows that tagged-BMCs expressed from a pLysS plasmid are associated with a 
magenta colouration of cells. In comparison, the same genes expressed from a pET3a vector did 
not cause cells to become coloured. This is consistent with previous results that showed strains 
expressing pLysS constructs were magenta compared to strains expressing genes from pET3a, 
Figure 4.1.  SDS PAGE, image B Figure 4.1, revealed that shell proteins were visible in the control 
strain expressing pLysS-mCherry-PduA-BJKNU. Bands appeared darker, indicating a higher protein 
concentration, in lanes 2 and 3 for PduA-mCherry BMCs, however this could be due to differences 
in cell density of the cultures. In addition, lanes 2 and 3 appear to contain many more bands. 
 
The results of the SDS gel analysis are largely inconclusive; the expression of shell proteins when 
bacterial cells are examined by SDS are not clearer depending on plasmid. Lanes 2 and 3 
representing pLysS-pduA-mCherry-BJKNU and pET3a-PduA-mCherry-BJKNU appeared to have many 
contaminating bands making individual shell proteins difficult to determine, but again this could be 
due to the higher density of the cell culture. This result differs from that of previous expression 
studies in Section 4.2.2.2 and may be due to overloading of protein on the gel. The band pattern is 
identical in both gels, and darker bands corresponding to those visualised previously in Figure 4.1 
can still be seen.  
 
Overall it is clear that bacterial strains containing BMC genes cloned with pLysS appear magenta in 
colour when cultured. This differs from strains containing BMC variants expressed from a pET3a 
plasmid which appear normal in colour. It was difficult to draw definitive conclusions on how the 
plasmid affected BMC protein expression when alalysis protein content by SDS-PAGE when whole 
cell lysates were analysed due to the amount of protein bands visualised by SDS.  
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4.2.2.2. Protein expression after induction    
Results have shown that the plasmid used may affect the expression of protein, causing colouration 
in cell cultures. To investigate further protein expression of each strain, cells were cultured and 
samples taken at specific time-points after induction. The protein content of the cells were analysed 
by SDS PAGE and Western Blots to determine if firstly, all shell proteins were visible when induced, 
and secondly, if protein expression increased over time. 
 
BL21(DE3) competent cells were transformed with the completed constructs listed in Table 4.1. 
Several colonies from the same transformation plate were used to inoculate a 5 ml starter culture. 
The starter culture was grown overnight as described in Section 2.2.2.2. A larger LB culture (250 
mL) was inoculated with the starter culture (1:100 dilution) and grown at 37 °C until an OD600 of 0.8 
was reached. The cultures were then induced with IPTG, as outlined in Section 2.2.5, and grown at 
19°C overnight.  
 
After induction with IPTG, 1 mL of cell culture was taken for SDS PAGE and Western Blot analysis at 
varying time-points: straight after induction (0 hours), 1 hour after induction, 2 hours after 
induction and overnight. An OD600 of the cultures were taken and then the cells were harvested by 
centrifugation at 4000 rpm for 1 min. Each cell sample was diluted by addition of 1 x PBS according 
to the OD600 to ensure that each cell sample was the same density allowing for any change in protein 
production after induction to be visualised.  Samples were run on pre-cast SDS gels, as described in 
Section 2.1.7.4 and were also analysed by Western Blotting as described in Section 2.1.7.5, using 
anti-mCherry to identify the tagged shell protein. The SDS-PAGE gels and western blots were 
produced using cell samples taken at the same times on the same days to ensure consistency. The 


















Table 4.2. The molecular weights of untagged shell protein compared with mCherry-tagged shell 
proteins.  
* PduK usually runs at ~20KDa on an SDS PAGE gel 
 
Figure 4.3 shows SDS gels and Western blots from cells expressing BMCs containing a mCherry shell 
protein fusion. Each lane consists of whole cell extracts from strains expressing the BMC mCherry-
tagged variants. Empty BMC shells containing PduA with an N-terminal mCherry tag, (Image A) 
appeared to show an increase in protein production which can be seen from lanes 0-O/N with bands 
for the shell proteins visible, as labelled, however PduN is not detectable by SDS PAGE due to its 
low abundance. In addition it is not easy to determine which band PduJ may be due to the lowest 
detectable marker band being 15 KDa. The corresponding western blot, image E, clearly shows the 
presence of mCherry-PduA expression, which again appeared to increase over time after induction 
with IPTG.  
 
  Molecular mass, KDa 
  




PduA 9.5 36.5 
PduB 24 51 
PduB' 28 55 
PduJ 9 36 
PduK 16 * 43 
PduN 9 36 
PduU 13 40 
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In comparison, expression of the other constructs do not appear to involve an increase in shell 
protein production as seen with mCherry-PduA BMCs, with the exception of image B which shows 
BMCs formed with mCherry-PduB.  
 
Image B, Pdu-A-mCherry-BJKNU, appeared to show an increased expression of predominately 
mCherry-PduA, with no noticeable increase in the expression of other shell proteins. The 
corresponding western blot, image F, confirms the presence of mCherry-PduA and the apparent 
increase in expression over time.  The SDS gel of BMCs with mCherry-PduB, image C, provides no 
noticeable band of tagged shell protein, however the western blot validates that mCherry-PduB is 
expressed, image G. Interestingly there is only one band when PduB is tagged on the N terminus, 
compared with the two bands visualised in the western blot for the PduB C-terminal tag, image H. 
Both mCherry-PduB and mCherry-WĚƵ ?ďĂŶds are visible by SDS PAGE, image D. PduK appears to 
run higher, between 20 and 25 KDa but this may be due to the samples not running as far on the 
gradient gel. Likewise when all SDS gels were examined, the position of PduK was variable, below 
20KDa when PduN-mCherry was analysed and higher than 20 KDa with mCherry-PduB.  
 
Expression of tagged PduJ, both N- and C- terminus did not appear to increase over time, although 
the bands for other shell proteins appeared to increase, Figure 4.3 (A) and (B). This is repeated by 
the western blots, images D and E, which show faint bands that appear not to increase in density 
over time for mCherry-PduJ and have only a slight increase over time with expression of PduJ-
mCherry.   
 
Expression studies were not carried out with BMCs containing mCherry-PduN as it had been 
previously found that an N-terminal PduN tag did not produce fully formed, functional 
microcompartment shells. 
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Protein production appeared to increase slightly over time when PduU was tagged on the N- or C- 
terminus, Figure 4.3 images O and P. All shell proteins were visible and matching western blots, 
images Q and R also showed that tagged PduU was expressed and that expression of PduU-mCherry 
appeared to increase over time. Although bands were visible for mCherry-PduU at all timepoints, it 
was difficult to see a correlation of band density. The bands did not get darker over time suggesting 
that protein production had not increased, with the sample taken overnight (O/N) appearing to be 
a lot fainter than the other bands, despite the SDS gel indicating that there may have been an 
increase in protein production.  
Overall, expression studies revealed that all bands representing shell proteins were visible. 
However, an apparent increase in protein expression over time, after induction, was only observed 
with some of the strains, most noticeably in Figure 4.3 (A), (B) and (D), corresponding to BMC tagged 
variants expressed from constructs; pLysS-mCherry-pduA-BJKNU, pLysS-pduA-mCherry-BJKNU and 
pLysS-pduA-B-mCherry-JKNU. Interestingly all of these BMC variants are expressed from a pLysS 
plasmid and appear to show larger increases in protein production after induction compared with 
the pET3a plasmids, with the exception of (pLysS) PduA-mCherry-B-JKNU which does not appear to 
show a protein increase over time. 
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Figure 4.3. SDS PAGE and Western blot analysis of protein expression directly after induction (0 hours), 
1 and 2 hours after induction and also overnight (O/N). SDS samples were equally loaded by measuring 
the OD600, pelleting the cells and resuspending in 1 x PBS buffer and lamelli buffer. Samples were then 
run on 15% gels. For each of the following, SDS gels and western blots (anti-mCherry) of BL21(DE3) cells 
a construct for the expression of shell protein-tagged BMC variants in either pET3a or pLysS are shown:  
A) and B) (plysS) mCherry-PduA-BJKNU, C) and D) (pLysS) PduA-mCherry-BJKNU, E) and F) (pLysS) PduA-
mCherry-PduB-JKNU, G) and H) (pLysS) PduA-B-mCherry-JKNU  I) and J) (pET3a) PduAB-mCherry-J-KNU 
K) and L) (pET3a) PduAB-J-mCherry-KNU M) and N) (pET3a) PduABJK-N-mCherry-U O) and P) (pET3a) 
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4.2.2.3. Effect of expressing BMCs in strains also containing an empty pLysS plasmid   
Results have suggested that constructs cloned with pLysS show a larger increase in protein 
expression after induction. In addition strains expressing proteins encoded by genes from a pLysS 
plasmid involve a magenta colouration of E. coli cells.  
 
To explore the role of pLysS in protein production, two strains were produced consisting of pET3a-
pduAB-mCherry-J-KNU and pLysS as well as pET3a-pduAB-J-mCherry-KNU and pLysS. These strains 
were cultured alongside strains containing pET3a BMC constructs alone to compare the effect of 
adding pLysS to the cells.  
 
Strains were produced by the transformation of BL21(DE3) pLysS cells with each of the pET3a 
constructs. In addition BL21(DE3) cells were transformed with the same constructs for comparison 
of expression without pLysS. Several colonies from the transformation plate were used to inoculate 
a 5 mL starter culture. The starter culture was grown overnight as described in Section 2.2.2.2. A 
larger LB culture (250 mL) was inoculated with the starter culture (1:100 dilution) and grown at 37 
°C until an OD600 of 0.8 was reached. The cultures were then induced with IPTG, as outlined in 
Section 2.2.5, and grown at 19°C overnight. 1 mL cell samples were taken for western blotting at 0 
hours, 1 hour, 2 hours after induction and also overnight (O/N). An OD600 was taken for each 
sample and cells were pelleted at 4000 rpm in a microcentrifuge. The cell pellets were then diluted 
with 1 x PBS according to the optical density to ensure gels were equally loaded, Any differences in 
protein concentration was therefore due to expression and not cell density, see Section 2.1.7.4. 
Samples were then run on a 15% SDS PAGE gel and western blots were carried out using anti-
mCherry, as outlined in Section 2.1.7.5.  
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Figure 4.4. Difference in protein expression between cells containing a pET3a mCherry-tagged BMC 
construct with and without pLysS. A) Western Blot analysis using anti-mCherry of mCherry-tagged PduJ 
BMCs expressed with and without pLysS. Samples were taken at time-points after induction with IPTG. 
B) The colour of the cells overnight were also recorded 1- PduAB-mCherry-J-KNU with pLysS, 2- PduAB-
J-mCherry-KNU with pLysS, 3- - PduAB-mCherry-J-KNU without pLysS and 4- PduAB-J-mCherry-KNU 
without pLysS. Cells expressing BMC variants in the presence of empty pLysS were pink or magenta 
indicating higher mCherry expression.  
 
Figure 4.4 (A) shows western blots of mCherry tagged-PduJ BMCs grown in both the presence and 
absence of pLysS.  Without pLysS it is difficult to establish an increase in mCherry-tagged PduJ over 
time, although from 0 to 1 hours after induction for mCherry-PduJ, an increase in band density is 
seen (Figure 4.4). There is no apparent increase in protein synthesis with PduJ-mCherry in the 
absence of pLysS and the bands for each time-point appear similar in density. In comparison, strains 
containing tagged BMCs as well as the empty pLysS vector show an increase in protein expression 
over time after induction for both mCherry-tagged PduJ BMCs, with far more protein present in 
overnight samples compared to samples taken at the time of induction. This suggests that the 
addition of empty pLysS plasmids to strains containing BMC variants increases the production of 
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shell proteins after induction. This shows a similar pattern to tagged shell protein constructs that 
were cloned with pLysS directly.   
 
Similarly, the colour of cell pellets were recorded, shown in Figure 4.4 (B). Strains containing pLysS 
were either pink or purple compared to strains lacking plysS. In addition to the western blot 
findings, this demonstrates that the addition of an empty pLysS plasmid effected protein synthesis. 
Results therefore indicate that the addition of pLysS to bacterial strains containing tagged-BMC 
variants cloned with pET3a, increase protein production when induced.  
 
4.2.2.4. Effect of plasmids on BMC purification  
Results have shown that although there appears to be a difference in the expression of mCherry-
tagged shell proteins encoded by pET3a and pLysS constructs, shown by the colour of cells, SDS gels 
are not as clear-cut. It is difficult to conclude, by SDS PAGE of whole cell extracts, if the plasmid had 
any effect on overall protein expression. 
 
Previous western blot analysis demonstrated that BMC tagged shell constructs cloned with pLysS 
generally showed a greater increase in protein after induction compared with pET3a constructs. 
Furthermore, the addition of empty pLysS plasmid to strains containing pET3a BMC constructs 
rescued the expression of shell protein after induction with a higher increase in expression over 
time compared to strains lacking pLysS.  
 
To investigate further protein expression levels, strains containing mCherry-tagged shell protein 
BMC variants cloned with pET3a, in the presence and absence of pLysS were grown for BMC 
purifications. SDS PAGE gels were carried out to compare the amount of purified protein with each 
strain and to determine if pLysS addition had any effect. In this way, the purification method could 
therefore be optimised.  
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BL21 (DE3) pLysS and BL21 (DE3) competent cells were transformed with pET3a constructs: 5,6,8,9 
and 10 listed in Table 4.1. Several colonies were picked from each transformation plate and used 
to inoculate 5 mL starter cultures. The starter cultures were grown overnight and subsequently 
used to inoculate 250 mL cultures (1:100). These cultures were then grown at 37°C and induced 
when an OD600 of 0.8 was reached. The cultures were then transferred to a shaking platform at 19°C 
and grown overnight. This process is outlined in Section 2.2.5.  The following morning, cells were 
harvested and BMCs were purified according to the original, unaltered Yper reagent method which 
involves purification with varying concentrations of salt, as described in Section 2.2.7.2 Samples 
were taken for each step of the purification protocol, prepared for SDS PAGE analysis and run on a 
15% gel as outlined in Section 2.1.7.4. Results are shown in Figure 4.5.  
 
Figure 4.5 demonstrates each step of the BMC purification process for strains containing mCherry-
tagged BMC constructs cloned with pET3a, in the absence and presence of pLysS. Interestingly, all 
purifications carried out from strains containing empty pLysS have visible shell protein in the final 
clarified supernatant fraction. In comparison, purifications carried out with only the BMC construct 
expressed have far less protein present in the final fraction. In addition the number of shell proteins 
visible are lower without pLysS present. For example, only mCherry-PduJ is visible Figure 4.5 (A), 
compared with mCherry-WĚƵ: ?WĚƵ ?WĚƵ ?ĂŶĚWĚƵ<ĐůĞĂƌůǇǀŝƐŝďůĞŝŶƚŚĞƉƵƌŝĨŝĞĚĨƌĂĐƚŝŽŶƐŚŽǁŶ
in Figure 4.5 (B). This is the case for all gels, with the exception of mCherry-PduU BMCs, image G. 
In the absence of pLysS, the final fraction clearly contains shell proteins and there appears to be no 
large difference between purifications of this BMC variant with or without pLysS.  
 
The reason why purifications seem to differ so dramatically between proteins expressed with and 
without pLysS is unclear. Some of the strains differ in protein content after a 3 hours exposure to 
Yper, depending on whether pLysS was present or not, as can be seen when cell lysate fractions of 
the SDS gels are compared. Shell protein bands do not appear to be visible in the cell lysate fraction 
in the absence of pLysS, images A and C, with mCherry-tagged PduJ BMCs. In comparison, when 
134 | P a g e  
 
pLysS is present, bands corresponding to each shell protein can be seen, and the shell protein band 
intensities are higher. Individual bands can be seen in cell lysate fractions with and without pLysS 
for PduN-mCherry BMCs, however the band intensities are higher in image F, indicating that there 
was higher protein synthesis with pLysS. It is difficult to compare the cell lysate fractions of 
mCherry-tagged PduU gels, due to overloading, nonetheless bands corresponding to shell proteins 
can be seen in images H and J, with pLysS, and are less noticeable in images G and I.  
 
When the protein fractions are compared, pellets 2 seemed to contain a large amount of protein 
that is lost in the purification method. After the addition of low salt buffer and subsequent 
centrifugation, see Section 2.2.7.2, BMCs should have remained in the supernatant. However, a lot 
of shell protein, for all strains, appear to pellet when centrifuged. In addition, in the absence of 
pLysS, more protein is present in the clarification pellet compared to the clarification pellets when 
pLysS is present. Overall the final BMC purification fraction contains less contaminating bands and 
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Figure 4.5. SDS PAGE analysis of tagged-BMC shell purification with and without pLysS. Each strain was 
grown in identical conditions and strains expressing the same tagged-shell protein with and without 
pLysS were cultured on the same day to minimise variation in protein expression due to growth 
conditions. BMCs were purified according to the Yper method (Section 2.2.7.2) and samples were taken 
for SDS PAGE analysis at each stage. Only constructs cloned with pET3a were studied. An N terminal 
PduN tag was not investigated at this construct was cloned later A) and B) PduAB-mCherry-J-KNU with 
and without pLysS C) and D) PduAB-J-mCherry-KNU E) and F) PduABJK-N-mCherry-U G) and H) 
PduABJKN-mCherry-U and I) and J) PduABJKN-U-mCherry. 
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As a result of the effect of pLysS on protein expression, future studies were carried out with both 
pLysS and pET3a constructs in each strain, with BMC shell proteins expressed from one of the 
plasmids. Adding pET3a to strains containing BMC constructs cloned with pLysS was to ensure that 
the cellular environment as well as the expression levels would be similar in each strain.  
 
4.2.3. Optimisation of the purification protocol 
It is evident that the addition of pLysS to cells expressing BMCs with tagged-shell proteins leads to 
a higher BMC yield when purified. However, when attempting the purification process with BMC 
shells containing either PduA-mCherry, mCherry-PduB or PduB-mCherry the process failed. All of 
these BMC variants were expressed from a pLysS plasmid. Therefore, further optimisation of the 
purification protocol was necessary. It is uncertain why some mCherry-tagged BMCs were able to 
purify better than others and may indicate that the shells form incorrectly with some tags as 
opposed to others.  
 
In addition purification repeats led to variable results; it was often difficult to purify mCherry-tagged 
BMC shells, which made subsequent visualisation by TEM inconsistent. To limit the variability, the 
cell growth conditions and purification protocol were optimised for mCherry-tagged BMCs.  
 
4.2.3.1. Effect of growth temperature 
To determine if temperature affects the expression of BMC shells and subsequent protein 
purification, cultures of BL21(DE3) cells containing pLysS-pduA-mCherry-BJKNU as well as empty 
pET3a plasmid were grown at 18°C and, 28°C. This strain was chosen for optimisation as previous 
BMC purifications from this strain were unsuccessful, with little or no purified shell protein present 
in the final fraction (data not shown). Live cell imaging results showed that the size and location of 
BMC foci were similar to that of the mCherry-PduA-BJKNU BMCs, which are known to form 
correctly, therefore, BMC purification would give further insights in to the formation and structure 
of this mCherry-tagged BMC variant.  
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Cell cultures (250 mL) were inoculated from the same 5 mL starter culture. The starter culture was 
inoculated from several colonies of a single transformation plate. Cultures were then grown to an 
OD of 0.8 and induced with IPTG. All cultures were then grown overnight at 19°C. BMCs were then 
purified according to Section 2.2.7.2 and samples were taken for SDS PAGE analysis. SDS gels of 
BMCs purified after initial growth at 18°C and 28°C were then compared to SDS gels of growth at 
37°C, which had previously resulted in no purified BMCs visualised by TEM from the final purified 
fraction.    
 
Purifications show that cells grown at a lower temperature result in a higher amount of protein 
expression (Images A and B, Figure 4.6), however, the resulting purified BMC fraction is not pure 
with many unknown contaminating bands. In comparison, cells grown at 37°C, Image C, express 
more shell protein and the final fraction is considerably purer, as shown in Figure 4.6. As a result of 
































Figure 4.6. The purification of PduA-mCherry-BJKNU BMCs after growth at varying temperatures. 
BL21(DE3) pET3a cells expressing BMCs with C-terminally tagged PduA from a pLysS vector, were grown 
at 18°C and 28°C from the same starter culture. BMCs were purified by the Yper method, with samples 
from each stage of the purification retained for SDS analysis. This was compared to a previous SDS gel 
of PduA-mCherry BMCs grown at 37°C. 15% SDS gels are as follows: A) Cells expressing PduA-mCherry 
BMCs grown at 18°C B) 28°C C) 37°C 
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4.2.3.2. Minimisation of protein loss in Pellet 2 
The efficiency of BMC purifications were variable depending on the mCherry-tagged shell protein 
expressed. However, it was commonly observed that a large amount of shell proteins were present 
in pellet 2 of the purification process leading to lower levels of shell protein in the final fraction. 
This is shown in Figure 4.5, which demonstrates that purification of all mCherry-tagged BMC 
variants included a large loss of protein at the pellet 2 stage.   
 
Although the reason why shell proteins pelleted at that stage of purification is unclear, the speed 
of centrifugation as well as expression levels of the shell proteins were identified as factors that 
may have contributed to the loss of shell protein in the BMC purification. In order to reduce the 
amount of protein lost in pellet 2, centrifugation speed after low salt buffer was added was reduced 
to 4000 rpm, however this did not affect the amount of protein in the pellet (data not shown). In 
addition the level of protein production was reduced by culturing cells at 37°C and inducing with 
one quarter of the normal IPTG used (100 ʅD ) ?,ŽǁĞǀĞƌƚŚŝƐĂůƐŽŚĂĚůŝƚƚůĞĞĨĨĞĐƚ ? 
 
Having shown that the BMC purification process could not be easily optimised to reduce the 
amount of shell protein in pellet 2 without the need for changing buffer composition, it was decided 
to continue using the BMC purification method as described in Section 2.2.7.2. The aim of tagged-
BMC purification was to analyse the formation, morphology and stability of isolated BMC shells 
outside of the cellular environment by TEM.  
 
4.2.3.3. Optimisation of BMC visualisation by TEM  
Previously, recombinant BMCs expressed in E. coli cells have been isolated and visualised by TEM. 
In addition, native Pdu BMCs produced in Salmonella enterica have been purified using an 
alternative method to the protocol used in this study and the resulting purified compartments have 
been visualised. This study aims to analyse recombinant mCherry-tagged Pdu BMCs by TEM, to 
determine the effect of the mCherry tag on the formation of microcompartment shells.  
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Initially BL21(DE3) strains containing empty pET3a as well as tagged shell protein constructs, pLysS-
mCherry-PduA-BJKNU or pLysS-PduA-mCherry-PduBJKNU were cultured for BMC purification 
according to Sections 2.2.2 and 2.2.5, with growth at 37°C and induction with IPTG to a final 
concentratŝŽŶŽĨ  ? ? ?ʅD ? The BMCs were then isolated following the Yper purification method 
outlined in Section 2.2.7.2, and samples were taken for SDS PAGE analysis at each stage of the 
purification process. The final clarified supernatant was subsequently dried onto a copper grid, 
fixed and negative stained for TEM, according to Section 2.5.2.2.  
 
Results of SDS PAGE showed that purified shell proteins were present in the final clarified 
supernatant. However, when analysed by TEM, BMC shells were not visualised. Membranous 
material as well as negatively stained proteins were seen for both mCherry-PduA-BJKNU and PduA-
mCherry-BJKNU samples, but BMC shells were not observed. This could be due to an impure 
fraction used for TEM analysis, with contaminating proteins making shells difficult to visualise. 
However the SDS gels show that shell proteins are the most abundant in that fraction. The lack of 
BMC shells could also be due to the method of preparation of visualisation by TEM, involving 
fixation with glutaraldehyde and numerous wash steps which could either prevent the adhesion of 
BMC shells to the surface of the grid, or subsequently cause them to be washed off.  
 
As previously described in Section 4.2.3.2, a large amount of shell protein is found at the pellet 2 
stage of the purification process, and results in decreased shell protein in successive fractions. To 
try and improve shell protein observation by TEM, pellet 2 from the same purification was prepared 
for thin sectioning according to the same protocol used for whole cell thin sectioning, as described 
in Section 2.5.2. This resulted in a vast improvement in the visualisation of BMC shells. As shown in 
Figure 4.7, clear BMC-like structures can be seen with shells containing mCherry-PduA or PduA-
mCherry. However, PduA-mCherry-BJKNU shells appeared malformed and broken; the size and 
shape of shells were varied, in contrast to mCherry-PduA-BJKNU shells which were fairly uniform. 
There were more shells present with the mCherry-PduA tag whereas there appeared to be other 
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proteins in the PduA-mCherry sample. The difference between the TEM results of the two mCherry-
tagged BMCs is likely to be a result of the placement of the mCherry tag and its effect on the 
formation of the BMC.  
 
Overall this method has been applied to two shell protein tags, one of which, mCherry-PduA-BJKNU 
is known to form intact BMC shells. The method was shown to be successful in visualising the 
















































Figure 4.7. Optimisation of TEM visualisation of mCherry-tagged BMCs. BL21(DE3) pET3a cells expressing 
mCherry-tagged PduA BMCs were grown overnight as described in section xxx and purified according to 
the Yper method. 15% SDS PAGE gels of the BMC purifications are shown for mCherry-PduA-BJKNU and 
PduA-mCherry-BJKNU tagged-shell variants, shown in the first column. The purified fraction of BMCs 
were then dried onto a copper grid for TEM analysis, depicted in column 2, however, no shell-like 
structures were visualised. Pellet 2 of the purification method was then fixed and prepared for thin 
sectioning and then observed by TEM, shown in column 3.  
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4.2.4. The formation of mCherry-Tagged PduB BMCs  
4.2.4.1. BMC purification as an indication of correct formation 
Previously, BMC purifications of compartments with mCherry-tagged shell proteins expressed from 
pET3a plasmids were carried out in the presence and absence of pLysS. Results showed that 
purifications were more efficient, with a higher level of shell proteins in the final fraction in the 
presence of and empty pLysS plasmid in the bacterial strain. Further purifications of mCherry-
tagged PduA BMC variants were carried out for optimisation studies and TEM analysis and despite 
protein being lost in pellet 2, the final purification fraction contained predominately shell proteins.  
The purification of mCherry-tagged PduB was repeatedly unsuccessful. BL21(DE3) cells were 
transformed with pET3a and either pLysS-pduA-mCherry-B-JKNU or pLysS-pduA-B-mCherry-JKNU. 
Several colonies were used to inoculate overnight starter cultures, which were subsequently used 
to inoculate 250 mL cultures of LB, containing ampicillin and chloramphenicol, as described in 
Sections 2.2.2.2.  Cells were grown at 37°C. When an OD600 of 0.8 was reached, protein synthesis 
ǁĂƐŝŶĚƵĐĞĚǁŝƚŚ/Wd' ? ? ? ?ʅD )ĂŶĚƚŚĞŶŐƌŽǁŶŽǀĞƌŶŝŐŚƚĂƐŽƵƚůŝŶĞĚŝŶ^ĞĐƚŝŽŶ ? ? ? ? ? ?ĞůůƐǁĞƌĞ
harvested the following morning and purified according to the Yper method in Section 2.2.7.2. 



























Figure 4.8. Purification of mCherry-tagged PduB BMCs. BL21(DE3) pET3a cells expressing either PduA-
mCherry-B-JKNU or PduA-B-mCherry-JKNU were grown overnight and purified using the Yper method. 
Samples were collected for SDS PAGE analysis and 2 µl of each fraction in 2 x sample buffer were run on 
a 15% SDS gel. A) Purification of PduA-mCherry-PduB-JKNU B) Purification of PduA-B-mCherry-JKNU 
 
SDS PAGE analysis of mCherry-tagged PduB purifications revealed that proteins were lost at each 
stage of the purification process. For the mCherry-PduB purification, proteins were predominantly 
lost in supernatant 1, pellet 3 and the clarified pellet. Shell proteins were mainly lost in pellet 1 and 
pellet 2 for PduA-B-mCherry-KNU BMCs. This difference in protein loss in each fraction could 
highlight differences between the formation of BMCs depending on the N- or C- terminal PduB tag. 
Overall there was an absence of shell proteins in the final purified fraction. This was very different 
to all of the other shell protein tags, where protein was visible to the end of the purification, despite 
some being lost in fractions. In this way, it was hypothesised that PduB fusions with mCherry failed 
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to form BMCs when the other shell proteins were also expressed. Therefore the purification process 
acted as an indicator for the formation of intact BMC shells.  
 
4.2.4.2. Insights into the morphology of tagged-PduB BMCs by TEM and live cell imaging  
To explore the formation of mCherry-tagged PduB shells further, live cell imaging and TEM thin 
sectioning was carried out. 
 
BL21(DE3) strains containing pET3a and either; pLysS-mCherry-PduA-BJKNU, pLysS-PduA-mCherry-
PduB-JKNU or pLysS-PduA-B-mCherry-JKNU were grown in 250 mL cultures at 37 °C until an OD600 
of ~0.6 was reached. Cells (1 mL) were then taken from the culture and pelleted by centrifugation 
for live cell imaging as outlined in Section 2.5.1. IPTG (100 µM) was then added to the cell culture 
to induce the expression of BMCs and cell samples were taken 2 hours after induction for live cell 
imaging and also thin sectioning and subsequent visualisation by TEM. Results are shown in Figure 
4.9.  
 
Live cell imaging of the control strain expressing mCherry-PduA-BJKNU, known to form complete, 
intact BMC shells demonstrated individual foci spread throughout the cytoplasm in cell before 
induction. Some cells were elongated, but there were also shorter cells present too. After induction, 
cells were elongated and many foci of mCherry signal were present in each cell. This corresponds 
to the TEM thin sections observed 2 hours after induction which show intact BMC shells 
approximately 100 nm in diameter.  
 
Interestingly, cells expressing PduA-mCherry-B-JKNU were associated with one inclusion body at 
one pole of the cell; there did not appear to be more than one inclusion per cell, with the exception 
of cells that were dividing, as observed by live cell imaging. There was little difference between cells 
visualised at the two different time points, except that cells appeared longer after induction. Thin 
sectioning of whole cells fixed 2 hours after induction revealed identical results to that of live cell 
imaging; cells contained and inclusion body at the pole; no BMC-like structures were visualised. This 
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indicated that an N-terminal PduB tag did not form any structures that resembled BMC shells when 
expressed with the other Pdu shell proteins.   
 
In comparison, a C-terminal PduB tag was very different to the N-terminal tag when expressed with 
the shell proteins necessary to form BMCs. PduA-B-mCherry-JKNU localised throughout the cell 
cytoplasm before induction, as can be seen by live cell imaging in Figure 4.9. The mCherry signal 
was completely cytoplasmic with no distinct foci visible. There appeared to be a variety of cell 
lengths with some elongated cells and some shorter cells. Live cell imaging 2 hours after induction 
showed similar results. The mCherry signal was completely cytoplasmic. This indicated that the 
formation of BMC shells containing PduB-mCherry was impaired. TEM analysis of thin sections of 
cells taken 2 hours after induction confirmed that there were no obvious intact BMC shells present. 
Throughout the cell cytoplasm, distinctive areas of low electron density can be seen. These areas 
are commonly observed with BMC shells, as can be seen in the mCherry-PduA-BJKNU-expressing 
cells, however in this case, definite shell outlines cannot be distinguished easily. Strands of shell 
proteins can be observed, as indicated by the white arrows in Figure 4.9, although these strands 
did not fold into completed shell structures. These data indicate that tagging PduB with mCherry in 
either the N- or C- termini results in a lack of BMCs when expressed with the other shell proteins.  
Consequently, further studies with m-cherry tagged PduB were not carried out. 
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Figure 4.9.  Analysis of the formation of mCherry-tagged BMCs. BL21(DE3) pET3a pLysS-pduA-mCherry-
B-JKNU and BL21(DE3) pET3a pLysS-pduA-B-mCherry-JKNU were analysed by live cell imaging directly 
before induction and also 2 hours after induction and TEM thin sectioning of whole cells 2 hours after 
ŝŶĚƵĐƚŝŽŶ ?^ĐĂůĞďĂƌƌĞƉƌĞƐĞŶƚƐ ?ʅŵ in fluroescence microscopy images and 0.2µm in TEM images.  
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4.2.5. Effect of tagging shell proteins with mCherry on BMC shell formation 
Live cell imaging and TEM thin sectioning provided insights into the morphology of BMC shells when 
PduB was tagged with mCherry. To explore the morphology of shells with each of the other shell 
protein tags, fluorescence microscopy and TEM was carried out directly before induction with IPTG, 
at an OD600 between 0.6 and 0.8 as well as 2 hours after induction, with an OD600 of approximately 
1.2 In addition the mCherry-tagged BMC variants were purified and pellet 2 was prepared for thin 
sectioning as previously described in Section 2.5.2 so isolated BMC can be visualised.  
 
Strains containing mCherry shell constructs and an additional plasmid, either pLysS or pET3a for the 
reasons described in Sections 4.2.2.1 and 4.2.2.3 were grown from starter cultures, which in turn 
had been inoculated from several colonies from a fresh transformation, as outlined in Sections 
2.2.2.2. Cultures (500 mL) were grown at 37°C until an OD of ~0.6 was reached. Cells were then 
harvested for both live cell imaging and thin sectioning as described in Sections 2.5.1 and 2.5.2.1. 
dŚĞĐĞůůĐƵůƚƵƌĞƐǁĞƌĞƚŚĞŶŝŶĚƵĐĞĚǁŝƚŚ ? ? ?ʅDŽĨ/Wd'ĂŶĚƚŚĞƚĞŵƉĞƌĂƚƵƌĞǁĂƐĚƌŽƉƉĞĚƚŽ ? ?
°C. After 2 hours of growth, cells were harvested for live cell imaging and thin sectioning again, the 
approximate OD600 of the cultures were ~1.2 at this stage. The cell culture was then left overnight 
at 19 °C. Cells were then pelleted by centrifugation and resuspended in Yper for BMC purification, 
as described in Section 2.2.7.2. Pellet 2 of the BMC purification was then prepared for thin 
sectioning using the same protocol as whole cell thin sectioning described in Section 2.5.2.  Live cell 
imaging data is shown in Figure 4.10 and TEM results are shown in Figure 4.11.  
 
4.2.5.1. Live cell imaging of whole cells at time points  
Live cell imaging results show a phase image with mCherry overlap. This allows the analysis of the 
location of the mCherry-tagged BMCs in relation to the cell. Before induction, it is easier to visualise 
individual foci in the cell cytoplasm. Foci are most distinctive in the control sample, mCherry-PduA-
BJKNU. Cells also appear elongated in this strain, which is common for cells expressing BMCs,and 
likely represents a stress response. After induction the control strain appears longer, with many 
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more foci spread throughout the cell. The foci also appear brighter. In comparison cells expressing 
PduA-mCherry-JKNU appear shorter before induction than the control strain. There are fewer 
mCherry foci per cell than the N-terminally tagged PduA BMC strain before induction and the foci 
appear bigger, indication either larger sized BMCs, or aggregated protein. Two hours after 
induction, the cells observed are longer in length and the mCherry signal is spread in areas within 
the cytoplasm, rather than in discrete foci, although some brighter foci-like signal can be seen. From 
these results, it is unclear whether PduA-mCherry tagged-BMCs form intact shells, however live cell 
images reveal that the fluorescent signal is unlike that of the control strain.  
 
Similarly, the mCherry-PduJ BMC strain contained individual foci of mCherry signal spread 
throughout the cytoplasm before induction. However, the cells observed appeared to vary in width, 
with some appearing to be wider than those previously visualised in the control strain. This was 
also true for cells after induction and cells were elongated in length both before and after induction. 
After induction, the mCherry signal was more cytoplasmic, although the patches of signal did not 
spread the length and width of the cell. It was difficult to establish discrete BMC foci, similar to the 
PduA-mCherry strain.  
 
Interestingly, a strain expressing PduJ-mCherry BMCs was hard to visualise by fluorescence 
microscopy. This was because the mCherry signal bleached extremely quickly and therefore made 
it highly difficult to take an image. The images for a strain containing PduJ-mCherry BMCs before 
and after induction appeared to contain mCherry signal in the cytoplasm, although the presence of 
foci could not be established.  
 
In a strain expressing mCherry-PduN, before induction large foci were observed at the poles of the 
cell, suggesting the mCherry-PduN was accumulating in inclusion bodies. After 2 hours of induction 
with IPTG, a noticeable difference was observed. There was a drastic reduction in the number of 
large foci observed at the cell poles, with the mCherry signal now a lot more dispersed throughout 
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they cytoplasm. Some cells exhibited a slight accumulation of mCherry-PduN however there was 
no real pattern to this, and was not forming discrete foci. 
 
A similar observation was made when looking at PduN-mCherry. Before induction large foci were 
again observed at the cell poles, with very little cytoplasmic signal. After induction, there was an 
increase in the cytoplasmic signal, and there was a reduction in the number of large large foci at 
the cell poles, however this was not to the same extent as that observed with mCherry-PduN. 
 
Discrete foci of mCherry signal could be observed in a strain expressing PduABJKN-mCherry-U BMCs 
before induction. There was a little background mCherry signal as shown by the faint red signal 
present throughout the cells. After induction the background signal was more obvious, where 
expression of shell proteins increased. The mCherry signal was brighter than before induction and 
more signal was present in the cytoplasm, rather than in discrete foci, although areas within the 
cell contained higher levels of signal compared to others. In these areas of high signal intensity, 
discrete foci could be visualised, but the overall fluorescence pattern was very different to that of 
the control strain.  
 
In comparison a PduU-mCherry expressing strain contained predominantly cytoplasmic signal 
before induction. Occasional bright foci of mCherry signal were visible, however, after induction 
the mCherry signal appeared to be brighter and completely cytoplasmic. Cells expressing mCherry-
tagged PduU on either the N- or C- terminus were elongated with a fixed cell width, similar to that 
of the control strain. However, it was unclear if mCherry-tagged PduU BMCs were able to form 
intact shell structures from the live cell imaging data as the fluorescent signal was largely 
cytoplasmic. This indicated that either shells were unable to form or that the mCherry-tagged shell 
protein was not being incorporated into the shell structure.  
 
 


















Figure 4.10. Analysis of the formation of mCherry-tagged BMCs. BL21(DE3) pET3a pLysS-mCherry-pduA-
B-JKNU, BL21(DE3) pET3a pLysS-pduA-mCherry-BJKNU, BL21(DE3) pLysS pET3a-pduA-mCherry-B-JKNU, 
BL21(DE3) pLysS pET3a-pduAB-mCherry-JKNU, BL21(DE3) pLysS pET3a-pduABJ-mCherry-KNU, 
BL21(DE3) pLysS pET3a-pduABJK-mCherry-N-U, BL21(DE3) pLysS pET3a-pduABJKN-mCherry-U, 
BL21(DE3) pLysS pET3a-pduABJKN-mCherryU, BL21(DE3) pLysS pET3a-pduABJKN -U-mCherry, were 
analysed by live cell imaging directly before induction and also 2 hours after induction. Scale bar 
ƌĞƉƌĞƐĞŶƚƐ ?ʅŵ ?
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4.2.5.2. TEM of whole cells at time points  
4.2.5.2.1. mCherry-tagged PduA 
TEM images of strains expressing shell constructs containing a mCherry-fusion tag are shown in 
Figure 4.11. Before induction, mCherry-PduA BMCs can be seen in distinctive patches with low 
electron density. The outlines of BMC shells can be observed, with some shells partially formed. 
After induction many more BMCs can be seen throughout the cytoplasm rather than in discrete 
patches. The majority of BMC shells are intact and the size of shells is fairly consistent (~100 nm). 
Although some spiral-shaped, rose-like shells were observed, these were not commonly visualised. 
When mCherry-PduA BMCs were isolated by thin sectioning of pellet 2 of the purification process, 
empty BMC shells were visualised. These shells were fairly uniform in shape and size, ranging from 
80-100 nm. No spiralled structures were seen in the isolated TEM sections, although some broken 
or partly formed BMCs were present.   
 
Initially from live cell imaging data, it appeared that a C-terminal PduA fusion was similar to that of 
the N-terminal tag. However a strain expressing PduA-mCherry formed structures that were 
different to mCherry-PduA BMCs, which are known to form correctly.  Similar patches associated 
with BMC shells were observed in cells visualised before induction, although unlike mCherry-PduA 
BMCs, shell protein outlines were not visible at all in these patches before induction. Two hours 
after induction BMC shell borders were observed in similar grey patches although they were not as 
well defined as that of mCherry-PduA BMCs, and the majority appeared broken or only partly 
formed. There were also inclusion body-like areas located in the cytoplasm. This indicated that 
BMCs tagged with mCherry at the C terminus of PduA did not form correctly. Furthermore, isolation 
of PduA-mCherry BMC shells revealed primarily unfolded strands of shell proteins as well as 
occasional intact BMCs, although these varied greatly in size and shape. In comparison to an N-
terminal PduA fusion tag, the C-terminal tag produced mostly malformed, partly formed or broken 
structures.  
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4.2.5.2.2. mCherry-tagged PduJ 
Live cell imaging of BL21(DE3) plysS cells expressing PduAB-mCherry-J-KNU revealed large foci 
spread throughout the cytoplasm (Figure 4.10). TEM analysis of cells before induction show small 
distinct areas of aggregated shell protein. These aggregatedstrands are fairly indistinct and difficult 
to visualise, but are highlighted by the white arrows in Figure 4.11. After induction, many more 
structures are present in the cell cytoplasm. Shells are well defined and some appear intact with 
the size ranging from 70  ? 130 nm in diameter. However many shells appear broken as the two 
strand ends do not meet, as demonstrated by the white arrow heads. In comparison to mCherry-
PduA BMC, there appears to be a larger proportion of broken shells with the PduJ tag, indicating 
that formation of BMCs is impaired.  
 
Interestingly, thin sections of mCherry-PduJ BMCs, taken from pellet 2 of the purification, revealed 
a network of protein strands, thought to be unfolded shell protein do to its similar appearance to 
the shells visualised in vivo. No BMC shell structures were observed by TEM in the isolated BMC 
thin sections. The growth and purification of this strain was repeated and identical protein strands 
were visualised. It is unclear why BMC shells were not observed when thin sectioning of whole cells 
2 hours after induction as well as live cell imaging indicated that there were intact shells present. 
The inability to purify intact BMC shell structures observed in thin sections of whole cells hints at 
either the instability of mCherry-PduJ shells outside of the cellular environment, or the vigorous 
process of preparation for thin sectioning may cause the intact and partially formed shells to 
completely unfold.  
 




156 | P a g e  
 
Figure 4.11. TEM analysis of whole cell thin sections and thin sections of pellet 2 from the purification 
process. The BL21(DE3) pET3a cells analysed include the expression of mCherry-PduA-BJKNU (first pane), 
PduA-mCherry-BJKNU (first pane), PduA-mCherry-PduB-JKNU and PduA-B-mCherry-JKNU. BL21(DE3) 
pLysS cells include the expression of: PduAB-mCherry-J-KNU (first pane), PduAB-J-mCherry-JKNU (first 
pane), PduABJK-mCherry-N-U (second pane), PduABJK-N-mCherry-U (second pane), PduABJKN-
mCherry-U (second pane) and PduABJKN-U-mCherry (second pane). Samples were taken at 2 time 
points, directly before induction and 2 hours after induction to compare BMC formation stages. BMCs 
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were then isolated by the purification method and thin sections of pellet 2 were visualised by TEM, 
shown in the right-hand column.  
 
It has already been shown in Section 4.2.3.3 that visualisation of the purified fraction of BMCs could 
not easily be observed by TEM. Therefore, to investigate the stru0cture of mCherry-PduJ BMC shells 
further, Atomic Force Microscopy (AFM) was used with a hydrophobic MICA surface as outlined in 
Section 2.5.4. PduAB-mCherry-J-KNU shells were compared to that of mCherry-PduA-BJKNU, shown 
in Figure 4.12. mCherry-PduA-BJKNU BMCs can clearly be visualised, with a size range of between 
75-150 nm, as measured in ImageJ (n=200). In comparison, a variety of structures are present in 
the mCherry-PduJ purification. The majority of protein appears aggregated and the presence of 
BMC shells cannot be definitively determined.  
 
Figure 4.12. Atomic Force Microscopy images of purified mCherry-tagged BMCs. mCherry-PduA-BJKNU 
and PduAB-mCherry-J-KNU were purified and dried on a hydrophobic MICA surface. They were 
subsequently analysed by AFM.  
 
Overall live cell imaging and thin sections of whole cells indicate that PduAB-mCherry-J-KNU BMCs 
are associated with the formation of both intact shells, as well as malformed or broken shell 
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structures. The shape and size of BMCs are more varied than that of mCherry-PduA BMCs and the 
visualisation of isolated BMCs shell structures has not been possible. Visualisation by TEM thin 
sections of pellet 2 was unsuccessful, with long strands of shell protein visible but no icosahedral 
shell structures. Furthermore AFM of purified mCherry-J BMCs showed aggregated proteins, but no 
long shell protein strands, nor intact shell structures were observed.  
 
Similarly the visualisation of PduJ-mCherry BMCs by live cell imaging was difficult due to the quick 
bleaching of mCherry signal. When visualised by TEM before induction, patches associated with 
shell protein can be seen. Although there were no intact BMC shells present, strands resembling 
unfolded shell proteins were visualised, as highlighted by the white arrowheads in Figure 4.11. 
Some curved strands were visualised, although these did not close to form the shell structures. Thin 
sections of pellet 2 revealed similar linear structures to those observed in vivo. Strands thought to 
be unfolded shell protein were visualised and no intact BMCs were seen. These data indicate that 
neither N- nor C- terminally tagged PduJ forms intact BMC shells when co-expressed with proteins 
necessary to form completed structures.  
 
4.2.5.2.3. mCherry-tagged PduN 
TEM thin sectioning images of BL21(DE3) pLysS cells expressing PduABJ-mCherry-PduN-U revealed 
unique structures dissimilar to any of the other shells containing an mCherry fusion tag. These 
structures, as demonstrated in Figure 4.11, were elongated and tubular and were present in cells 
both before induction as well as after induction. Before induction, these elongated BMCs can be 
seen in distinct areas in the cell cytoplasm and appear to be open-ended without closure to form 
an intact structure. After induction, in addition to the tube-like BMCs located throughout the 
cytoplasm, spiralled BMC shells were also present. TEM of isolated mCherry-PduN shells, once again 
revealed the presence of tubular BMC shells, the majority of which did not appear to have shell 
protein at either end of the tubular structure. Interestingly, these elongated, open-ended shells 
were fairly consistent in width, ranging from 35 nm to 55 nm, measured using ImageJ software.   
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Cells expressing the C-terminal tagged PduN BMC variant were analysed by TEM and were found to 
contain mostly intact delineated shells before induction. These shells were fairly regular in size, 
around ~120 nm, however, the shape tended to be inconsistent with the formation of rounded 
structures as well as more regular BMC-like structures similar to those observed with mCherry-A-
BJKNU BMCs. After induction cells were packed with irregular, misshaped and broken BMC shells. 
It was difficult to visualise any intact structures. This indicates that formation of PduN-mCherry 
BMCs was dependent on shell protein concentration, with the overproduction of shell proteins 
resulting in a lack of intact structures.  
 
4.2.5.2.4. mCherry-tagged PduU 
Live cell imaging of tagged-PduU BMCs revealed that discrete foci could be seen before induction 
in some cells, but after induction the mCherry signal was largely cytoplasmic, although foci could 
still be visualised, especially with the N terminal tag. However TEM thin sectioning results before 
and after induction were very interesting. For both PduU-tagged BMCs, before induction discrete 
areas of BMC shells were observed. BMCs appeared to be intact and regular in size and shape. After 
induction, cells were packed with intact shells, ranging from ~60  ? 150 nm in size. Shells appeared 
very similar to those observed in the control strain, BL21(DE3) pET3a pLysS-mCherry-PduA-BJKNU 
and are therefore considered to be forming intact BMC structures. The difference in live cell imaging 
between tagged-PduU BMCs and the control is therefore unclear, however this could be due to 
mCherry expression levels or the difference in abundance of PduA compared with PduU.  
 
As previously mentioned, it is unclear if mCherry-tagged PduU is incorporated into the BMC 
structure, as the live cell imaging results revealed that the signal was largely cytoplasmic.  
 
4.2.8. Immuno-gold labelling of thin sections of whole cells and isolated 
BMCs  
To determine if the mCherry-tagged shell protein was incorporated into the BMC shell, and to also 
investigate the location of the mCherry-tagged shell protein in the BMC structure, immuno-gold 
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labelling was carried out from both thin sections of whole cells as well as isolated BMCs. This 
involved growing cell 250 ml cell cultures from inoculation by an overnight starter culture and 
growth at 37°C in a shaking incubator at 180 rpm. Cultures were induced when an OD 600 of 0.6  ? 
 ? ? ?ǁĂƐƌĞĂĐŚĞĚ ?ĨƚĞƌŝŶĚƵĐƚŝŽŶǁŝƚŚ ? ? ?ʅD/Wd' ?ĐĞůůƐǁĞƌĞŐƌŽǁŶĂƚ ? ? ?ĨŽƌ ?ŚŽƵƌƐ ? ? ?ŵůŽĨ
cells from each culture were then harvested by centrifugation at 4000 rpm and then fixed for TEM 
thin sectioning and immuno-gold labelling according to Section 2.5.3.  In addition, the remaining 
~200 ml cell cultures were grown overnight, and purified as described in Section 2.2.7.2. Pellet 2 of 
the purification process was then prepared for immuno-gold labelling using the same protocol as 
whole cell Immuno-gold labelling. The strains initially grown for TEM include: BL21(DE3) pET3a 
pLysS-mCherry-pduA-BJKNU, BL21(DE3) pET3a pLysS-pduABJKNU and BL21 (DE3) pLysS pET3a-pdu-
ABJKN-mCherry-U.  
 
Results of immuno-gold labelling using an anti-mCherry polyclonal antibody does not appear to be 
conclusive. It has been found that there are several limitations when using this method to analyse 
BMC shells either in vivo or in vitro. The negative control shown in Figure 4.13, image A, lacking 
exposure to the primary antibody, does not appear to have any unspecific binding. When ~100 cells 
were observed, <5 cells had any gold particles at all, and those that did had a maximum of 2 particles 
per cell. This indicated that there was very little unspecific binding. However the second negative 
control, containing a construct with BMC shells, but no mCherry tag, revealed gold labelling 
surrounding the outer membrane of the cell wall, Image B. There was no gold labelling within the 
cell cytoplasm or attached to BMC shells. When cells expressing mCherry-PduABJKNU were imaged, 
some gold label localised to the outer membrane of the cell, however gold labelling could be seen 
in discrete areas with low electron density, Image C. These areas are highly likely to contain BMCs, 
however staining was not possible as the density of the gold particles was lost, making it the 
visualisation of the labelling compared to the location of the shells unattainable.  
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In comparison, labelling of Pdu-ABJKN-mCherry-U BMCs resulted in more gold particles associated 
with the outer membrane of the cell compared to the BMC shells in the cytoplasm, Image D. Gold 
particles associated with areas of low electron density were thought to have attached to the 
mCherry-PduU component of the shell. However as the sections could not be stained in the same 
way as conventional TEM, it was difficult to visualise both the location of the gold and the BMC 
shells in the same cell.  
 
Similarly, immuno-gold labelling of isolated BMC shells were inconclusive. The location of BMC 
shells compared to the gold could not be determined due to the staining method. Unfortunately 
due to time contraints this experiement was only carried out once. Further optimisation of the 
immuno-gold labelling of thin sections is therefore required.   
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Figure 4.13. TEM thin sections of whole cells prepared for immune-gold labelling using 15 nm gold 
particles conjugated to an anti-Rabbit secondary antibody. The primary antibody used was anti-mCherry. 
A) Negative control of BL21(DE3) pET3a pLysS-mCherry-pdu-ABJKNU with no primary antibody used in 
the labelling process, B) Negative control, BL21(DE3) pET3a pLysS -pdu-ABJKNU with no mCherry present 
to test for unspecific antibody binding, C) Positive control BL21(DE3) pET3a pLysS-mCherry-pdu-ABJKNU 
including primary antibody D) BL21(DE3) pET3a pLysS-pdu-ABJKN-mCherry-U. 
 
4.2.9. Co-expression with PduV-Cerulean 
To investigate the relationship between PduV and the BMC shell, mCherry-tagged BMCs were 
expressed with PduV-Cerulean. Live cell imaging was subsequently used to study the respective 
localisation of mCherry and Cerulean fluorescent signal. The BMC tagged-variants studied involve 
those that were found to form similar structures to that of the control, mCherry-PdA-BJKNU. These 
include shells comprised of the following shell protein tags: PduA-mCherry, mCherry-PduJ, PduJ-
mCherry, mCherry-PduN, PduN-mCherry, mCherry-PduU and PduU-mCherry.   
 
Initially, FRET was going to be used to determine possible interactions between the shell proteins 
and PduV. However due to supervisory problems it was not possible to carry out these experiments 
to achieve a complete data set.  Preliminary experiments explored the comparative localisation of 
PduV and PduA by FLIM FRET, suggesting that the two were located within a small distance (a few 
nm) of one another. 
 
FLIM FRET differs from traditional FRET in that the FRET effect is determined by a shortening of the 
lifetime of the donor flurophore rather than the measurement of the emission intensity of the 
acceptor fluorophore. This allows for greater precision as traditional emission based measurements 
can be susceptible to other external factors such as variations in protein expression. 
 
4.2.9.1. Live cell imaging results of PduV with each tagged shell protein 
To explore the localisation and presence of PduV and PduV-associated filaments in comparison to 
mCherry-tagged shell proteins, BL21(DE3) cells co-expressing PduV-Cerulean with each mCherry-
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tagged BMC were visulaised by live cell imaging. Strains were grown in 5 mL starter cultures 
overnight from several colonies on an agar plate, as outlined in Section 2.2.2.2. The starter culture 
was then used to inoculate 25 mL of LB media and the resulting cultures were grown at 37°C until 
an OD600 of between 0.4 and 0.6 was reached.  Cells (1 mL) were then harvested and prepared for 
live cell imaging with agar pads, as outlined in Section 2.5.1.  
 
mCherry-tagged BMCs have previously been described earlier in the chapter (4.2.5.1). BMC variants 
from strains co-expressing PduV-Cerulean appear to be very similar to those previously described, 
with the exception of PduABJKN-mCherry-U. The mCherry signal from this strain, with N-terminally 
tagged PduU, localises to highly enlarged foci with some background cytoplasmic signal when co-
expressed with PduV-Cerulean, Figure 4.14. In comparison foci visualised in a strain expressing the 
mCherry-PduU tag in the absence of PduV appeared smaller and more evenly distributed 
throughout the cell. This difference could be a result of a possible interaction between PduU and 
PduV. Live cell imaging results of the overlap image of PduV-Cerulean and mCherry-PduU shows 
clear colocalisation between the two fluorescent signals, indicating an interaction between PduU 
and PduV. This is shown by the white foci as the arrowheads demonstrate. Interestingly there are 
no PduV filaments in this strain, indicating that an N terminal PduU tag impairs the function of PduV, 
although the mechanism for this is unknown. PduV also appears to be largely cytoplasmic, shown 
by the Cerulean signal spread throughout the cells. This could be due to the inability of PduV to 
polymerise into a filamentous structure or attach to other filaments in the cell.  
 
Similarly there are no PduV filaments in the C terminally tagged PduU, with the majority of the 
Cerulean signal localising throughout the cell cytoplasm. The mCherry signal in this strain also 
appears to be largely cytoplasmic, as was the case with the strain expressing PduABJKN-U-mCherry 
BMCs without PduV-Cerulean (Figure 4.10). However TEM analysis revealed that BMC shells were 
able to form intact structures when PduU was tagged with mCherry. This indicates that either the 
cells are packed with BMC shells causing cytoplasmic signal, or not all of the mCherry-tagged PduU 
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is incorporated into the BMC structure. Results also suggest that PduV is somehow prevented from 
forming or attaching to as filaments were not visible when PduV-Cerulean was co-expressed with 
PduU-mCherry BMC variants. Similar to the N-terminal PduU tag, PduV-Cerulean localisation in the 
PduU-mCherry strain is associated with a high background level of Cerulean signal in the cytoplasm. 
Some of the signal localises to discrete foci, which in the composite image can be seen to mostly 
overlap with mCherry foci in the cell.  This suggests that even though PduV function may be 
impaired due to the complete lack of filaments, PduV is still able to localise to BMCs when PduU is 
tagged.  
 
Interestingly, in addition to PduU, BMC shells formed with mCherry-tagged PduJ are associated with 
impaired PduV function. A strain co-expressing PduAB-mCherry-J-KNU with PduV-Cerulean is 
shown in Figure 4.15. Markedly, filaments appear highly elongated in this strain with filaments 
often spanning the length of the cell. In comparison there are no PduV-Cerulean associated 
filaments present with the PduJ-mCherry BMC tag. However despite the lack of filaments, unlike 
the PduU tags, PduV does not appear to be cytoplasmic as when co-expressed with mCherry-tagged 
PduJ, but instead localises predominantly to discrete foci that overlap with the localisation of 
mCherry signal in the composite image. Therefore, despite the presence of either elongated 
filaments, or no filaments at all, BMCs formed with tagged PduJ are still seen to localise with PduV-
Cerulean, which is also the case with tagged PduU. The reason why there is an absence of filament 
formation or an elongation in filament length is currently unknown. 
 
BMCs formed with the mCherry-tagged shell proteins; PduA-mCherry and mCherry-PduN and 
PduN-mCherry contain structures very similar to that of the control strain with mCherry-PduA when 
co-expressed with PduV-Cerulean. Although the localisation of mCherry signal is different to that 
of the control, as described in Section 4.2.5.1, filamentous structures were visualised in all three 
strains. In addition to filaments, PduV was also seen in foci which were evenly distributed 
throughout the cells in strains expressing BMCs variants with PduA-mCherry and mCherry-PduN 
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tags. The PduN-mCherry BMC strain appeared to have a higher level of cytoplasmic PduV-Cerulean 
signal; although filaments were still present there was a large reduction in the number of PduV-
Cerulean foci per cell. The mCherry signal in the PduN-mCherry strain was also largely cytoplasmic, 
with a few larger foci per cell rather than many, evenly distributed smaller foci. This indicates that 
the localisation of PduV corresponds to the localisation of the BMCs, especially when the Cerulean 
and mCherry images are overlapped showing co-localisation of BMCs with PduV foci. PduV-
Cerulean was also shown to co-localise with BMC shells containing either PduA-mCherry or 
mCherry-PduN.  
 
Overall, co-expression of mCherry-tagged BMCs with PduV-Cerulean leads to varying results 
depending on the specific shell protein that is tagged, as well as the terminus that mCherry is fused 
to. PduV-Cerulean is seen in linear structures in strains containing; mCherry-PduA, PduA-mCherry, 
mCherry-PduJ, mCherry-PduN and PduN-mCherry. BMCs with a C-terminal PduJ tag as well as PduU 
tagged on either terminus with mCherry do not contain filaments when co-expressed with PduV-
Cerulean. Interestingly, cells expressing BMCs with mCherry-PduJ were associated with highly 
elongated PduV filaments. These data suggest that both PduJ and PduU are involved in an 
interaction nbetween the BMC and PduV, or the polymerisation of PduV into filaments. Disruption 
of this process by the addition of an mCherry protein fusion led to either the absence of linear 
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Figure 4.14. Investigating the effect of each mCherry tagged empty BMC variant on the localisation and 
organisation of PduV within the cell. A) BL21(DE3) pET3a-pduV-cerulean pLysS-mCherry-pduA-B-JKNU, 
B) BL21(DE3) pET3a-pduV-cerulean pLysS-pduA-mCherry-BJKNU, C) BL21(DE3) pLysS-pduV-cerulean 
pET3a-pduAB-mCherry-JKNU, , D) BL21(DE3) pLysS-pduV-cerulean pET3a-pduA-mCherry-B-JKNU, E) 
BL21(DE3) pLysS-pduV-cerulean pET3a-pduABJK-mCherry-N-U, F) BL21(DE3) pLysS-pduV-cerulean 
pET3a-pduABJKN-mCherry-U, G) BL21(DE3) pLysS-pduV-cerulean pET3a-pduABJKN-mCherryU, H) 
BL21(DE3) pLysS-pduV-cerulean pET3a-pduABJKN -U-mCherry, were analysed by live cell imaging directly 
ďĞĨŽƌĞŝŶĚƵĐƚŝŽŶĂŶĚĂůƐŽ ?ŚŽƵƌƐĂĨƚĞƌŝŶĚƵĐƚŝŽŶ ?^ĐĂůĞďĂƌƌĞƉƌĞƐĞŶƚƐ ?ʅŵ ? 
 
4.2.9.2. PduV filament length analysis  
Whilst looking at the effect of tagging each Pdu MCP component with mCherry on the localisation 
of PduV, it was noticed that in some of the strains where filaments were observed, the length of 
these filaments varied from that of the control strain expressing mCherry-PduA. In order to examine 
this in more detail, images were then processed in MetaMorph software to calibrate distance per 
pixel and allow the accurate measurement of filament length. Data for filament length was 
collected in Microsoft Excel and grouped to be able to plot a histogram. OriginLab was subsequently 
used to plot the data to a LogNormal fit. The plots for this data, as well as a summary of the effect 
of mCherry tags on filament formation is shown in Figure 4.15 below.   
 
Results show that when fitted to a LogNormal distribution, the average PduV-Cerulean-associated 
filament length with BMCs containing mCherry-PduA is 2.16 µm (n=369). The histogram 
demonstrates that filament length ranges from approximately 1 µm to 9 µm. Tagging PduA at the 
C-terminus had no immediately noticeable effect on PduV filament length within the cell. When 
analysed the filament length was found to increase to 2.53 µm (n=209). To determine whether this 
was a statistically significiant increase, a two tailed, unpaired ^ƚƵĚĞŶƚ ?Ɛ d-Test was carried out 
between the two complete data sets, and using a level of significance (p) value of 0.05 it was found 
this was not a statistically significant difference (p=0.69). When looking at the histogram, it was 
noted that the range of filament lengths was greater, with filaments up to 14 µm observed. 
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The addition of an mCherry tag to the N-terminus of PduJ had a visible effect on the length of PduV-
Cerulean-associated filaments, with the filaments clearly being much longer. When analysed it was 
found that the average length was 4.95 µm (n=316), with filament lengths ranging from 1 µm to 29 
µm, over 3 times longer than that observed with filaments containing mCherry-PduA. Again to 
determine whether this was a statistically signifŝĐŝĂŶƚŝŶĐƌĞĂƐĞ ?Ă^ƚƵĚĞŶƚ ?Ɛd-Test was carried out 
(between this dataset and that of mCherry-PduA) and it was found this was a statistically significant 
difference (p=1.57 x10-29). 
 
PduN provided a very interesting finding, with the effect on PduV-Cerulean-associated filaments 
varying depending upon where PduN was tagged. The addition of mCherry to the C-terminus had 
little effect, with the average length increasing to 2.50 µm (n=242). However Student ?Ɛd-Testing 
revealed that this was a statistically significant difference (p=0.0004). The range of filament lengths 
was also less spread out, ranging from 0.5 µm to 9µm. The addition of an mCherry tag to the N-
terminus of PduN resulted in PduV-Cerulean-associated filaments being much shorter. The average 
filament length was reduced to 1.02 µm (n=99), ǁŚŝĐŚ ^ƚƵĚĞŶƚ ?Ɛ d-Testing revealed to be a 
statistically significant finding (p=8.65 x10-53), while filament lengths ranged from 0.3 µm to 2.9 µm.  
 
A summary of all average filament lengths, Standard Errors of Mean (SEMs) and filament length 
ranges is shown in Figure 4.15(B). The finding that the addition of a fluorophore to the Pdu shell 
proteins could affect the length of PduV, and that this effect could differ based on whther the 
flurophore was at the N or C terminus of the shell protein was of interest as it suggested that there 
could be as yet unidentified regulatory mechanisms in the formation of PduV filaments. The 
fluorescent tagging could potentially either be directly affecting the interaction of the tagged shell 
protein with PduV, or perhaps the effect it is having on the structure/formation of the BMC shells 
is in turn affecting the regulation of PduV filement length.       




























Figure 4.15. The effect of tagging shell proteins of the Pdu MCP on the length of PduV associated 
filaments in the cell. A) Histograms showing the range in length of PduV-Cerulean-associated filaments 
in cells expressing mCherry-PduA, PduA-mCherry, mCherry-PduJ, mCherry-PduN and PduN-mCherry. 
Line of best fit was plotted using a LogNormal plot. B) Table showing the average filament length (with 
Standard Error of Mean (SEM)), and the range of filament lengths when each mCherry tagged variant is 
expressed in the Pdu shell. 
 
4.2.10. Analysis of PduV with as, aBj, abjk, abjkn, abjknu, microscopy 
results  
Previous studies have shown that the presence of PduV associated filaments within E. coli is 
dependent upon the expression of empty Pdu BMC shells (Parsons et al. 2010). However, it is not 
known whether it is the presence of the whole shell, or certain shell proteins which are required. 
To explore this a series of experiments were carried out using constructs expressing different shell 
proteins to determine which were necessary for filament formation. PduV-Cerulean was co-
expressed in cells expressing PduAB, PduABJ, PduABJK, PduABJKN and PduABJKNU. Strains were 
grown in 5 mL starter cultures overnight from several colonies on an agar plate, as outlined in 
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Section 2.2.2.2. The starter culture was then used to inoculate 25 mL of LB media and the resulting 
cultures were grown at 37°C until an OD600 of between 0.4 and 0.6 was reached.  Cells (1 mL) were 
then harvested and prepared for live cell imaging with agar pads, as outlined in Section 2.5.1.  
 
As expected, when expressed in the presence of PduABJKNU (the previously described empty shell) 
PduV-associated filaments were observed and PduV was distributed to Foci throught the cell, as 
shown in Figure 4.16. When expressed in the presence of PduAB and PduABJ, no filaments were 
observed and PduV was shown to be cytoplasmic and often accumulating to one intense Foci. 
Interestingly when PduABJK was expressed filaments were observed, which are highlighted by 
white arrows in Figure 4.16. This suggested that it was perhaps PduK that was required for PduV to 
either associate with pre-existing filaments, or to polymerise to form filaments. It was expected 
that filaments would also be observed in the presence of PduABJKN, however surprisingly no 
filaments were observed w0ith PduV accumulating into large, intense foci, again shown in Figure 










Figure 4.16. Investigating which Pdu shell proteins are required for the presence of PduV-associated 
filaments. L21(DE3) pET3a-pduV-cerulean pLysS-pduAB, BL21(DE3) pET3a-pduV-cerulean pLysS-pduABJ, 
BL21(DE3) pLysS-pduV-cerulean pET3a-pduABJK, BL21(DE3) pLysS-pduV-cerulean pET3a-pduABJKN and  
BL21(DE3) pLysS-pduV-cerulean pET3a-pduABJKNU, were analysed by live cell imaging. White arrows 
highlight the presence of PudV filaments. ^ĐĂůĞďĂƌƌĞƉƌĞƐĞŶƚƐ ?ʅŵ ?
 
4.3. Summary 
It became clear from the characterisation of PduK that fusions of YFP to either the N- or C- terminus 
of the protein prevented the protein from participating in the correct folding of the BMC. Although 
the fusion of mCherry to the N-terminus of PduA allowed for its correct incorporation into a folded 
BMC, it seemed prudent to investigate whether any of the remaining shell proteins could be tagged 
with a fluorescent protein. In this respect it was decided to investigate the effect of fusing mCherry 
to either the N- or C- terminus of PduB, J, N and U. In terms of being able to use super-resolution 
approaches to investigate the structure of BMCs it is important to know which shell proteins can 
be modified. 
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To address this problem required a significant amount of recombinant DNA technology. Firstly each 
of the genes for the various shell proteins had to be engineered such that the gene encoded for an 
mCherry fusion at either the N- terminus or C-terminus. These engineered shell protein constructs 
then had to be cloned into a plasmid containing genes for the other shell proteins. Moreover the 
genes for the shell proteins had to be cloned in the order of pduABJKNU. Only after this had been 
accomplished would it be possible to look at the effect of the fusions upon BMC formation. 
 
The cloning allowed unexpected and frustrating observations to be made. Uppermost among these 
was that differences could be seen when the genes were incorporated into either a pET3a or pLysS 
vector (Figure 4.2). Normally pET3a is the main vector that would be used for expression studies. 
In contrast pLysS has been used as a compatible plasmid to allow for the use of two plasmids in E. 
coli. The vector was developed so as to allow the production of lysozyme, which acts as a natural 
repressor of the T7 polymerase. However what was observed in the studies reported herein was 
that more successful production of BMCs was observed either when the BMC shell genes were 
cloned into pLysS, or it was co-transformed with the genes on a pET3a plasmid (Figure 4.4 and 4.5). 
A study of the protein profile of strains containing either pET3A or pLysS variants showed that 
protein synthesis was successful in both cases, but BMC formation was more favoured in the 
presence of pLysS. It may be that lysozyme helps to reduce the activity of the T7 promoter, reducing 
stress within the E. coli cell and allowing more successful folding of the BMCs. This could also explain 
why more fluorophore is observed with pLysS, as the reduced cell stress response allows for more 
correct folding of the fluorophore. However it is interesting to note how difficult it is to get 
standardisation of expression within the E. coli system. 
 
The construction of the various shell protein-mCherry fusions eventually allowed for a full 
characterisation of the various strains harbouring the relevant constructs. What was most 
interesting to observe was that really only the mCherry-PduA and mCherry-PduU constructs 
allowed proper BMC formation (Figure 4.11). All other combinations resulted in formation of 
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aberrant structures. This highlights how fortunate it was that the mCherry-PduA worked, as this 
was the first such fusion to be made. However it also highlights that the attachment of the 
comparatively bulky mCherry to the shell proteins generally results in mal-formation of the 
compartment, presumably through either improper folding or through steric hindrance in the 
 “ƚŝůŝŶŐ ?ƚŚĂƚƚĂŬĞƐƉůĂĐĞƚŽŵĂŬĞƚŚĞƐŚĞůů ? 
 
The most interesting observations of the effects of the mCherry-fusions on BMC formation came 
from the images of the isolated BMC fractions (Figure 4.11). In fact, it proved technically challenging 
to isolate the BMCs, but the purification was made slightly eaiser due to the colour associated with 
the presence of the mCherry. The procedure for the isolation of the BMCs had to be modified as 
each construct led to the BMCs separating into slightly different fractions. Nonetheless it was 
possible to gain very clear images of fully intact BMCs, BMCs that had not quite closed, BMCS in 
various stages of folding and some large filaments (Figure 4.11). 
 
From these experiments we can start to make some generalisations concerning the shell proteins. 
For PduA, the C-terminal region is more sensitive to modification than the N-terminus. It would 
seem likely that the C-terminal region plays a role in the shell protein-shell protein interaction. PduB 
cannot be modified at all, suggesting that it plays a major role within the facet of the overall 
structure. dŚŝƐŝƐĐŽŶƐŝƐƚĞŶƚǁŝƚŚƉƌĞǀŝŽƐĨŝŶĚŝŶŐƐƚŚĂƚŚŝŐŚůŝŐŚƚĞĚƚŚĞŝŵƉŽƌƚĂŶĐĞŽĨWĚƵĂŶĚ ?ŝŶ
the formation of the BMC shell (Cheng et al. 2011). PduJ plays a role in preventing longer filaments 
forming, filaments that can form with PduA alone. It seems likely that PduJ is required to help in 
protein sheet formation, preventing the formation of PduA and possibly PduB into long filaments. 
PduN plays a key role in closing the BMC by providing the vertices for the structure. The spectacular 
image of long drawn out BMCs with the PduN-mCherry only go on to confirm this role (Figure 4.11). 
The effect of fusions on PduU are less obvious, especially as BMCs can form in the absence of PduU.  
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As well as the effects on the shape and formation of BMCs of tagging shell proteins, potential new 
regulatory mechanisms for shell proteins in the formation and length of PduV filaements were 
observed. Of particular interest was the finding that the tagging of PduU at either its N or C-
terminus, or the absence of PduU from the operon resulted in the abolition of PduV filaments. 
Having been previously been shown to be non-essential in the formation of empty BMC shells 
(Parsons et al. 2010) this finding gives provides insight as to why PduU exists and the role it plays in 
the overall Pdu metabolome. 
  











Chapter 5: The Characterisation of PduV  
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5.1. Introduction 
Within eukaryotic cells there is a cytoskeleton of filamentous structures which play key roles in a 
diverse variety of cellular processes including maintenance of cell structure, intracellular transport 
of cargoes, endocytosis and chromosome segregation. This network is predominantly made up by 
the filaments of two proteins, actin and tubulin. Actin and tubulin filaments are formed by the 
polymerisation of globular actin or tubulin monomers to form the filament (Wegner 
1976)(Summers & Kirschner 1979). A key characteristic of this process is the hydrolysis of the 
nucleotides ATP and GTP in the case of actin and tubulin respectively (Carlsson et al. 1977; 
Weisenberg, Deery & Dickinson 1976). More recently,  homologues of both actin (MreB) and tubulin 
(FtsZ) have been identified within bacteria, with the hydrolysis of nucleotides again being required 
for their polymerisation to form filamentous structures (Bork, Sander & Valencia 1992; Erickson 
1995; de Boer, Crossley & Rothfield 1992). 
 
As has previously been shown, the BMC associated protein PduV is observed in linear, filamentous 
like structures within E. coli when co-expressed with the empty Pdu shell (Parsons et al. 2010). 
Currently it is not known whether PduV is able to polymerise to form filaments, or if it is attaching 
to existing filamentous structures within the cell. Interestingly sequence analysis of PduV has shown 
similarities with members of the Ras-like GTPase family of proteins, and preliminary experiments 
using purified PduV have suggested it may have a weak GTPase activity (Parsons et al. 2010). The 
fact that PduV is both observed in filamentous like structures, and is predicted to have a weak 
GTPase activity, suggests that it may also be a component of the bacterial cytoskeleton, in the same 
manner as MreB and FtsZ. 
 
This investigation aims to further characterise PduV, its ability to exist in filamentous like structures 
and to determine if this is dependent upon its predicted GTPase activity. To do this, the process for 
purifying recombinant PduV from E. coli was optimised by co-expression with the empty Pdu shell, 
and the ability for PduV to polymerise into filaments in vitro was examined by fluorescence 
181 | P a g e  
 
microscopy. In addition, through the use of sequence alignments with other known GTPase 
proteins, several amino acids residues believed to be involved in the binding and hydrolysis of GTP 
were mutated by site directed mutagenesis. These mutants were then examined by fluorescence 
microscopy to investigate their ability to form filaments in vivo and attempts were made at 
measuring the GTPase activity of PduV and these mutants. Finally, in order to understand further 
WĚƵs ?Ɛ ĞǆŝƐƚĞŶĐĞ ŝŶ ĨŝůĂŵĞŶƚŽƵƐ ƐƚƌƵĐƚƵƌĞƐ ? ƚŚŝŶ ƐĞĐƚŝŽŶƐ ŽĨ ĐĞůůƐ ĞǆƉƌĞƐƐŝŶŐ WĚƵs ĂŶĚ ĞŵƉƚǇ
microcompartments were examined by transmission electron microscopy.  
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5.2. Results 
5.2.1. Purification of Recombinant PduV 
An N-terminally His-tagged version of PduV was purified by affinity chromatography using a nickel 
column. This purified PduV could then be used to determine if filaments could be seen in vitro. In 
addition, as PduV is thought to be related to the small GTPase superfamily of proteins, activity 
assays could be carried out with purified protein to measure any potential GTPase activity 
associated with PduV.  
 
Initially, a BL21(DE3) strain containing pET14b-pduV was grown overnight in a starter culture. 1L of 
LB media with chloramphenicol was inoculated with 1 mL of starter culture as outlined in section 
2.2.2.2. The culture was then grown at 37°C on a shaking platform until an OD600 of 0.8 was 
reached .Protein expression was induced with IPTG and the growth temperature was dropped to 
19°C. The cells were cultured overnight and harvested as described in Section 2.2.5. The cells were 
resuspended in binding buffer and sonicated, Section 2.2.6.1 and the sonicated lysate was 
centrifuged and the supernatant was applied to the nickel column, as described in Section 2.2.7.  
 
The protein however was very difficult to purify due to the formation of precipitates during the 
purification process. When the supernatant was loaded into the top of the nickel column, or shortly 
after elution, the protein would either form precipitates or crash out of solution entirely. This 
indicated that PduV is largely insoluble outside of the cellular environment. After the purification 
was repeated in excess of 5 times with little success, it was decided that a strain expressing PduV-
GFP would be cultured and the tagged protein purified. This was done to see if the addition of GFP 
could improve the solubility of the PduV, in a similar manner to Maltose Binding Protein and other 
tags, while also allowing the visualisation of any filamentous structures in the purified fraction by 
live cell imaging. 
 
BL21(DE3) cells with pET23b-pduV-GFP were cultured and purified using the same method as 
previously described. Expression of the protein fusion caused the cells to become green. When the 
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green lysate was loaded onto the column, the location of PduV on the column could easily be seen, 
meaning that the majority of the protein eluted from the column could be collected in one fraction, 
leading to a higher yield of protein. In addition, the PduV-GFP fusion protein was easier to purify as 
the formation of precipitates did not occur with any of the purification repeats. This suggests that 
the addition of GFP is beneficial in increasing the solubility of PduV under the conditions used for 
the purification.  
 
5.2.1.1. Optimisation of PduV Purification  
There were 2 main aims for the use of purified PduV. The first was to determine if filaments that 
had been previously seen through live cell imaging, could be visualised outside of the cellular 
environment. In addition purified PduV-GFP could also be applied to GTPase assays to establish if 
PduV has the ability to bind and hydrolyse GTP.  
 
It had already been shown that the addition of a GFP tag to PduV improved the solubility of the 
protein. The purification method was further optimised for these experiments by co-expressing 
mCherry-PduA-BJKNU with PduV-GFP using the following strain: BL21(DE3) pLysS-mCherry-pduA-
BJKNU pET23b-pduV-GFP. This was necessary as PduV has only been visualised in a filamentous 
structure in the presence of Pdu BMCs, either from expression of the whole pdu operon, or by 
expression of recombinant pdu-encoded shell proteins containing the minimum set required for 
empty BMC formation (Parsons et al. 2010). Therefore by co-purifying PduV-GFP with the Pdu BMC 
shell it was more likely that filaments would be observed in vitro. 
 
This strain was cultured and purified in an identical manner to the PduV-GFP purification protocol 
described above in Section 5.2.1. Samples were collected throughout the purification process and 
subjected to SDS PAGE analysis as shown in Figure 5.1 below, with PduV-GFP observed at 47 KDa. 
A large band can be seen in lane 6 of Figure 5.1 indicating that the final elution was relatively pure. 
However no distinguishable bands corresponding to shell proteins could be seen in the final elution.  
 












Figure 5.1. Optimising the expression of PduV. 5-20% SDS-PAGE gel showing the purification of PduV-
GFP expressed in BL21-DE3 cells. Lane 1 shows the cell lysate after sonication, lane 2 the flow through 
after loading of the lysate onto the column, lane 3 the flow through after washing the column with 
binding buffer, lane 4 the flow through after washing the column with wash buffer 1, lane 5 the flow 
through after washing the column with wash buffer 2 and lane 6 the final elution of purified PduV-GFP 
from the column. 
 
During the purification of PduV-GFP, in the presence of mCherry-PduA-BJKNU, it was noticed that 
a large amount of the fluorescent green colouration of the lysate was flowing through the column 
and into the initial flow-though. This was unusual as the column did not appear saturated with 
protein and did not occur when PduV-GFP was expressed and purified alone. To investigate why 
PduV-GFP was flowing through the column a sample of this fraction was quickly applied to a 
microscope slide and imaged by fluorescent microscopy, Figure 5.2.  
 
Fluorescence imaging revealed that the initial column flow through contained linear structures 
consisting of PduV-GFP when co-expressed with mCherry-PduA-BJKNU, as can be seen in images B 
and C from Figure 5.2.  The transmitted light image, shown in panel A, indicated that there was no 
contaminating material (dust, dirt etc.) on the slide that PduV-GFP could have adhered to, to cause 
the presence of linear structures. 
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The presence of filaments was observed in the flow-through fraction during a subsequent repetition 
of the purification of PduV-GFP in the presence of BMCs. In addition the flow through from each 
subsequent stage in the purification process was collected and imaged, however a filament-like 
arrangement of PduV-GFP was only seen in the initial flow-through after the cell lysate was loaded 
onto the column (data not shown). This would suggest that the filaments would also be present in 
the crude lysate, however when examined prior to application to the nickel column no filaments 
were observed. 
 
5.2.2. Investigating the ability of PduV to Form Filaments in vitro 
The filamentous structures observed in the flow-through during PduV-GFP purification gave some 
indication that PduV-GFP filaments may either be able to exist outside of the cellular environment, 
or even polymerise in vitro. However the conditions necessary for filamentous structures to occur 
in vitro are completely unknown. The fact that these structures were only seen in the initial flow 
through and not in subsequent washes of the column would indicate that either BMC shells were 
not present in high enough concentrations further along in the purification, or that PduV needs to 
be present in a certain concentration for filament formations to occur. It may also indicate that if 
PduV-GFP attaches to pre-formed filaments in the cell rather than self-assemble, the existing 
structures did not bind to the column when the cell lysate was loaded and therefore passed into 
the first flow-through. Therefore subsequent fractions did not contain cellular filaments for PduV-
GFP to bind to so none were visualised by fluorescence microscopy.  
 
Nevertheless it was clear that PduV-GFP filaments could be observed in vitro in specific conditions. 
To determine these conditions, a flow cell was created as described in Section 2.5.1.2. A flow cell 
allows PduV-GFP to be visualised by microscopy while solutions are pipetted onto the microscope 
slide. The effect can then be seen in real-time. The flow cell was used to add MgCl2 to the sample, 
in order to see if the addition of Magnesium, which is needed for nucleotide hydrolysis had any 
effect.  Interestingly, the addition of 1 µl of 1M MgCl2 caused the individual foci of PduV-GFP to 
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clump together into larger, non-linear aggregates. In this case, PduV-GFP was also co-purified with 
mCherry-Pdu-A-BJKNU and some mCherry foci were also present on the microscope slide. However 
due to the addition of extra liquid to the slide, it was very difficult to capture an image or timelapse 
of the protein clumping, therefore this could not be recorded. The addition of GTP was also 
considered, however as filaments had previously be observed in the sample containing only PduV-
GFP it was believed there would be enough GTP within the cell extract to facilitate any filament 
formation. It would have been interesting however if time had permitted to repeat the experiment 
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Figure 5.2. In vitro polymerisation of PduV-GFP. A sample of the initial flow through from loading cell 
lysate onto the column showing what appears to be filamentous structures of PduV-GFP. A) Phase 
contrast image image showing the absence of any filamentous structures observable by light 
microscopy, B) GFP signal showing filament like structures of PduV-GFP (white arrows) C) GFP and 
mCherry composite. The PduV-GFP and mCherry tagged BMC shell proteins did not appear ot interact, 
however the presence of BMC shells required for PduV filament formation in vivo in the flow through 
was confirmed. ^ĐĂůĞĂƌ P ?ʅŵ. 
 
5.2.2.1. Exploring PduV Polymerisation by Sedimentation Assays  
In order to explore the conditions required for PduV-associated filaments to be visualised in vitro, 
a series of sedimentation assays were carried out. It has long been known that ultracentrifugation 
at 100,000 rpm results in filamentous proteins being found in the pellet, and this strategy has 
recently been used to good effect in the case of the bacterial cytoskeletal protein MreB (Defeu 
Soufo et al. 2015). In these assays a constant amount of PduV-GFP was incubated with either 
mCherry-tagged BMCs which had been purified by the Yper method and subsequently added to the 
assay along with GTP, MgCl2 or a combination of these components. After incubation, the solutions 
were spun using an ultracentrifuge for 20 mins at 4 °C, 100,000 rpm. Samples of the supernatant 
and pellet fractions were then analysed by SDS PAGE; any PduV-GFP observed in the pelleted 
fraction would indicate that the protein had aggregated, possibly indicating the ability to assemble 
into filamentous structures. The incubation conditions and subsequent SDS Page analysis are shown 
in Figure 5.3.  
 
Comparison of pellets and supernatants for each sample are shown in Figure 5.3. For the first two 
samples, the band for PduV-GFP is stronger in the supernatant than the pellet, indicating that the 
majority of the protein remained soluble and unaggregated in these conditions. This included the 
control sample with PduV-GFP in 20 mM Tris-HCl as well as with the addition of GTP in excess. When 
MgCl2 was added, without Pdu BMC shells present, sample 3, PduV-GFP can be seen predominately 
in the pellet. This supports the previous observation that MgCl2 promoted the aggregation of PduV. 
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Equal amounts of PduV-GFP can be seen in the pellet and supernatant of sample 4, containing PduV-
GFP and Pdu BMC shells. This suggests that the addition of BMC shell protein to PduV-GFP also 
promotes aggregation, but to a lesser degree than the addition of MgCl2. When MgCl2 and GTP 
were added to PduV-GFP, the predominant band in the pellet corresponded to that of PduV-GFP, 
however there was still PduV-GFP in the supernatant, sample 5. There was an increase in PduV-GFP 
in the pellet compared to the supernatant in sample 6, containing BMC shells as well as MgCl2 and 
in 7 and 8, containing BMCs in both with either GTP or GTP and MgCl2 respectively, PduV-GFP was 
seen in both the pellet and supernatants in similar quantities.  
Data therefore indicated that the presence of BMCs and MgCl2 were likely to promote the 









Figure 5.3. Exploring the conditions required for PduV to polymerise into filaments in vitro. A) and B) 
show 15% SDS-Page gels from sedimentation assays. Both the pellet and supernatant for each of the 8 
assays were run on the gel. C) shows the condition for each of the 8 assays carried out. 
 
5.2.2.2. Mutagenesis of Suspected GTPase Residues Within PduV 
In order to further investigate the potential role of GTP in PduV polymerisation to form self-
assembling filaments, or the role of GTP in facilitating attachment to pre-existing filaments in the 
A B 
C 
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cell, several mutations of the predicted GTP binding site of PduV were engineered. The aim of these 
mutants was to prevent nucleotide hydrolysis by the prevention of nucleotide binding.  
 
Initially, the amino acid sequence of PduV was aligned with that of other small GTPases found in 
bacteria such as EutP and ERA. This alignment revealed several residues that were conserved in all 
of these proteins, as shown in Figure 6.4. Further investigation using an NCBI conserved domain 
search revealed the presence of a P-loop, or Walker A motif, namely GxxxxGK(S/T).  This is a 










Figure 5.4. Identifying potential residues in PduV involved in GTP hydrolysis. Sequence alignment of PduV 
with two known small GTPases, EutP and ERA. Residues 8, 13, 14 and 43 identified as possible residues 
involved are highlighted. 
 
The positions of these residues in PduV are: Glycine 8, Glycine 13 and Lysine 14. Threonine 43 was 
also thought to be involved in the GTPase activity of PduV, where it may be responsible for the 
release of GDP after GTP hydrolysis. Therefore these residues were subjected to overlap extension 
mutagenesis, involving the site-directed mutagenesis of each of these amino acids to Alanine.  
 
Overlap extension mutagenesis involved the design of forward and reverse primers, listed in Table 
2.3, for each mutation that included the individual base changes to cause the amino acid to change 
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from the original to alanine. Two PCR reactions were set up for each mutant, the first with the 
engineered forward primer and a T7 terminator primer and the second reaction with a PduV 
forward primer and the designed reverse primer. After running the PCR products on a 1% agarose 
gel to remove excess base pairs and check the band sizes, the gel extracted PCR products from the 
two reactions were combined using a PduV forward primer and T7 reverse primer. This is described 
in more detail in Section 2.3.1.2.   
 
The final PCR product of each PduV variant was subcloned into a pET3a vector using restriction sites 
NdeI and SpeI. The pduV gene was then sequenced and subsequently subcloned to allow the 
encoded protein to be produced with a C-terminal Cerulean fluorescent protein. This was achieved 
by the digest of pET3a-pduV-Cerulean with NdeI and SpeI, replacing wild-type pduV with the 
mutant.   
 
The ability of these PduV mutants to form filaments in vivo was then investigated by fluorescence 
microscopy. Cells expressing pLysS-mCherry-pduA-BJKNU and pET3a-pduV-Cerulean, including the 
four PduV mutants were each cultured in 25 mL of LB media with antibiotics at 37 °C until an OD600 
of 0.6 was reached. The cells were then prepared for live cell imaging as described in Section 2.5.1. 
The images obtained are shown in Figure 5.5 below.  
 
Figure 5.5 shows that only cells co-expressing mCherry-tagged BMC shells with wild-type PduV-
Cerulean exhibited PduV filaments. The mCherry signal looked fairly similar in all of the strains, with 
the presence of many small, evenly distributed foci throughout the cell cytoplasm. In all of the 
mutant strains, PduV-Cerulean formed large foci located within the cytoplasm but also occasionally 
at the cell poles. It is clear that the mutation of each of the residues thought to be involved in GTP 
binding prevented either the formation of self-assembling filaments, or the attachment of PduV to 
pre-existing ones. However, the wild-type PduV-Cerulean strain, grown at the same time and in the 
same conditions as the mutants contained many elongated linear structures. This experiment was 
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repeated three times in the same growth conditions but on different days, and yielded the same 
results. 
 
Interestingly, the absence of filaments did not seem to affect the distribution of mCherry foci within 
the cytoplasm, and foci of PduV-Cerulean was still seen to colocalise, observed by an overlap with 
signal for the mCherry-PduA-BJKNU shells resulting in white foci. This indicated that the potential 
inability for PduV to bind GTP had no effect on the ability of PduV to colocalise and interact with 
the Pdu BMC shell. Alternatively, the mutations may have affected the stability of the PduV protein, 
which whilst not affecting its distribution or colocalisation with BMC shells may have meant it was 
unable to from stable filaments. Attempts were made to measure the GTPase activity of wild-type 
PduV and these mutants to try and determine if the observatons were a result of diminished GTPase 
activity of PduV, however these preliminary GTPase activities were unsuccessful. 
  
















































































Figure 5.5. Effect of mutating residues 8, 13, 14 and 43 on the ability of PduV to form filaments. Live cell 
images acquired show the Phase, mCherry, Cerulean and Composite signals. The E. coli strains visualised 
include mCherry-PduABJKNU co-expressed with A) PduV-Cerulean, B) PduV(G8A)-Cerulean C) 
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mutated form of PduV abolished the formation of filament structures, PduV did appear to colocalise 
with BMC shells. This can be seen by the presence of white foci, highlighted by white arrows. Scale Bar: 
 ?ʅŵ 
 
5.2.2. Exploring the Presence of PduV Filaments by TEM 
To characterise the structure of PduV filaments by electron microscopy (EM), TEM thin sectioning 
of cells co-expressing mCherry-PduA-BJKNU and PduV-Cerulean was investigated.  TEM images of 
this strain were compared to a strain grown on the same day, in the same conditions but only 
expressing the mCherry-tagged Pdu BMC shells. This was to determine if filaments were present 
and if they were likely to be due to PduV-Cerulean expression, or due to the overexpression of some 
shell proteins, such as PduA and PduJ, which are associated with filament-like structures.  
 
5.2.1.1. Thin Section Analysis of Cells Expressing PduV 
BL21 (DE3) cells co-expressing pET23b-PduV-GFP and pLysS-mCherry-pduA-BJKNU were cultured 
from a fresh transformation of BL21(DE3) competent cells with pLysS-mCherry-pdu-ABJKNU and 
pET3a-pduV-cerulean. Several colonies from the transformation plate were used to inoculate a 5 
mL starter culture, which was in turn grown at 37 °C overnight. 50 mL of LB was then inoculated 
with 500 µl of starter culture and grown at 37 °C in a shaking incubator, as outlined in Section 
2.2.2.2. Cells were grown to an OD600 of ~0.6 and harvested for TEM as outlined in Section 2.5.2.1.  
 
Thin section images are shown in Figure 6.6. Images A and B demonstrate linear structures that 
were not observed in a control strain that only contained mCherry-tagged BMCs. These filamentous 
structures ranged from 45 nm to 52 nm in width when measured using imageJ (n=25). The filaments 
appeared to rarely be associated with BMCs and although they appeared to localise very near to 
BMC shells, the filaments were not seen to overlap or attach with the fully-formed BMC shells.  
These data provide evidence that firstly, TEM can be used to clearly visualise linear structures within 
the cell. It also shows that filaments are present when PduV-Cerulean is co-expressed with 
mCherry-tagged BMC shells but not when mCherry-tagged BMC shells are expressed alone. 
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However overexpression of PduA or PduJ has been associated with long, linear structures present 
in the cell cytoplasm. As it is not certain if the filaments visualised by TEM were a result of the 
expression of PduV, immuno-gold labelling of PduV-GFP filaments was carried out to determine the 
localisation of PduV in the cell, using anti-GFP.   
Figure 5.6. Investigating the presence of filamentous structures in cells. TEM analysis of whole cell thin 
sections and thin sections. A) and B) both show cells expressing PduV-GFP and mCherry-PduA-BJKNU, white 
arrows highlight filaments and black arrows highlight BMCs. 
 
5.2.2.2. Immuno-gold TEM of Cells Expressing PduV 
Cells co-expressing PduV-GFP and mCherry-PduA-BJKNU were grown and harvested as outlined in 
section 5.2.2.1. Cells were then prepared for immuno-gold labelling as described in Section 2.5.3, 
whereby 15 nm gold particles conjugated to secondary antibody were used to specifically target 
anti-GFP and therefore label the localisation of PduV-GFP in the cell.  Several controls were used in 
this experiment, including a negative control lacking primary antibody and a negative control using 
a strain expressing BMCs alone. This was to ensure that there was no unspecific binding. Results 
showed that in these negative controls, the vast majority of cells did not have any gold particles; 
cells that did contain gold particles had between 1 and 4, indicating that we can be confident any 
gold particles seen when PduV-GFP was expressed was due to specific binding.  
197 | P a g e  
 
Figure 5.7 shows the results of immuno-gold labelling. Filaments were clearly visible, but due to the 
differed method of counterstaining compared with conventional microscopy, Pdu BMC shells were 
not as clearly visible. Gold particles can mostly be seen to associate with inclusion-like areas of the 
cytoplasm that have a high electron density. Some particles have localised to the outer edge of the 
filament structures, but only within the electron dense regions. The filaments appear to originate 
or protrude from these electron dense regions. However there was no clear pattern of gold particle 
distribution along these linear structures. Therefore evidence that the observed filaments are 
associated with PduV could not be convincingly provided by this immuno-gold labelling technique. 
However, the absence of filaments when PduV was not expressed would suggest that PduV had 
some involvement in the presence of the filaments, and may even suggest that the filaments were 
a result of PduV polymerisation rather than attachment to pre-existing filaments in the cell.  
Figure 5.7. Investigating the presence of PduV-GFP in filamentous structures. TEM thin sections of whole 
cells prepared for immuno-gold labelling using 15 nm gold particles conjugated to an anti-Rabbit 
secondary antibody. The primary antibody used was anti-GFP. A) and B) both show cells expressing 




bacterial cell, and what the importance of its polymerisation into filament like structures was in this 
process. In order to investigate this both biochemical assays and microscopic techniques were 
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utilised. The starting point for these biochemical assays was to optimise the purification of PduV, 
to produce a high yield of pure, soluble PduV. Initial attempts to purify a His-tagged PduV using a 
nickel column were unsuccessful, with PduV forming precipitates, or becoming completely 
insoluble, indicating a high level of instability outside of the bacterial cell. In order to try and prevent 
this, a variant of PduV with a C-terminal GFP tag was expressed, which proved much more stable, 
with high yields of protein purified.  
 
There were 2 main aims for this purified PduV, a) to see if it was possible to observe filamentous 
structure seen within the cell in an in vitro environment, and b) to examine the GTPase activity of 
PduV by GTP hydrolysis assays. Previous studies have shown that the presence of filamentous PduV 
structures within the cell are dependant on the presence of empty Pdu BMC shells, therefore, it 
was assumed that the same would apply in an in vitro environment. In order to explore this, PduV-
GFP was co-purifed with PduABJKNU. During this purification it was noted that a large amount of 
PduV-GFP was not binding to the column, an observation not seen when PduV-GFP was purified 
alone. A sample of the unbound protein was examined by fluorescence microscopy, which revealed 
the presence of linear structures, similar to PduV filaments observed within the cell. This 
phenomenon was also observed in subsequent purifications. Each subsequent fraction during the 
purification process was also examined, however filamentous structures were only observed in the 
initial column flow-through. Whilst this provided the first signs that filamentous PduV structures 
could be formed in vitro the conditions required for this formation were not clear due to the fact 
that they were only observed in the initial flow-through from the column. Possible explanations for 
this are that empty BMC shells were not present in high enough concentrations in subsequent 
fractions of the purification, that there is a criticial concentration of PduV needed for filament 
formation that was only achieved in the initial flow through, or that there were other unknown 
factors playing a role in this. In order to further examine these conditions needed for filament 
formation in vitro, a series of sedimentation assays were carried out. It has long been known that 
filamentous proteins such as F-Actin can be pelleted by ultracentrifugation at 100,000 RPM. When 
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subjected to ultracentriguation at 100,000 RPM on its own, PduV remained in the supernatant, 
indicating it had not polymerised into filaments. However, when incubated with either empty BMC 
shells, MgCl2 or a combination of both PduV-GFP was found in the pellet, suggesting that the 
presence of BMC shells and MgCl2 caused PduV to aggregate, possibly into filamentous structures. 
The fact that the addition of MgCl2 had such a dramatic effect was of interest, as Magnesium is 
required for nucleotide hydrolysis, which is essential for the polymerisation of other proteins such 
as Actin and Tubulin. This, coupled with the fact that PduV has previously been shown to have 
similarities to other small GTPase proteins, suggested that PduV polymerisation may have been 
dependant on the hydrolysis of GTP.  
 
In order to investigate if GTP hydrolysis was required for the formation of PduV filaments, key 
amino acid residues for GTP hydrolysis within PduV were identified through alignment with other 
known GTPases. These residues were then mutated to Alanine residues and the effect on PduV 
filament formation was investigated in vivo. This was done through the use of fluorescence 
microscopy which revealed that the mutation of these residues abolished the presence of PduV 
filaments within the cell. In order to confirm that this was due to a reduction in GTP hydrolysis, it 
was hoped that the GTPase activity of each of these PduV variants could be measured through the 
use of GTPase assays. Whilst these attempts to quantify the GTPase activity of PduV were 
unsuccessful, fluorescence microscopy results did suggest that the ability of PduV to bind and 
hydrolyse GTP is needed for PduV filament formation.  
 
Overall, the work described in this chapter has revealed evidence that the formation of filamentous 
structures by PduV is dependant on the ability of PduV to bind and hydrolyse GTP, whilst also 
confirming previous findings that it is also dependant on the presence of empty BMC shells. 
Furthermore, it has been shown that it is possible for PduV to form these filamentous structures in 
an in vitro evironment, however the conditions for this formation remain unknown. 
  










Chapter 6: Summary 
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The aim of the research in this thesis was to develop a further understanding of how Pdu bacterial 
microcompartment shells are formed, and how they are spatially arranged within the cell. Previous 
work had suggested that PduK within the Pdu BMC shell interacts with the small-GTPase like protein 
PduV which has been shown to form filament like structures (Parsons et al. 2010).  
 
In order to observe this interaction in vivo a series of fluorescence microscopy experiments were 
planned. In generating the required plasmids it was found that PduK had to be present in the natural 
order of the pdu operon in order for intact BMC shells to form. Whilst it had previously been found 
that not all of the shell proteins are required for proper empty BMC with PduU and PduT being non-
essential, the importance of gene location within the operon had not been obserbed. Subsequently, 
it has been shown that the location of PduJ within the pdu ŽƉĞƌŽŶ ĚĞƚĞƌŵŝŶĞƐ ŝƚ ?Ɛ ĨƵŶĐƚŝŽŶ ?
highlighting the importance of gene position (Chowdhury et al. 2016). It was also shown that 
tagging PduK with fluorescent protein at either the N or C-terminus prevented the correct 
formation of the BMC shell, which came as a surprise due to the fact BMCs have previously been 
visualised by tagging of another shell component, PduA (Parsons et al. 2010). This finding 
ultimiately meant that it was not possible to use a tagged variant of PduK to explore its interaction 
with PduV.  
 
Previous work has shown that there in an unknown C-terminal extension on PduK, though it has 
been speculated to house an Fe-S Center (Crowley et al. 2010). It has been suggested that the C-
terminal region may be associated with binding either internalized proteins or external facing 
proteins (possibly PduV?) or the uptake/control of external substrates. A series of truncations of 
PduK with different lengths of this C-terminal extension removed from the cell were generated and 
incorporated into the Pdu operon.  It was observed that these truncated forms of PduK were not 
able to replace full length PduK, with improperly formed BMC shells generated. TEM analysis 
revealed structures suggesting that the BMC was unable to close properly. This came as a surprise 
as it had been thought that this C-terminal region would not play a role in the formation of the BMC 
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shell, as the N-terminal region of PduK contains a BMC-shell protein domain, thought to be involved 
in forming the structural hexameric tile that forms a key component of the facet of the overall BMC 
shell structure. Subsequently, work in this lab has shown that this C-Terminal extension is not 
required for PduK to interact with the P18 peptide used to target proteins to the interior of the 
BMC shell derived from the N-Terminus of PduP (Lawrence et al. 2014), further indicating that the 
C-teƌŵŝŶĂůĞǆƚĞŶƐŝŽŶ ?ƐƌŽůĞŝƐƚŚĂƚŽĨŵĂŝŶƚĂŝŶŝŶŐƚŚĞƐŚĂƉĞŽĨƚŚĞDƐŚĞůůƚŚĂŶƉůĂǇŝŶŐĂƌŽůĞŝŶ
the internalisation/transport of proteins. Further work is required to fully understand that function 
ŽĨWĚƵ< ?ĂŶĚŝƚ ?ƐŝŶƚĞƌĂĐƚŝŽŶǁŝƚŚŽƚŚĞƌWĚƵƉƌŽƚĞŝŶƐ ?   
 
Having seen that the tagging of PduK with a fluorescent protein at both the N and C-terminus 
prevented the proper formation of BMC shells, it was decided that the effect of tagging other 
proteins in the BMC shell, PduA, PduB, PduJ, PduN and PduU with a fluorescent protein, mCherry 
would be investigated.  
 
During the construction of plasmids needed to undertake this study, it was found that the vector 
used for the expression of BMCs containing these tagged variants of shell proteins had a dramatic 
effect on the expression of these BMC shells. When using pET3a, the main vector that would be 
used for expression studies, the BMC shells were not expressed correctly. However when using, 
pLysS a plasmid not usually used for expression studies, the expression of BMCs was much more 
successful. When examining this finding, it was found that using pET3A or pLysS resulted in 
successful protein synthesis, but BMC formation was more favoured in the presence of pLysS. The 
most reasonable explanation for this was that lysozyme also expressed from the pLysS plasmid, 
reducing T7 promoter activity, reduced stress within the E. coli cell, allowing more successful folding 
of the BMCs.  
 
Once the conditions for successful production of BMC shells containing the tagged Pdu shell 
components were identified, it was possible to look at the effect of tagging these proteins with 
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mCherry. It was found that only the mCherry-PduA and mCherry-PduU constructs allowed proper 
BMC formation. All other combinations resulted in formation of aberrant structures, showing that 
the attachment of the comparatively bulky mCherry to the shell proteins generally results in mal-
formation of the compartment, presumably through either improper folding or through steric 
ŚŝŶĚƌĂŶĐĞŝŶƚŚĞ “ƚŝůŝŶŐ ?ƚŚĂƚ takes place to make the shell. The most interesting observations of 
the effects of the mCherry-fusions on BMC formation came from the images of the isolated BMC 
fractions. Using these observations the following conclusions could be drawn: For PduA, the C-
terminal region is more sensitive to modification than the N-terminus, PduB cannot be modified at 
all, suggesting that it plays a major role within the formation of the overall structure. Tagging of 
PduJ at the N-terminus gave mixed results, with intact BMC shells observed by fluorescence 
microscopy, whilst TEM showed forrmation of long strands of shell proteins. Tagging PduJ at the C-
terminus again resulted in long strands of protein, indicating that tagging PduJ at either end of the 
protein prevents proper formation of BMC shells. The tagging of PduN at the N-terminus resulted 
in the formation of long, tubular BMC shells, whilst tagging at the C-terminus resulted in the 
formation of irregularly shaped BMC shells, providing further evidence for PduN playing a key role 
in closing the BMC by providing the vertices for the structure. The sensitivity of PduB, J and N to 
fluorescent tagging, and more so the impact this has on the formation of the BMC is consistent with 
prevous fidings which have shown that they are essential to proper BMC shell formation . The effect 
of fusions on PduU are less obvious, especially as BMCs can form in the absence of PduU (Parsons 
et al. 2010). 
 
As well as the effect of tagging the Pdu shell proteins had on the formation of the BMC shell, the 
effect on PduV filaments within the cell was also investigated. Whilst it has previously been shown 
that tagging PduA at the N-terminus has no adverse effect on BMC shell formation, and 
subsequently no effect on PduV filaments, the effect of tagging other shell proteins was unknown. 
The tagging of PduA at the C-terminus, as well as PduN at the C-terminus had little effect on PduV 
filament length. Interestingly, tagging of PduN at the N-terminus resulted in much shorter PduV 
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filaments being observed in the cell, an interesting finding given that Pdu shells when expressed 
with this protein form longer elongated shells. Interstingly, the presence of N-terminally tagged 
PduJ resulted in a doubling of PduV filaments, despite the Pdu proteins forming long filamentous 
strands in the cell (an opposite effect to that observed with N-terminally tagged PduN) whilst C-
terminal tagging abolished the presence of filaments completely. Interestingly, the tagging of PduU 
at either the N or C-terminus resulted in the abolishment of PduV filaments, despite intact BMC 
shells forming. This finding was also observed when PduV was expressed with BMC shells lacking 
PduU, indicating that PduU plays a regulatory role in the formation of PduV filaments. It had been 
hoped that the relationship between PduV and these shell proteins could be investigated further 
by looking for interactions using FLIM technqiues, however due to time constraints this was not 
possible. 
 
The final portion of this thesis aimed to further characterise PduV, a member of the Pdu family, 
about which little was known. It had been observed in filamentous structures within the cell, 
however the way in which it formed these filaments, and the role these had in organising BMCs was 
unknown. Once a method had been developed to consistenly purify sufficient quantities of PduV 
attempts were made to replicate its ability to form filaments in vitro. Whilst filament-like structures 
were observed during certain steps of the purification process (namely after initial loading onto the 
Nickel column), the conditions required for this assembly remained unknown. A series of 
sedimentation assays gave further insight into these conditions, showing that PduV would pellet 
after ultracentrifugation when incubated with empty BMCs, MgCl2 or a combination of both. The 
fact that MgCl2 was able to cause this was of particular interest as Magneisum is required for 
nucleotide hydrolysis, and it had previously been speculated that PduV may have GTPase activity.  
 
The finding that incubation with MgCl2 resulted in PduV sedimentation (possibly through the 
formation of filaments) was investigated further by examining the GTPase activity of PduV. Upon 
sequence alignment with other known GTPases key residues within PduV were identified, and were 
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mutated by extension overlap mutagenesis. Fluorescence microscopy studies showed that the 
mutation of these filaments resulted in the abolishment of PduV filaments within the cell, 
suggesting that nucleotide hydrolysis was required for filament formation, similar to other filament 
forming proteins such as Actin and Tubulin. Attempts were made to quantify this activity, however 
attempts using 2 assays proved unsuccessful.  
 
Overall, the work in this thesis has resulted in some interesting findings, posing further questions 
to be answered in order to gain an understanding of Pdu microcompartments. Having shown that 
PduK must be expressed in its natural order poses an interesting question into how the BMC shell 
is assembled, and whether other shell components are also so sensitive to the order in which they 
are expressed. Furthermore, the finding that truncating PduK to remove the uncharacterised C-
terminal region results in aberrant formation of BMC shells is of great interest, as it had previously 
been thought that it was only the N-terminal domain of PduK that played a role in shell formation.  
Further work is needed to understand what role the C-terminal region plays in shell formation, and 
if it does have roles in binding to other internal and external proteins as previously thought. The 
exercise of tagging each shell protein at its N and C-terminus with the fluorescent protein mCherry 
revealed the interesting findings about each as outlined above, as well as revealing a potentially 
regulatory function for PduU in the formation of PduV filaments. In addition the fact that N-
terminally tagging PduN resulted in the formation of long tubular BMC shells, which in turn resulted 
in shorter PduV filaments suggested a spatial regulatory mechanism for PduV filament length. 
Finally, mutagenesis studies provided further evidence for the fact that PduV function is dependant 
upon its ability to hydrolyse nucleotides, and further work should be done to quantify this activity.  
 
In order to further develop the work presented in this thesis there are a number of different 
avenues to continue exploring. First and foremost, further work is required to understand how 
PduV filaments form and whether they do this alone, or through the interaction with other 
filaments such as MReB or FTsZ. This could be done through continuing to investigate the formation 
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of PduV filaments in vitro as well as undertaking fluorescence microscopy experiments with 
fluorescent tagged MReB/FTsZ. More work is also required to quantify the GTPase activity of PduV, 
which may require the optimisation of either the GTPase activity assay or the purification of PduV 
in order to eradicate the presence of other nucleotide hydrolysis proteins such as GroEL. The 
interaction between PduV and the shell proteins also requires further investigation as well as 
potential regulation of PduV filament formation and length. It may be best to do this with a 
combined biochemical and microscopic approach using immunoprecipitation assays and FRET/ 
FLIM FRET in order to provide sound evidence for these interractions. Finally, further work is 
required to understand the mechanism of Pdu shell formation. Having seen that shell formation 
required PduK to be expressed in the correct order within the pdu operon, similar work should be 
carried out to determine if the same is necessary for the other shell proteins. Continuing along work 
with PduK, further work is required to identify why the C terminal region is required for shell 
formation. The first port of call here would be to investigate if the absence of the C-terminal region 
affects the interaction of PduK with other shell proteins, again a combined biochemical and 
microscopic approach may be best for this in order to fully examine these potential losses of 
interaction. 
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